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ABSTRACT 
 
 
 
 Porphyrins and their analogs are a class of chemically and biologically important 
compounds that have found a variety of applications in different fields such as catalysis, 
medicine, and materials. The physical, chemical, and biological dependence of the 
peripheral substituents of porphyrins on their properties has prompted great effort 
towards the synthesis of new porphyrins with different electronic, steric, and 
conformational environments. To this end, porphyrins have been prepared using a 
modular approach from bromo- and triflate synthons. These synthons underwent 
palladium-catalyzed cross-coupling with chiral amines, amides, alcohols, and boronic 
esters to create products that were tested for biological activity. 
 Metalloporphyrins were screened as catalysts for cyclopropanation and C-H 
amination, yielding excellent results. By changing the porphyrin catalysts’ chiral groups, 
all four enantiomers could be produced in the cyclopropanation of styrene derivatives 
with ethyl diazoacetate (or t-butyl diazoacetate). Similarly, a variety of sultams were 
produced from benzenesulfonyl azides in high yields and high enantioselectivities using 
chiral cobalt porphyrins as catalysts. 
 Porphyrins, metalloporphyrins, and the catalytic products generated were tested 
for activity in a variety of medicinal collaborations, namely as therapeutics for 
methicillin-resistant Staphylococcus aureus, Alzheimer’s disease, malaria, viral 
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infections that include influenza and herpes, and cancer, as well as biological studies with 
ferrochelatase. They were also used in materials experiments with two different polymer 
groups.  
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CHAPTER 1:  PORPHYRIN FUNCTIONALIZATION VIA PALLADIUM  
CATALYZED CARBON-HETEROATOM CROSS COUPLING REACTIONS 
 
Introduction 
 
Porphyrins and related tetrapyrrolic macrocycles play essential roles in 
biological systems in such processes as electron transfer, light harvesting, dioxygen 
transport, and substrate transformations.1 The significance of these processes has 
stimulated intense interest in synthesizing novel porphyrin complexes that mimic these 
systems. These porphyrins have important applications in a number of fields, including 
catalysis, 2-13 polymer synthesis,14 materials,15-16 and photodynamic therapy.17-26  
Chiral porphyrins have found a range of useful applications in asymmetric 
catalysis, chiral recognition/sensing, and enzymatic mimicry.10,27-31 Several approaches 
have been described for the syntheses of chiral porphyrins.3,32-33 Historically, the 
preparation of substituted porphyrins has been limited by the acidic and oxidative 
reaction conditions which restrict substituent incorporation on the porphyrin 
macrocycle. These methods are typically associated with low-yields and tedious 
purifications.34 As a result, the development and application of new synthetic strategies 
to overcome these difficulties has been the focus of porphyrin research during the last 
several decades.  
In recent years, considerable progress has been made in the development of 
palladium-catalyzed cross-coupling reactions for the synthesis of chiral porphyrins. 
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Smith and co-workers were the first to apply C–C cross-coupling methodologies to 
haloporphyrins.35 Since their seminal report in 1989, reactions developed by Suzuki, 
Stille, Heck, and Sonogashira have been used to create new carbon–carbon bonds 
using palladium-mediated catalysis.36-64 With these systems, a single porphyrin 
precursor can be converted into a large number of functionalized derivatives.65 The 
generation of suitable precursors has been the key to the success of these reactions, and 
research has shown that bromo- and iodo-porphyrins have played the most important 
roles. 36-37,66-67 
In light of the results obtained from halogenated porphyrins in transition metal-
mediated carbon–carbon bond formation reactions, the application of palladium-
catalyzed carbon-heteroatom bond cross-couplings was a natural extension. Therien 
and co-workers’ 1998 report on C–B bond formation provided the first examples of 
palladium-catalyzed carbon-heteroatom cross-coupling reactions using porphyrins.66 
Since then, a variety of boronic esters, amines, amides, alcohols, thiols, selenols, 
diphenylphosphines, diphenylphosphine oxides, and phosphanes have been coupled to 
many different porphyrin scaffolds, typically in high yields. 
 This chapter provides a detailed overview of important, recent advancements in 
palladium-catalyzed porphyrin carbon-heteroatom bond formation through July of 
2009. The reactions presented in this chapter will be categorized by the type of carbon-
heteroatom bond formed and subcategorized by the position functionalized on the 
porphyrin, including the meso- and β-positions on the porphyrin macrocycle and the 
aryl groups post ring cyclization. In addition, sections highlighting personal 
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contributions are included with the supporting information and spectra from these 
projects at the end of the chapter in order of appearance in the text. 
 
General Mechanistic Overview  
Scheme 1: Carbon‒heteroatom cross-coupling palladium cycle using halogenated 
porphyrins 
[Pd0] Por-X
Nu-H + BaseBase-H+ X-
Por-Nu
Por
X
Por
Nu
oxidative
addition
transmetalation
reductive
elimination
A
BC [PdII][PdII]
Legend:
Por = Porphyrin
X = Halogen
Nu = Nucleophile  
 
The general palladium-catalyzed cross-coupling reaction with porphyrin 
halides consists of a palladium source, ligand(s), an aryl halide, a soft nucleophile, a 
base, and the solvent. As shown in Scheme 1, palladium(0) ligand complex A 
undergoes oxidative addition with the porphyrin halide, increasing both the oxidation 
state and coordination number of the palladium by two to form B. Complex B then 
undergoes transmetalation with a base-activated nucleophile to form complex C. 
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Complex C then undergoes reductive elimination to release the coupled-porphyrin 
product, decreasing both the oxidation state and coordination number by two to 
regenerate the initial palladium(0) species A. 
The typical catalytic cycle begins with a palladium(0) complex undergoing 
oxidative addition. This step, which is typically the rate-determining step, is affected 
by several factors. First, bulky, unsaturated palladium species containing four or less 
phosphine ligands typically react rapidly to initiate the catalytic cycle. Pd(PPh3)4 and 
Pd2(dba)3, are two of the most common palladium sources, followed by the air-stable 
palladium(II) precursors Pd(PPh3)2Cl2, Pd(dppf)Cl2, and Pd(OAc)2, which are readily 
reduced to active palladium(0) complexes through the addition of other phosphine 
ligands. Two additional factors also affect the reaction rate. First, the relative reactivity 
of the aryl halide or pseudo-halide plays an important role. Reactivity follows the 
expected trend of I > OTf > Br » Cl.68 Second, the reaction is typically faster when 
electron-withdrawing groups are employed and the substrate is relatively less sterically 
hindered.  
The mechanism of the transmetalation step is highly dependent on the reaction 
conditions and organometallic substrates involved. Several palladium carbon-
heteroatom cross-coupling mechanisms containing intricate and complex catalytic 
cycles have been reported and reviewed elsewhere.69-73  
Once reductive elimination occurs, the product is released to regenerate the 
initial Pd(0) complex. The elimination of organic substrates occurs from a cis-
orientation and the order of elimination for C–C bond formation is diaryl > aryl/alkyl > 
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dipropyl > diethyl > dimethylpalladium(II). This suggests that π-orbital overlap aids in 
the resulting bond formation, and an increase in steric bulk assists in the dissociation of 
the product.  
The choice of potential reaction solvents is extremely broad, and includes non-
polar, non-coordinating solvents such as toluene and benzene; polar, coordinating 
solvents such as tetrahydrofuran (THF), dimethoxyethane (DME), N,N-
dimethylformamide (DMF), and dimethylsulfoxide (DMSO); and polar, protic solvents 
such as methanol, ethanol, and even water. Solvent mixtures are often used to optimize 
the solubility of the substrates. 
The base may be used either in solution or as a suspension. Common base 
choices include alkali carbonates, alkoxides, hydroxides, and phosphates.  
 
Oxidative Addition of Palladium with Porphyrin Halides 
Haloporphyrins are large electron rich substrates capable of undergoing 
palladium-catalyzed cross-coupling reactions. The electron rich nature of the porphyrin 
ring decreases the reactivity of the oxidative addition step, slowing the rate of the 
reaction. In addition, the steric environment of many porphyrin substrates results in a 
more hindered approach of the nucleophile during the transmetalation step. These 
challenges account for much of the delay in applying palladium-catalyzed cross-
coupling reactions to porphyrin substrates.  
The recent isolation and characterization of several meso-η1-palladio 
intermediates by Arnold and co-workers have provided important details into the 
6 
 
mechanistic aspects of the oxidation addition step of palladium-catalyzed cross-
coupling reactions with porphyrin substrates.74-77 This work, outlined below, provided 
an important framework for the successful preparation of mono-, di-, tri- and tetra-
coupled products, as well as the stepwise formation of dimers, trimers, and complex 
arrays. 
5,15-Diphenylporphyrin H2(DPP) 1, pioneered by Therien for Stille and 
Negishi type couplings,37 was brominated at either one or both of the sterically 
unencumbered meso-positions to form meso-haloporphyrins 2 and 3 (Figure 1). These 
meso-haloporphyrins were then subjected to oxidative addition to form the 
corresponding meso-η1-palladio-species B. Arnold and co-workers were the first to 
isolate and characterize the first peripherally-metalated porphyrins, meso-η1-
palladioporphyrin 4 and 5 (Figure 2).74 
 
N
N N
N N
N N
N
MH H BrH
N
N N
N
M BrBrM
1: M = H2
[Zn(1)]: M = Zn
[Ni(1)]: M = Ni
2: M = H2
[Zn(2)]: M = Zn
[Ni(2)]: M = Ni
3: M = H2
[Zn(3)]: M = Zn
[Ni(3)]: M = Ni  
Figure 1: Structure of 1 diphenylporphyrin (DPP); 2 meso-bromodiphenylporphyrin 
(mono-BrDPP); and 3 meso-dibromodiphenylporphyrin (di-BrDPP).  
 
7 
 
Fe
N
N N
N
M Pd
P
P
Br
N
N N
N
M Pd
P
P
Br
4 5
 
Figure 2: Geometry of σ-bound palladium trans-bis(triphenylphosphine) derivatives 
and the dppf organopalladioporphyrin.  
 
Stoichiometric amounts of both the H2(DPP) and Ni(DPP) mono-
bromoporphyrins (2 and [Ni(2)]), Figure 1) when reacted with Pd(PPh3)4 in near-
boiling toluene led to the rapid (less than 40 minutes), quantitative formation of the 
corresponding meso-η1-palladioporphyrins (Figure 2) in up to 80% yield. Bidentate 
diphosphines, such as 1,2-bis-(diphenylphosphino)ethane (dppe), 1,2-bis-
(diphenylphosphino)propane (dppp), and 1,2-bis-(diphenylphosphino)ferrocene (dppf), 
were also evaluated, and the reactions proceeded in a similar fashion to the 
monophosphines. The more crowded and rigid alkenyl cis-1,2-bis-
(diphenylphosphino)ethylene provided only the reduced (dehalogenated) H2(DPP) 
product 1. 
The concurrent double oxidative addition of the dibromodiphenylporphyrin 
required much longer reaction times and higher palladium/ligand loading. UV-visible 
spectroscopy was used to show that the addition of one electron-donating Pd(PPh3)2Br 
led to a more basic (electron-rich) porphyrin ring, as evidenced by a red shift of UV-
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vis absorption. It was concluded that the enriched electronic character of the porphyrin 
ring significantly decreased the rate of the second oxidative addition step. 
Arnold and co-workers explored palladium complexes of bidentate nitrogen 
donor ligands and chiral bisphosphine ligands for the oxidative addition of mono-
brominated Ni(DPP) ([Ni(2)], Table 1).75,77 Tetramethylethylenediamine (tmeda) and 
2,2'-bipyridine (bipy) were evaluated for their ability to force a cis-configuration of the 
metal center for use in self-assembled supramolecular systems with success. 
 
Table 1: Palladium Oxidative Addition of a meso-Brominated Porphyrin 
N
N N
N
M Pd L
Br
Pd2(dba)3 / L
toluene, 90-105 oC
tmeda
NN
N N
N
N N
N
M Br
tmeda
bipy
P
P
tol-BINAP
P
P
CHIRAPHOS
P
P
diphos
932
[Ni(2)] 57
80
76
2
[Ni(2)]
[Ni(2)]
2
L
6
(R)-tol-BINAP
(R,R)-CHIRAPHOS
(R,R)-diphos
bipy 91
entry por ligand (L) yield (%)
1
3
2
4
5
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They also used diphos, which is chiral at both phosphorus atoms; 
CHIRAPHOS, which has a chiral carbon backbone; and tol-BINAP, which is chiral as 
a result of atropisomerism about the binaphthyl bond. The reactivity decreased in the 
order diphos > CHIRAPHOS > tol-BINAP. It initially appeared that there was a 
substantial steric component; however, evaluation of dppf, a non-chiral bulky 
bisphosphine ligand, was shown to proceed rapidly in direct contrast to the trends 
established with diphos, CHIRAPHOS, and tol-BINAP.  
In an effort to address these observations, 31P-NMR was used to explore the 
influence of decreasing electron density on the palladium coordinated phosphorus atom 
using 31P-NMR. The resulting chemical shifts indicated that decreasing electron 
density led to an increase in activity:  CHIRAPHOS > diphos > dppf > tol-BINAP. 
Although the requisite balance of both of these factors toward efficient oxidative 
addition is indisputable, the relative influences of increased steric bulk versus the 
electron density remain unclear. 
 
Palladium-Catalyzed C-B Coupling 
The palladium-catalyzed syntheses of arylboronic acids have received much 
attention in recent years. These compounds are generally thermally stable and inert to 
atmospheric conditions, making them particularly useful synthetically. For this reason, 
they have become key reagents for transition metal-catalyzed Suzuki-Miyaura cross-
couplings, providing a powerful and general methodology for accessing a broad range 
of carbon–carbon bond formations.78-80  
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 In 1995, Miyaura and co-workers reported the palladium-catalyzed reaction of 
the pinacol ester of diboronic acid with haloarenes to give direct access to arylboronic 
esters.68 Later, Masuda and co-workers described a series of reactions using 
pinacolborane, a hydroborane, as a boron source for palladium-catalyzed cross-
couplings.81 The methodologies developed for preparing these organoboron 
compounds from aryl halides have played an important role in the synthesis of 
borylated porphyrins. The desired borylated porphyrins are typically functionalized via 
Suzuki-Miyaura couplings to produce the corresponding porphyrin analogs.  
Pinacolborane and the pinacol ester of diboronic acid are the most common 
boron sources and have been applied to porphyrin borylation to produce high yields of 
porphyrinyl meso-, beta-, and aryl boronates, including those with base-sensitive 
functional groups. Stronger bases, such as K3PO4 and K2CO3, promote the continued 
palladium-catalyzed reaction of the organoborate with unreacted halogenated 
porphyrin precursors to give the undesired Suzuki-Miyaura dimer product.68 The use of 
weaker bases, such as triethylamine or acetates, minimizes this alternate reaction 
pathway.  
It is worth noting that porphyrins containing borylated aryl groups are generally 
synthesized from borylated aldehydes, rather than through palladium-catalyzed 
borylation after the cyclization of the porphyrin macrocycle. Although this approach 
has contributed to porphyrin functionalization, it will not be discussed herein. 
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Meso-Borylation 
Pinacolborane was used as the transmetalating agent in the palladium-catalyzed 
cross-coupling reaction reported by Masuda and co-workers in 1997 to produce 
arylboronates from a wide range of aryl halide precursors.81 This report inspired 
Therien and co-workers to use pinacolborane to prepare the first examples of meso-
borylated porphyrinyl species where the boronic esters were directly appended to the 
zinc(II) porphyrinato framework (Scheme 2).66  
 
Scheme 2: Therien’s application of Suzuki coupling to porphyrins 
N
N N
N
Ph
B
Ph
Zn
3 mol % Pd(PPh3)2Cl2
10 equiv triethylamine
DCE (0.01M), 90 °C, 45 min
H
B
O O+[Zn(2)]
[Zn(7)]
O
O
N
N N
N
Ph
B
Ph
Zn
H
B
O O+[Zn(3)]
O
O
B
O
O
86% yield
[Zn(8)]
79% yield
12.5 equiv
3 mol % Pd(PPh3)2Cl2
20 equiv triethylamine
DCE (0.01M), 90 °C, 12 h
25 equiv
 
 
The formation of the Zn(II) mono-substituted porphyrin [Zn(7)] was complete 
in 45 minutes as monitored by thin layer chromatography; however, the Zn(II) di-
substituted porphyrin [Zn(8)]required 12 hours for complete conversion. Porphyrins 
[Zn(7)] and [Zn(8)] were then used as transmetalating agents in Suzuki-Miyaura 
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couplings. Therien and coworkers continued efforts in this area focused on 
synthesizing more elaborate donor-bridge-acceptor, porphyrin-spacer-quinone 
complexes for use as electron transfer assemblies.82  
In a separate report, Osuka and co-workers used the methodology employed for 
the synthesis of porphyrin [Zn(7)] to produce mono-boronyl complexes of bis(3,5-
dioctyloxyphenyl)porphyrinatozinc(II) [Zn(9)] and p-dodecyloxyphenyl derivative 
[Zn(10)] (Figure 3). The porphyrylboronate products obtained were subsequently used 
in the synthesis of meso-meso linked hetero-metalated multiporphyrin arrays and 1,4-
phenylene-bridged diporphyrin arrays.49,83 
 
N
N N
N
BZn
O
O
93% yield
N
N N
N
BZn
O
O
O
N
N N
N
BZn
O
O
90% yield
O
R
R
O O
OO
R R
RR
[Zn(9)]: R = -(CH2)7CH3 [Zn(10)]: R = -(CH2)11CH3 [Zn(11)]
 
Figure 3: Synthesis of zinc(II) meso-boronyl-diphenylporphyrin derivatives by Osuka 
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Lindsey and co-workers also used this methodology to synthesize the zinc(II) 
meso-boronyl dimesitylporphyrin ([Zn(11)], Figure 3), which was then meso-coupled 
with 5-(4-iodophenyl)-dipyrrin to form a dipyrrinato-porphyrin.84 The excited-state 
energy transfer of triads composed of two porphyrins bridged with a 
bis(dipyrrinato)metal complex were studied, and it was concluded that the 
bis(dipyrrinato)zinc complexes underwent highly efficient energy transfer. 
In 2003, Diederich and co-workers designed and synthesized dendritic 
metalloporphyrins with hydrogen-bonding capability as mimics of hemoglobin (Hb). 
Low yields were reported when meso-brominated porphyrins were used as the 
electrophile in Suzuki cross-coupling reactions. As a result, they developed an 
alternative synthesis using porphyrinyl boronates as transmetalating agents, and 
compared two different carbon–boron bond forming methodologies. Their results 
showed that Therien and co-worker’s pinacolborane method (Scheme 3a) generated 
greater yields for this porphyrin substrate when compared to Miyaura’s diboronic acid 
method (Scheme 3b).85-86 
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Scheme 3: Diederich’s comparison of pinacolborane and diboronic acid 
methodologies 
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N
BrZn
HB
O
O
OO
O O
CO2EtCO2Et
CO2EtCO2Et
N
N N
N
BZn
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b)
BB
O
O O
O
Pd(dppf)Cl2
KOAc
DMSO, 80 °C, 24 h
33% yield
Pd(PPh3)2Cl2
TEA
DCE, 90 °C, 18 h
"quant"
[Zn(12)] [Zn(13)]
 
 
In 2001, Mitzutani and co-workers developed two versions of water-soluble 
gable-type porphyrin DNA intercalators. Their synthesis consisted of two borylated 
intermediates: meso-boronyl-diphenylporphyrin [Zn(15)], and meso-boronyl-
triphenylporphyrin [Zn(17)] (Scheme 4a and 4b).87 The methodology developed by 
Therien and co-workers was employed for the borylation step in both syntheses. The 
gable-type porphyrins were produced in overall yields of 44 and 51%, respectively. 
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Scheme 4: Mitzutani’s water-soluble gable-type porphyrins 
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Meso-boronyl-trimesitylporphyrin [Zn(19)] was later synthesized in 96% yield 
by Nocera and co-workers using the Therien method (Scheme 5).88-89 Dihalogenated 
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xanthene and dibenzofuran linkers were used to synthesize cofacial bisporphyrins 
containing [Zn(19)] to give the Suzuki-Miyaura coupling product. The corresponding 
“Pacman” porphyrins were metalated with manganese and successfully applied to the 
catalytic disproportionation of hydrogen peroxide. Later work by Nocera and co-
workers used [Zn(19)] as the structural base for iron(III) “Hangman” porphyrins which 
also showed the ability for catalytic O–O activation.88 
 
Scheme 5: Nocera’s A3B meso-boronyl-trimesitylporphyrin  
N
N N
N
BrZn
HB
O
O
N
N N
N
BZn
O
OPd(PPh3)2Cl2
TEA
DCE, 90 °C, 45 min
[Zn(19)]
96% yield
[Zn(18)]
 
 
β-Borylation 
Modification of the β-positions usually requires lengthy syntheses, lower 
yields, and difficult separations. However, β-alkylated porphyrins more strongly 
resemble the photosynthetic reaction centers of biological photocatalysts, and as such 
are targeted for use as biomimetic light-harvesting complexes.  
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In one of the first examples of beta-functionalization via palladium-catalyzed 
cross-coupling, Nocera and co-workers reacted 2-bromo-7,12,17-triethyl-3,8,13,18-
tetramethylporphyrinatozinc(II) [Zn(20)] with bis(pinacolato)diboron to give the 
desired borylated product [Zn(21)] in 76% yield (Scheme 6).47 The β-borylated 
porphyrin was then subjected to Suzuki-Miyaura coupling conditions to produce the 
corresponding β,β’-bisporphyrin.  
 
Scheme 6: Nocera’s β-borylated β-substituted zinc porphyrin 
N
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N
Br
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[Zn(21)]
76% yield
[Zn(20)]
 
 
In 1974, Callot reported on the efficient synthesis of β-brominated 
tetraphenylporphyrin 22a using N-bromosuccinimide.90 The yield and scale of β-
bromotetraphenylporphyrin 22a was later improved by Zhang and co-workers.91 These 
two developments provided a foundation for the synthesis of β-functionalized 
tetraarylporphyrin derivatives. 
In 2005, Zhang and Suslick reported the synthesis of β-boronyl-
tetraphenylporphyrinato zinc(II) [Zn(23)] (Scheme 7).92 Bringmann and co-workers 
expanded on this work in 2008 using electron-rich and electron-deficient free-base and 
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metallo-tetraphenylporphyrin derivatives to produce the corresponding β-boronyl-
tetraarylporphyrins (Table 2).93 They also showed the synthesis of these porphyrins 
could be accelerated through the addition of 10 mol % 18-crown-6 or by microwave 
irradiation. The study by Bringmann and co-workers also confirmed the solvent 
dependence of this reaction as originally reported by Chen and co-workers in 2006.94  
 
Scheme 7: Zhang and Suslick’s synthesis of β-boronyl-tetraphenylporphyrinato 
zinc(II) 
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Table 2: Lambert’s Synthesis of β-Boronyl-Tetraarylporphyrins 
entrya Br-por time (h) yield (%)
1 22aphenyl 3 70
2 22b4-tolyl 3 65
3 22c4-ClPh 2 56
4 22d4-MeOPh 3 64
5 [Zn(22a)]phenyl 3 62
6 [Zn(22b)]4-tolyl 3 67
Ar
7 [Ni(22a)]phenyl 3 58
8 [Ni(22b)]4-tolyl 3 60
9 [Cu(22a)]phenyl 4 53
10 [Cu(22b)]4-tolyl 4 50
11 [Pd(22a)]phenyl 4 61
a Reactions were performed with 20 mol % Pd(dppf)Cl2 with
2.5 equiv of bis(pinacolato)diboron and 10 equiv of KOAc in
3.35 mM toluene/H2O (83 % v/v) at 110 °C.  
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Bringman and co-workers went on to report the synthesis of chiral, β-β’-linked, 
bis(tetraarylporphyrins) via an optimized Suzuki-Miyaura coupling procedure.93 The 
resulting chiral bis-porphyrins bearing different meso-aryl residues or different metal 
centers could be employed as asymmetric mono- or bi-metallic catalysts or as chiral 
reporter groups.  
 
C-B Borylated DoD Project and Spectrum 
As part of a Department of Defense research project, a porphyrin that was able 
to bind and destroy biological warfare agents was desired. Several previously 
synthesized porphyrins were thoughtfully selected based on peripheral groups and 
metal centers for fluorescence binding assays with nerve agent mimics. One porphyrin 
that captured a significant amount of interest was [Zn(7)] (Scheme 2) as it 
demonstrated dual modes of binding, potentially both to the zinc metal center and to 
the boronic ester side unit. Based on the initial screening that indicated potential 
binding, efforts were made by Dr. Julie Harmon’s group to incorporate the porphyrin 
into a polymer. In order to make the polymers, additional [Zn(7)] needed to be 
synthesized.  
The meso-brominted diphenylporphyrin 2 (Figure 1) was a staple starting 
material that was essential to several projects in the Zhang Laboratories. Brian Davis 
and Mishka Peart, undergraduate students, assisted in the synthesis of several batches 
of 2 in gram quantities in yields up to 65% in very high purity. The formation of 
[Zn(2)] and its further C-B cross-coupling using pinacolborane was accomplished in 
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very high yield following the procedure developed by Hyslop et al. 1H-NMR and UV-
vis spectra were obtained to confirm the synthesis by comparison with the previously 
published literature values. 
In collaboration with Brent Hilker, product [Zn(7)] was combined with 
poly(methyl methacrylate) and polymerized. The resulting products were physically 
characterized using several methods. Differential Scanning Calorimetry (DSC), 
Dielectric Analysis (DEA), AC (σAC), and DC (σDC) conductivity were evaluated. 
Permittivity (ε’), loss factor (ε’’) and dielectric response of beta (β), alpha (α), and 
conductivity relaxations were studied. The electric modulus formalism was used to 
reveal the β, α, and conductivity relaxations. The apparent activation energies (Ea) for 
the molecular relaxations were presented.  
 
Results from this study are reported in Hilker, B.; Fields, K. B.; Stern, A.; 
Space, B.; Zhang, X. P.; Harmon J. P. Dielectric Analysis of Novel Poly(methyl 
methacrylate) Zinc(II) mono-pinacolborane diphenylporphyrin composites, 
Polymer, 2010, 51, 4790-4805. 
 
 Continued studies on [Zn(7)], which reports on steady state and time resolved 
fluorescence spectroscopy measurements, indicates that the porphyrin is well dispersed 
under all loading conditions. Tan delta (δ), dissipation factor, was shown to increase 
with porphyrin loading although locally affected by free volume restriction. Havriliak-
Negami (H-N) fitting using the complex electric modulus (M*) was performed on the 
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conductivity region 160 to 190 ⁰C and degradation region 190 to 250 ⁰C.  Average 
relaxation times, τ(M”) are reported from 160 to 250 ⁰C. Currently, this article is in the 
process of being prepared and submitted to the journal Polymer. 
 
Hilker, B.; Vetromile, C. M.;  Fields, K. B.; Zhang, X. P.; Larsen, R. W.; Harmon J. P. 
Analysis of Poly(methyl methacrlyate)-Zinc(II)monopinacolborane Diphenyl 
Porphyrin Composites Part 2: Fluorescence Spectroscopy, Dielectric Dissipation 
Factor, and Conductivity Relaxations. Polymer, 2010, In Preparation. 
 
 
 
 
Compound [Zn(7)] Spectroscopic Data 
1H-NMR (400 MHz, CDCl3, δ): 10.28 (s, 1H, meso-H), 9.94 (d, J = 4.8 Hz, 2H, βH), 
9.39 (d, J = 4.4 Hz, 2H, βH), 9.12 (d, J = 4.8 Hz, 2H, βH), 9.06 (d, J = 4.8 Hz, 2H, 
βH), 8.23 (d, J = 1.6 Hz, 2H, H-Ph), 8.22 (d, J = 2.0 Hz, 2H, H-Ph), 7.78 (m, 6H, H-
Ph), 1.85 (s, 12H, -0-C(CH3)2-C(CH3)2-O-). UV-vis (CH2Cl2): λmax (log ε) = 391 
(4.67), 411 (5.71), 506 (3.60), 540 (4.29), 573 (3.57) nm. 
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1H-NMR for compound [Zn(7)] Zinc(II) mono-pinacolborane diphenylporphyrin 
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Palladium-Catalyzed C-N Coupling 
Amination   
Meso-Amination 
The alkyl and aryl-amino couplings to meso-halogenated porphyrins were 
reported in 2003 by Chen and Zhang.95 In this study, both the free-base and zinc 
complex of 10-mono-bromo-5,15-diphenylporphyrin 2 and 10,20-di-bromo-5,15-
diphenylporphyrin 3 were coupled with a variety of amines (Scheme 8). Combinations 
of the palladium source, phosphine ligand, and base were screened in THF or toluene 
to identify optimal reaction conditions.  
 
Scheme 8: Chen and Zhang’s meso-aminoporphyrins 
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Both palladium(II) acetate and tris(dibenzylideneacetone)dipalladium(0) were 
evaluated in combination with a variety of electron-rich, bulky biphenyl mono-
phosphine (L1, L4, and L5, Figure 4) and bis-phosphine ligands (L7 and L9, Figure 4) 
as catalysts for the amination reactions. Results showed that there was no significant 
difference between the two palladium sources; however, the DPEphos ligand L7 was 
selected for continued study because of its high catalytic activity and low cost.  
 
PCy2 PCy2 PCy2 PCy2 P(tBu)2 P(tBu)2
NMe2
O
PPh2
PPh2
O
PPh2
PPh2
PPh2
PPh2
Fe
PPh2
PPh2
N HN
Cl
L1 L2 L3 L4 L5 L6
L7 L8 L9 L10 L11  
Figure 4: Common ligands: mono-phosphines, bis-phosphines, and N-heterocyclic 
carbene.  
 
Although the yields generated in THF and toluene were comparable, THF was 
chosen as the solvent since it provided greater homogeneity. Finally, screenings 
showed that K2CO3 was catalytically ineffective and the strong base NaOtBu led to 
side-products; therefore, the weak base Cs2CO3 was chosen as the preferred base. 
Increased reaction temperatures were used as the reaction was shown to be sluggish at 
room temperature. 
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On the basis of the initial screenings, optimized reaction conditions were 
established and a variety of amines were evaluated as substrates for palladium-
catalyzed cross-coupling with bromoporphyrins. In general, both electron-rich and 
electron-poor substrates were suitable, and typically high yields were produced in less 
than 24 hours (entries 1-12, Table 3). However, sterically demanding diarylamines and 
aliphatic amines (entries 13-16) were sluggish, requiring much longer reactions times. 
 
Table 3: Chen and Zhang’s Amination of meso-Bromoporphyrins with Amines 
entrya Br-porbamine
time
(h)c
yield
(%)d
1
9
2
3
4
5
6
7
8
10
a Reactions were carried out at 68 °C under N2 using 1 equiv of Br-por, 3.6 (M = H2) or 4.8 (M = Zn) equiv of
amine, 5 mol % Pd(OAc)2 with 7.5 mol % DPEphos (Pd : L7 = 1 : 1.5) in the presence of 1.4 equiv of base per Br.
Concentration: 0.01 M Br-por in THF.
b Structures of Br-por are shown in Figure 1.
c Reaction times have not been optimized.
d Represents isolated yields of > 95% purity as determined by 1H-NMR.
e The reaction was conducted using 10 mol % Pd(OAc)2 and 15 mol % DPEphos in the presence of 2.8 equiv of
NaO-t-Bu.
[Zn(2)]n-HexNH2 50 80
15
16
17 [Zn(3)] 17 90
11
12
13
14e
19 [Zn(3)] 62 95
18 [Zn(3)] 16 94
NH2
H
N
CH3
NH
H
N
NH2
NH2
F3C
H3C
NH2tBu
tBu
[Zn(2)] 13 95
2 19 98
[Zn(2)] 13 99
2 16 94
[Zn(2)] 22 94
[Zn(3)] 13 82
3 20 65
[Zn(3)] 17 82
3 15 71
[Zn(3)] 16 84
3 15 95
[Zn(3)] 50 30
2 24 84
[Zn(2)] 25 61
2 40 66
entrya Br-porbamine
time
(h)c
yield
(%)d
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The use of 18-crown-6 for the palladium-catalyzed amination of aryl iodides 
with secondary cyclic amines was first reported by Wolfe and Buchwald in 1997.99 
The rate acceleration observed in this reaction was shown to be a result of the 
activation of NaOt-Bu by 18-crown-6 through solvation of Na+. 
Inspired by Wolfe and Buchwald’s report, Suda and co-workers used crown 
ether additives to establish a methodology that would be suitable for the palladium-
catalyzed cross-coupling of aliphatic secondary amines with bromoporphyrin 
synthons.96 In their initial report in 2003, they employed meso-bromo-5,15-
diphenylporphyrin and its zinc and nickel complexes for the preparation of meso-
amino substituted porphyrins.  
As illustrated in Table 4, the reported use of crown ether additives in the 
palladium-catalyzed cross-couplings provided Suda and co-workers with access to a 
wide variety of aminoporphyrin analogs, including alkyl amines (entries 1-4), cyclic 
amines (entry 5), and primary and secondary aromatic amines (entries 6-7).  
In general, the reactions proceeded efficiently and the desired products were 
produced in moderate to high yields. Of particular interest was the reaction of m-
phenylenediamine (entry 8, Table 4) which produced the corresponding meso-amino 
substituted Ni(II) porphyrin in 96% yield. This reaction proceeded with minimal 
production of the dicoupled product, providing a free amino group as a synthetic 
handle for further functionalization. 
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Table 4: Suda’s Palladium-Catalyzed Amination of meso-Bromo Substituted 
Porphyrin 2 with Amines  
 
entrya amine
time
(h)
yield
(%)c
1d 0.5
4
2.5 815
Ph(Me)NH 3 quant.
6
7
8
4 80
3 quant.
5 96NH
i-PrNH2
NH2
a Reactions were carried out at 68 °C under N2 in THF with 2 equiv of amide, 6.7 mol % Pd(OAc)2; and 19.4
mol % rac-BINAP in the presence of 23 equiv of NaOtBu and 4.5 mol % 18-crown-6. Concentration: 0.01 M
Br-por in THF.
b See Figure 1 for structures.
c Isolated yields.
d Recovered 70% of 2.
e Recovered 12% of [Zn(2)].
CH3
NH2H2N
Br-porb
2
[Ni(2)]
[Ni(2)]
[Ni(2)]
[Ni(2)]
[Ni(2)]
2e 0.5 55n-hexylNH2 [Zn(2)]
3 0.5 85[Ni(2)]
ND
entrya amine
time
(h)
yield
(%)cBr-porb
n-hexylNH2
n-hexylNH2
 
 
Carbazates and azoesters are known to be biologically active.100 Their 
combination with porphyrins that are well known for their photosensitizing and tumor-
localizing abilities inspired Arnold and co-workers to extend the scope of carbon–
nitrogen bond couplings to protected hydrazines. In 2005, they reported the first 
synthesis of meso-substituted azoporphyrins via palladium-catalyzed cross-coupling 
(Schemes 9 and 10).97  
 
 
 
 
 
28 
 
Scheme 9: Arnold’s meso-monosubstituted azoporphyrins 
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Scheme 10: Arnold’s meso-disubstituted azoporphyrins 
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The palladium-catalyzed cross-coupling of ethyl and tert-butylcarbazates with 
meso-bromoporphyrins resulted in the expected mono-meso-azo-product which 
spontaneously oxidized in air to produce [Ni(27)]. In addition, despite beginning with 
only one bromo substituent, a significant amount of the bis-aminated product [Ni(30)] 
(Scheme 10) was observed. Bis-amination presumably resulted from the activation of 
the opposite meso-C–H bond by addition of the first azo (or hydrazo). Arnold and co-
workers also evaluated the scope of the hydrazination/oxidation reaction using 
benzophenone hydrazone to produce [Ni(29)] in comparable yield.  
In 2006, Arnold and co-workers used a palladium-catalyzed cross-coupling 
approach to synthesize an aminoporphyrin using the sulfate salt of hydrazine (Scheme 
11).98 This was the first reported example using an unprotected hydrazine sulfate as an 
ammonia surrogate. When 2 equivalents of meso-bromotriphenylporphyrin [Ni(31)] 
were reacted in the presence of 1 equivalent of hydrazine, the meso- 
aminotriphenylporphyrin [Ni(32)] was produced in 51% yield. However, if equivalent 
molar ratios of the porphyrin and hydrazine were reacted for an extended period of 
time, the bis(diporphyrinylamine) [Ni(33)] was produced in 25% yield. The authors 
noted that the delocalized electronic structure of the bis(diporphyrinylamine) and its 
analogs may have relevance for use in molecular electronic devices. 
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Scheme 11: Arnold’s meso-amino porphyrin via hydrazine sulfate cross-coupling 
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β-Amination 
In 2001, van Lier and co-workers reported palladium-catalyzed carbon-
heteroatom intermolecular cross-coupling using porphyrin substrates.101 The focus of 
their report was the convenient and efficient synthesis of a host of new photodynamic 
therapy agents from a single porphyrin starting material. The report was vague 
regarding the conditions employed and the yields obtained. However, this work is 
important because it highlighted the first successful application of Buchwald-Hartwig 
conditions to the amination of mono- and di-β-bromoporphyrins using a variety of 
amines (Scheme 12 and Figure 5). 
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Scheme 12: β-Aminoporphyrin synthesis by van Lier and Zhang 
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Figure 5: Van Lier’s Buchwald-Hartwig cross-coupling partners. 
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 In 2007, Zhang and co-workers investigated the direct employment of free-base 
β-bromoporphyrins 2 and 3 in palladium-catalyzed amination reactions (Scheme 12 
and Table 5).91 Their report began with an improvement on the synthesis of β-
bromotetraphenylporphyrin from tetraphenylporphyrin, first developed by Callot.90 
The authors noted that when the bromination reaction was carried out by slow addition 
of 3 equivalents of pre-dissolved N-bromosuccinimide (NBS) to a 0.4 mM solution of 
the desired tetraphenylporphyrin in pyridine and chloroform at 60 °C, a 64% yield of 
the mono- brominated product 22a was obtained. In addition, they noted that the new 
reaction conditions were amenable to multigram scales.  
 
Table 5: Synthesis of β-Aminotetraphenylporphyrins via Palladium-Catalyzed  
C–N Bond Formations of β-Bromotetraphenylporphyrin with Amines 
 
entrya amine time (h) yield (%)
1
2b
3b
24 48
24 75
5 46
4b 24 71
H2N
H2N NO2
H2N
N
H2N
a Reactions were carried out at 100 °C under N2 in THF with 1 equiv of 22a;
4 equiv of amine, 10 mol % Pd(OAc)2; and 20 mol % BINAP in the presence
of 2 equiv of Cs2CO3. Concentration: 0.01 M 22a in THF.
b 4 equiv of Cs2CO3.
Br-por
22a
22a
22a
22a
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Zhang and co-workers used free-base β-bromotetraphenylporphyrin (β-BrTPP) 
22a to demonstrate the efficient synthesis of a variety of β- substituted alkyl and aryl 
amines, amides, alcohols, and thiols.91 The palladium sources Pd(OAc)2 and Pd2(dba)3 
were screened in combination with the bis-phosphine ligands DPEphos L7, Xantphos 
L8, and BINAP L9 as potential catalytic systems. The coupling of alkyl and aryl 
amines to the β-position generally favored product formation using a combination of 
Pd(OAc)2 and BINAP L9. The resulting porphyrins were used to further examine the 
correlation between porphyrin structure and catalytic reactivity for cobalt(II) 
porphyrin-based asymmetric cyclopropanation. 
In 2007, Torres, Guldi, and co-workers used a nitrogen-based linker to attach 
porphyrins to phthalocyanines.102 The resulting products provided an extended π-
conjugated system capable of promoting energy transfer. The authors envisioned the 
pH and redox-sensitive nitrogen linker could act as an “active” spacer or switch for use 
in the field of molecular materials.  
Two approaches were used by Torres, Guldi, and co-workers to prepare the 
desired porphyrin-phthalocyanine dyads from β-aminoporphyrins via palladium-
catalyzed amination. Specifically, [Ni(37)] was coupled with iodophthalocyanine 
[Zn(38)] and iodophthalonitrile to form dyad 39 and its precursor [Ni(40)], 
respectively (Schemes 13 and 14).102  
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Scheme 13: Torres, Guldi, and co-workers’ porphyrin-phthalocyanine dyad: the first 
method 
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Scheme 14: Torres, Guldi, and co-workers’ porphyrin-phthalocyanine dyad: the second 
method 
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As part of the study, the two synthetic methods for achieving dyad synthesis 
were compared. In the first method, [Ni(37)] and [Zn(38)] were cross-coupled to 
produce the corresponding porphyrinylaminophthalocyanine 39 in 70% yield (Scheme 
13). In the second method, 4-iodophthalonitrile was cross-coupled with [Ni(37)] under 
identical conditions to form nickel complex of porphyrinylaminophthalonitrile [Ni(40)] 
in 60% yield (Scheme 14).  
Although the synthetic yields indicate that the two cross-coupling reactions 
employed are comparable, Torres, Guldi, and co-workers made note of some important 
considerations that should be taken into account when preparing dyad 39. Specifically, 
hexabutoxyiodo zinc(II)phthalocyanine [Zn(38)] (Scheme 13), which was formed as a 
mixture from reaction of two different phthalonitriles in a 1:3 ratio in the presence of 
Zn(OAc)2·2H2O under refluxing conditions using N,N-dimethylaminoethanol (DMAE) 
as the solvent, had strong tendencies toward aggregation. As a result of aggregation, 
the desired mono-iodophthalocyanine [Zn(38)] was only isolated in a low 19% yield. 
In the second method, the phthalocyanine portion of the dyad 39 was then 
prepared through condensation of the nickel complex of 
porphyrinylaminophthalonitrile [Ni(40)] with an excess of 4-tert-butylphthalonitrile in 
a refluxing solution of o-dichlorobenzene and N,N-dimethylaminoethanol (DMAE). 
Zinc chloride was added during macrocycle formation (template procedure) to provide 
the porphyrin-phthalocyanine dyad 39 in 33% yield. The overall yield for the two-step 
synthesis is 20% (Scheme 14).  
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In an effort to improve this system, aryl bromides were coupled to β-
aminotetraphenylporphyrinatonickel(II) [Ni(37)] using a palladium-catalyzed cross-
coupling approach to provide the corresponding aminated products [Ni(41)] in 45-78% 
yields (entries 1-4, Table 6).103-104 These products could be used to prepare porphyrins 
bearing fused rings through the oxidative cyclization of N-arylaminoporphyrins to give 
42 (Figure 6).103-104 
 
Table 6: Palladium-Catalyzed Cross-Coupling of Nickel(II) Aminoporphyrins with 
Aryl Halides  
 
yield (%)
1
2
3
4
Br
Br
Br
Br 69
78
68
45
Me
Cl
Br
N
N N
N
NH2
Ni
Br Ar
Pd(OAc)2
rac-BINAP
KOtBu
toluene
100 °C, N2
N
N N
N
HN
Ni
Ar
a Reactions were carried out at 100 °C under N2 using 1 equiv of aminoporphyrin
[Ni(37)], 2.8 equiv of aryl bromide, 29 mol % Pd(OAc)2 with 25 mol % rac-BINAP
(Pd : L = 1.16 : 1) in the presence of 2.13 equivalents of KOtBu. Concentration:
6.4 mM aminoporphyrin in toluene.
[Ni(37)] [Ni(41)]
entrya Br-Ar time (h)
24
2
2
24
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Figure 6: Cavaleiro’s N-Aryl aminoquinolinoporphyrin. 
 
Aryl Amination 
In 2001, Van Lier and co-workers reported the first palladium-catalyzed 
carbon-heteroatom intermolecular cross-coupling reactions using porphyrin 
substrates.101 In their communication, they successfully coupled 5-(4’-iodophenyl)-
10,15,20-trimesityl-porphyrinatozinc(II) [Zn(43)] with aniline, pyridin-2-amine, 
piperidine, and morpholine using conditions previously employed by Hartwig and co-
workers (Scheme 15).69-72 No yields were reported in this study.  
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Scheme 15: Van Lier’s initial report of aryl C‒N amination 
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In 2003, Zhang and co-workers used para-bromo-substituted diphenyl and 
tetraphenylporphyrins to synthesize a series of alkyl and arylaminoporphyrins via 
palladium-catalyzed amination (Tables 7 and 8).105 In their report, a practical “one-
pot” protocol was used to perform double and quadruple couplings in good to excellent 
yields. As shown in Table 7, electron-rich and electron-deficient arylamines (entries 3-
5), sterically hindered amines (entries 6-7), aliphatic amines (entries 8-13), secondary 
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aliphatic-aromatic amines (entries 14-15) and aromatic-aromatic amines (entries 16-
17), as well as imines (entry 18) were very suitable substrates. The quadruple 
amination of tetra(para-bromophenyl)porphyrin proceeded with similar success (Table 
8). In both cases, the zinc porphyrin complexes were generally produced in lower 
yields in comparison to the free-base porphyrins.  
In their report, Zhang and co-workers observed that a strong ligand dependency 
existed for palladium-catalyzed amination (Tables 7 and 8). For example, simple 
aromatic amines were successfully coupled using the sterically hindered mono- and 
bis-phosphines, L6 and BINAP L9, respectively. Electron-withdrawing and sterically 
hindered aromatic amines were also successfully coupled with the bulky 
monophosphine, L2. Similarly, alkyl amines as well as both types of secondary amines 
preferred the bulky monophosphines, L2 and L6. However, the sterically demanding 
imine performed best with the hindered monophosphine, L5. 
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Table 7: Palladium-Catalyzed Double Amination Reactions of Bromoporphyrins with 
Various Amines 
 
entrya time (h) yield (%)b
24 95
ligandamine
4
48 76
5
48 93
6
48 88
7
48 87
10e
48 96L1
11
48 96
14
48 90
48 88
48 81
18f 48 52
L9
L9
L2
L9
L2
L2
L2
L2
L2
L5
Br-por
45
45
45
45
45
45
45
45
45
45
45
48 66L9[Zn(45)]
48 68L6[Zn(45)]
1
2c,d
3d
a Reactions were carried out under N2 with 1 equiv of Br-por, 4 equiv of amine, 2.5 mol % Pd(OAc)2,
and 5 mol % ligand in the presence of 4 equiv of NaOtBu per Br. Concentration: 0.01 M Br-por/solvent.
b Isolated yields of >95 % purity as determined by 1H-NMR. c Cs2CO3 used instead of NaOtBu. d
Toluene used instead of THF. e Reaction performed at 68 °C. f Pd2(dba)3 used instead of Pd(OAc)2.
8
48 73L6[Zn(45)]
9
48 93[Zn(45)]
12
13
L6
15
48 53L8[Zn(45)]
48 73L2[Zn(45)]
16
17 48 57L6[Zn(45)]
N
NN
N
HNR1R2
BrBr
45
M
[Pd]/Ligand
Base
N
NN
N
NN
R1
R2R2
R1
46
M
NH2O2N
NH2
NH2
NH2MeO
N
NH2
NH2
NH2
NH
H
N
H
N Me
THF, 100 °C
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Table 8: Palladium-Catalyzed Quadruple Amination Reactions of Bromoporphyrins 
with Various Amines  
 
N
N
NH HN
H N
R1
R2
Br
Br Br
Br 47
N
N
NH HN
N
N
R1
R2
R2
R1
N
N
R1
R2
R1
R2
48
[Pd]/Ligand
Base
entrya yield (%)bligand
NH2
amine
NH2
H
N Me
H
N
Br-por
91L9
THF, 100 °C, 72 h
471
a Reactions were carried out at 100 °C under N2 with 1 equiv of Br-por. 4 equiv of amine, 2.5 mol % Pd(OAc)2,
and 5 mol % ligand in the presence of 4 equiv of NaOtBu per Br in THF for 72 h. Concentration: 0.01 M Br-por
in THF.
b Isolated yields of >95 % purity as determined by 1H-NMR.
86L6472
82L9473
81L2474
 
 
In 2007, Beletskaya and co-workers reported on the successful palladium-
catalyzed cross-coupling between hydroxypiperidenes and meso-bromophenyl 
polyalkylated porphyrins (Table 9).106 Their work, inspired by the reported anti-HIV 
activity of trans-3,4-dihydroxypiperidines, specifically focused on the preparation of 
different combinations of hydroxypiperidines and porphyrin pharmacophores. 
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Table 9: Beletskaya’s amination of mono- and Di-bromoporphyrins 49 and 51  
N HN
NNH
3 equiv amine
2-3 mol % Pd(OAc)2
3-4.5 mol % ligand
NaOtBu, dioxane
80-100 °C, 20 h
N HN
NNH
N
HNN
NH
NN
N
HNN
NH
BrBr
6 equiv amine
4-6 mol % Pd(OAc)2
6-9 mol % ligand
NaOtBu, dioxane
80-100 °C, 20 h
51 53
52 54
Br
N
entry amine
NaOt -Bu
(equiv)
isolated yields (%)
NH
O NH
NH
NH
HN
N NH
HO
HO
HO
HO
OH
OH
Br-por
N NH
HOF
53
53
51
4
4
4
82
82
-
-
-
83
-
-
-
di mono reduced
53 4 82 - -
53
53
51
16
16
8
44
7
-
30
21
70
trace
26
17
53
53
51
20
16
8
19
11
-
23
28
50
19
28
45
53 18 trace 11 47
53
51
28
16
-
-
25
18
34
48
51 16 - 56 34
1a,c,d,e,f
2a,c,f ,g
3b,c,f ,h
4a,e,f ,k
5a,f ,g
6a,i, j
7b,f ,g
8a,f ,g
9a,i, j
10b,g, j
11a,i, j
12a,i, j
13b,i, j
14b,f ,g
a Reaction conditions: amine (6 equiv), Pd(OAc)2 (4-6 mol %), ligand (6-9 mol %) in dioxane for 20 h.
b Reaction conditions: amine (3 equiv), Pd(OAc)2 (2-3 mol %), ligand (3-4.5 mol %) in dioxane for 20 h.
c 20 equiv of amine. d Cs2CO3 used as base. e Ligand L2. f100 °C. g Ligand L3. h Ligand L4. i Ligand t-Bu3P·HBF4
j80 °C k 5 equiv of amine.
R
R' R'
R R
R'
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The authors showed that the correct choice of ligand was very important in the 
successful formation of the desired products. For example, simple secondary amines, 
such as piperidine (entries 1-3, Table 9) and morpholine (entry 4, Table 9), could be 
coupled with either 5-(4’-bromophenyl)-2,3,7,8,12,18-hexamethyl-13,17-
dibutylporphyrin 49 or 5,15-bis(4’-bromophenyl)-3,7,13,17-tetramethyl-2,8,12,18-
tetraethylporphyrin 51 in 77-83% yields without complications using ligands L2, L3, 
and L4 (Table 9). However, the aminations of hydroxypiperidines and their derivatives 
were complicated by two factors: the competitive cross-coupling of the hydroxyl group 
and reduction of the aryl halide, which is a known problem in the arylation of aliphatic 
amines.107-109  
The couplings of monohydroxypiperidines (entries 5, 8, and 14, Table 9) with 
mono-brominated porphyrin 49 using ligand L3 led to the desired products in 50-70% 
yields. However, when the dibrominated porphyrin substrate 51 was used with ligands 
L3 or t-Bu3P-HBF4 (entries 6-7 and 9-10, Table 9), three products were produced:  the 
diaminated product; the partially aminated/partially reduced product; and the fully 
reduced product. Hydroxypiperidines containing secondary alcohol were shown to 
function as powerful reducing agents in the coupling reactions. Palladium-mediated 
coupling reaction of mono-brominated porphyrin 49 with dihydroxypiperidines using 
t-Bu3P-HBF4 as a supporting ligand gave the desired product in less than 20% yields 
(entry 12, Table 9). As a result of reduction, the reaction of dibrominated porphyrin 51 
with dihydroxypiperidines produced only the mono-aminated products (entries 11 and 
13, Table 9). 
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Torres, Guldi, and co-workers constructed porphyrin-phthalocyanine dyads 
using palladium-catalyzed amination of iodophthalocyanine [Zn(38)] with aryl-
aminoporphyrins.102 Using the same Buchwald-Hartwig conditions described in their 
β-aminated examples (Schemes 13 and 14), 5-(4’-aminophenyl)-10,15,20-
triphenylporphyrin [Zn(53)] and Zn(II)-2(3), 9(10), 16(17)-tri-tert-butyl-23-
iodophthalocyanine [Zn(38)] were cross-coupled to give the 
porphyrinylaminophthalocyanine 54 in 41% yield (Scheme 16).  
 
Scheme 16: Torres, Guldi, and co-workers aryl porphyrin-phthalocyanine dyads 
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C-N Amination PAPA-DPP Project and Spectrum 
As part of a collaboration with Dr. Venkat Bethanbotla’s group, the Zhang 
group prepared and provided a new porphyrin monomer with an amino group 
connecting the porphyrin core and aniline unit that could be electropolymerized and 
studied further (Figure 7). Cyclic voltammetry, FTIR spectroscopy, and MALDI-TOF 
mass spectrometry were used for the characterization of poly(10-(4’-
aminophenylamino)-5,15-diphenylporphyrin) (PAPADPP) by graduate student 
Aysegul Uygun. Atomic force microscopy (AFM) and scanning electron microscopy 
(SEM) were used to investigate the surface of the electropolymerized porphyrin 
polymer. For AFM studies, the polymer film was grown on indium tin oxide (ITO) 
electrodes and tapping-mode AFM images were taken. The PAPADPP formed a 
smooth layer on the ITO electrode and grew perpendicular to the electrode surface. Its 
conductivity was 10-5 S/cm.  
 
N
NH N
HN
NH
NH2
55  
Figure 7: 10-(4’-phenylenediamino)-5,15-diphenylporphyrin (PAPADPP). 
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An oligonucleotide (ODN)-probe was physisorbed onto the PAPADPP film 
and tested for hybridization with complementary and non-complementary ODN 
segments. Biological recognition was monitored by comparison of the electrochemical 
signals (cyclic voltammetry) from single and double strand state oligonucleotides. The 
oxidation current of the double strand oligonucleotide was lower than that of the single 
strand, which corresponded to a decrease in PAPADPP electroactivity and an increase 
in the stiffness of the polymer structure. The morphology of the physisorbed ODN-
probe and its hybridization were observed on ITO electrodes using AFM and SEM. 
 
 Results are reported as follows:  Uygun, A.; Myjavcova, R.; Yavuz, A. G.; 
Ruppel, J. V.; Fields, K. B.; Frankhauser, A; Zhang, X. P.; Bhethanbotla, V. R.; 
Bednar, P. Electrochemical polymerization and investigation of properties of 
poly(5-(4’-aminophenylamino)-10,20-diphenylporphyrin). Electroanalysis. 
Submitted: September 30, 2010. Manuscript ID: elan.201000609. 
 
The general palladium-catalyzed C-N cross-coupling procedure was used to 
couple 10-bromo-5,15-diphenylporphyrin 20.7 mg (0.038 mmol) with p-
phenylenediamine 33.1 mg (0.307 mmol) using Pd(OAc)2 1.0 mg (10 mol %) and 
DPEphos 4.3 mg (20 mol %) in the presence of Cs2CO3 105.2 mg (0.307 mmol). The 
reaction was conducted in THF 5 mL (0.02 mmol/mL) at 100 °C for 24 hours. 
Compound 55 was isolated in 82.5% yield (18.9 mg). Previous batches had also been 
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prepared by Dr. Joshua Ruppel and Anita Frankenhauser, although not fully 
characterized with both a publishable proton and carbon NMR. 
 
 
Compound 55 Spectroscopic Data  
1H-NMR (300 MHz, CDCl3): δ (9.94, s, 1H), (9.30, d (J = 4.4 Hz), 2H), (9.17, d (J = 
4.4 Hz), 2H), (8.88, d (J = 4.4 Hz), 2H), (8.71, d (J = 4.8 Hz), 2H), (8.18, m, 4H), 
(7.75, bs, 7H), (6.87, d (J = 8.4 Hz) 2H), (6.57, d (J = 8.8 Hz) 2H), (3.45, bs, 2H), (-
2.38, bs, 2H). 13C-NMR (75 MHz, CDCl3): δ 134.6, 131.5, 131.1, 127.9, 127.7, 126.9, 
122.0, 117.8, 116.5, 112.3, 103.6. 
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1H-NMR of 55 10-(4’-phenylenediamino)-5,15-diphenylporphyrin  
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Amidation 
Meso-Amidation 
Suda and co-workers reported a useful methodology for the palladium-
catalyzed cross-coupling of primary and secondary amides (Scheme 17).96 They 
explored the use of meso-bromo-5,15-diphenylporphyrin 2 and its zinc and nickel 
complexes for the preparation of meso-amido-substituted porphyrins. The effect of the 
central metal ion on the reaction with benzamide showed a remarkable acceleration 
when the nickel complex [Ni(2)] was used. In addition to the nearly quantitative 
production of amidoporphyrin using benzamide (entry 3, Table 10), the amidation 
system was shown to be effective with formamide (entry 4, Table 10), acetamide 
(entry 5, Table 10) and pyrrolidinone (entries 6, Table 10). 
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Scheme 17: Suda’s palladium-catalyzed amidation of meso-bromo substituted 
porphyrin 2 with amides 
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Table 10: Suda’s Amidation of Nickel(II) meso-Bromoporphyrin [Ni(2)]  
entrya amide time (h) yield (%)
a Reactions were carried out at 100 °C under N2 in dioxane with 2 equiv of amide, 6.7 mol %
Pd(OAc)2; and 19.4 mol % BINAP in the presence of 2.4 equiv of Cs2CO3. Concentration:
0.01 M Br-por in dioxane.
b See Figure 1 for structures.
c Reaction conditions same as in a, exceptthey were done at 68 °C in THF in the presence
of 12 equiv of Cs2CO3. Concentration: 0.01 M Br-por in THF.
3
4
5
5 >99
2 85
1 83
6 1 80
H2N
O
H2N H
O
H2N CH3
O
HN
O
Br-porb
[Ni(2)]
[Ni(2)]
[Ni(2)]
[Ni(2)]
2c 24 32[Zn(2)]
1c 242 ND
 
 
Zhang and co-workers independently developed a method for the palladium-
catalyzed cross-coupling of free-base and zinc bromoporphyrins with primary and 
secondary amides (Scheme 17).110 In addition to benzamide (entries 1-3, Table 11), the 
amidation system reported by Zhang and co-workers could be applied to acetamide and 
other alkyl amides (entries 4-11, Table 11), as well as carbamates and N-
phenylacetamides (entries 12-19, Table 11). The amidation system was also shown to 
catalyze reactions with cyclic amides, such as pyrrolidinone, and 4-benzyloxazolidin-
2-one in good yields (entries 20-25, Table 11). The efficient use of free-base 
porphyrins as synthons for palladium-catalyzed cross-coupling highlights the 
importance of this methodology as it eliminates the need for metalation/demetalation 
steps which would result in reduced yields of the desired cross-coupled products. 
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Table 11: Palladium-Catalyzed Cross-Coupling of meso-Bromoporphyrins with 
Amides 
a Reactions were carried out under N2 in THF with 1 equiv of Br-por; 4 equiv of amide, 10 mol % Pd(OAc)2;
and 20 mol % Xantphos in the presence of 2 equiv of Cs2CO3. Concentration: 0.01 M Br-por in THF.; Br-por
3: 8 equiv of amide and 4 equiv of base. b 2.5 mol % Pd2(dba)3. c 5 mol % Pd2(dba)3. d10 mol % Pd2(dba)3. e
20 mol % Pd(OAc)2. f 20 mol % Xantphos. g 40 mol % Xantphos. h 2 equiv of amide and 1.5 equiv of base. i
NaOt-Bu. j 8 equiv of amide. k Exists as a mixture of stereoisomers.
entrya amide time (h) yield (%)temp (ºC)
68
80
100
100
80
100
80
68 22 60
21 71k
22 69k
10 70k
16 60k
2 73
8 65
17 71
80
100
100
68
19
30
30
22
66k
57k
59
62k
H2N
O
Et
H2N
O
H2N
O
H2N
O
H2N
O
Bu
H2N
O
F
H2N O
O
F
F
HN
O
OHN
O
HN
O
HN
O
F
HN
O
Br-por
2
[Zn(2)]
3
2
2
2
2
3
3
3
3
3
68 19 882
80 17 68[Zn(2)]
68 21 832
80 17 62[Zn(2)]
80 19 602
80 17 46[Zn(2)]
100 19 832
100 17 21[Zn(2)]
100 24 922
80 17 24[Zn(2)]
80 18 892
80 19 75[Zn(2)]
80 18 83k2
4b
8
11
12f
13
5h
6i
3
15
18
22
25
1
2c,f
20b
21d,g
23c
24c,f
17
19
14
16
9
10e,g,i
7
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 Chiral porphyrins have found a range of useful applications in several areas 
such as asymmetric catalysis, chiral recognition/sensing, and enzymaticmimicry.27-31 
As a part of their program to develop metalloporphyrins as practical catalysts for 
atom/group transfer reactions,111-130 Zhang and co-workers systematically probed the 
relationship between the structure of the porphyrin and reaction selectivity in 
asymmetric cyclopropanation reactions. 
 Meso-dibromoporphyrins 3 bearing three different meso-aryl groups (Scheme 
18) were readily prepared in gram scale via selective bromination of the corresponding 
5,15-diarylporphyrins.38,48,53 These three synthons were then coupled with (R)-(+)-4-
benzyl-2-oxazolidinone, a commercially available chiral amide, under the palladium-
catalyzed amidation conditions previously established. The corresponding chiral meso-
amidoporphyrins 58a-c were produced as a mixture of two atropisomers (α,α- and α,β-
isomers) in approximately equal amounts. The cobalt complexes of these products, 
[Co(58)], were subsequently evaluated for their ability to perform cyclopropanation 
reactions with styrene and ethyl diazoacetate. Although cyclopropane products were 
generated in high yields, the diastereoselectivity was moderate (cis:trans = 26:74) and 
enantioselectivity was low (≤ 12 % ee).131 
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Scheme 18: Palladium-catalyzed cross coupling of 3 with a chiral amide 
N
N N
N
Ar
Ar
BrBr M
Pd(OAc)2
Xantphos
Cs2Co3
THF
ON
O
O N
O
N
NN
N
Ar
Ar
M
58
Ar =
Yield 62% 72% 79%
Isolated as a mixture of (α,α− andα,β−)
atropisomers in roughly equal amounts.
3
58a 58b 58c
 
 
β-Amidation  
As discussed in the section on β-amination, van Lier and co-workers also 
reported in the same 2001 paper on palladium-catalyzed carbon–heteroatom 
intermolecular cross-coupling between β-substituted porphyrins and amides.101 They 
noted that a moderate yield was obtained for the amidation of β-
bromotetraphenylporphyrin [Zn(22a)] with the cyclic amide, ε-caprolactam, forming 
[Zn(59)] (Scheme 19). 
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Scheme 19: Palladium-catalyzed cross coupling of [Zn(22)] with ε-caprolactam 
N
N N
N
Br
Zn
N
N N
N
N
Zn
ONH
O
Pd(dppf)Cl2
dppf , NaO-t-Bu
[Zn(22a)] [Zn(59)]  
 
 In 2007, Zhang and co-workers reported the efficient synthesis of a variety of 
β-substituted porphyrins by coupling β-bromotetraphenylporphyrin 22a with alkyl and 
aryl amines, amides, alcohols, and thiols (Scheme 20).91 The palladium sources 
Pd(OAc)2 and Pd2(dba)3 were screened in combination with various bidentate 
phosphine ligands such as DPEphos L7, Xantphos L8, and BINAP L9 as potential 
catalysts. For example, using a Xantphos L8/Pd2(dba)3-based catalytic system, 
amidation reactions of β- bromotetraphenylporphyrin 22a with both aromatic and 
aliphatic amides were successfully catalyzed to produce desired β-amidoporphyrins 60 
in 65-76% yields (entries 1-2, Table 12). The amidation system was also productively 
applied to methyl carbamate and pyrrolidinone (entries 3-4, Table 12).91 
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Scheme 20: Palladium-catalyzed cross coupling of 22a with amides 
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Table 12: Synthesis of β-Amidotetraphenylporphyrins 
entrya amide time (h) yield (%)
a Reactions were carried out at 100 °C under N2 in THF with 1 equiv of 22a; 4 equiv of
amide, 10 mol % Pd(OAc)2; and 20 mol % Xantphos in the presence of 2 equiv of Cs2CO3.
Concentration: 0.01 M 22a in THF. b 4 equiv of Cs2CO3.
1
2
3b
24 65
28 76
5 45
4 24 71
H2N
O
H2N C5H11
O
H2N O
O
HN
O
H2N
O
Me
Me
H
H2N
O
Me
OMe
H
S-(+)
S-(–)
5 24 86
6 24 46
Br-Por
[Zn(22a)]
22a
22a
22a
22a
22a
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One of the practical aspects of the palladium-catalyzed cross-coupling 
amidation method developed by Zhang and co-workers is its mild reaction conditions 
under which potential racemization of chiral centers could be prevented. This feature 
was demonstrated by reactions of 22a with commercially available chiral amides (S)-
(+)-(2,2-dimethylcyclopropanecarboxamide and (S)-(–)-2-methoxypropionamide 
(entries 5-6, Table 12). It was shown the corresponding chiral β-amidoporphyrins 60 
could be formed in 86 and 46% yields, respectively, without racemization. 
 
Aryl Amidation  
In 2004, Zhang and co-workers reported that 5,10-bis(2’,6’-
dibromophenyl)porphyrins 61a-k were versatile synthons for the modular construction 
of chiral porphyrins via palladium-catalyzed amidation reactions with chiral amides.132 
The quadruple carbon–nitrogen bond formation reactions could be accomplished in 
high yields under mild conditions and suitable to different chiral amide building 
blocks, forming a series of D2-symmetric chiral porphyrins (Scheme 21). The 
cobalt(II) complexes of these chiral porphyrins were shown to be excellent catalysts 
for the enantioselective and diastereoselective cyclopropanation of a variety of alkene 
substrates with diazoacetates. 
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Scheme 21: Quadruple carbon–nitrogen bond formation to form a series of D2-
symmetric chiral porphyrins 
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Zhang and co-workers continued to develop D2-symmetric chiral porphyrins to 
further explore the catalytic properties of these systems. The new designs they reported 
were based on the hypothesis that it is possible to control diastereoselectivity and 
enantioselectivity through the combined use of the chiral R* and meso-R groups.123 
This is illustrated by catalysts derived from chiral porphyrins containing the bulkier 
2,6-methoxyphenyl groups at the meso positions (61g, Table 13). Palladium-catalyzed 
amidation reactions between tetrabromoporphyrin 61g and chiral acyclic amide 62c or 
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62d, both of which possess intramolecular O–H–N hydrogen bonding interactions, 
resulted in chiral porphyrins, cobalt(II) complexes of which were shown to be effective 
catalysts with improved enantioselectivity for cyclopropanation and aziridination of a 
range of alkene substrates. 
 
Table 13: Amidation of D2-Symmetric Chiral Porphyrins 
entrya 61 63
1 61a 63a
7 61d 63g
11
61i 63p
12
61i 63q
13
61j 63t
14
61k 63u
6 61c 63f
8 61e 63h
9 61f 63
10 61g 63j
61h 63n
61i 63o
5 61b 63e
4 61a 63d
3 63c61a
Ph
pentaFPh
3,5-di-t -BuPh
3,5-di-t -BuPh
4-n-heptyl
4-CF3Ph
4-AcetylPh
2,4,6-triMePh
2,6-diMeOPh
3,5-diMeOPh
3,5-di-t -BuPh
4-t-BuPh
Ph
Ph
2 61a 63bPh
62
62a
62a
62c
62d
62a
62a
62a
62a
62a
62a
62a
62a
62a
62d
62c
62b
R
H
61i 63r3,5-di-t -BuPh 62e
61i 63s3,5-di-t -BuPh 62f
61g 63k2,6-diMeOPh 62d
61g 63l2,6-diMeOPh 62e
61g 63m2,6-diMeOPh 62f
15
16
17
18
19
20
21
78
64
75
71
86
77
46
66
84
59
yield (%)b
63
60
59
88
85
79
72
63
65
74
79
a Reactions were carried out under N2 in THF with 1 equiv of Br-por; 16 equiv of amide, 10
mol % Pd(OAc)2; and 20 mol % Xantphos in the presence of 8 equiv of Cs2CO3.
Concentration: 0.01 M Br-por in THF. b Isolated yields.   
 
In their continuing efforts to create more effective catalysts, Zhang and co-
workers synthesized chiral porphyrins containing rigid and cyclic structures as well as 
functional groups capable of participating in intramolecular O–H–N hydrogen 
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bonding. Their work ultimately led to the development of chiral porphyrins 63l and 
63r using (S)-(–)-2-tetrahydrofurancarboxamide (entries 12 and 18, Table 13).123 The 
cobalt(II) complexes of these chiral porphyrins were shown to impart a substantial 
increase in enantioselectivity for catalytic cyclopropanation with diazosulfones over 
previously reported cobalt(II) porphyrin catalysts. Through these investigations, a 
“Group of Six” D2-symmetric chiral porphyrins (Figure 8) have emerged and their 
cobalt(II) complexes were demonstrated to have catalytic capabilities for a range of 
carbene and nitrene transfer reactions.  
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Figure 8. The “Group of Six” chiral D2-symmetric porphyrins.  
 
Zhang and co-workers investigated the use of cobalt(II) porphyrins for the 
catalytic aziridination of styrene and its various derivatives with sulfonyl azides.122 
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2,6-Diisobutanamidophenyl-substituted porphyrin 63s (entry 19, Table 13) was 
designed and synthesized on the basis of potential hydrogen bonding interaction in the 
presumed metal-nitrene intermediate of the catalyst. The cobalt complex [Co(63s)] 
(Figure 9) was indeed shown to be a highly effective catalyst for the aziridination of a 
variety of aromatic olefins with various arylsulfonyl azides. 
 
N
N
N
N
HN
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O
O
NH
NH
O
O
Co
[Co(63s)]  
Figure 9: Cobalt(II) complex of 3,5-ditbutyl-i-BuPhyrin.  
 
C-N Amidation Projects and Spectra  
Bromoporphyrins 
Beginning with the 2004 Journal of the American Chemical Society 
cyclopropanation communication these 5,10-bis(2’,6’-dibromophenyl)porphyrins have 
served as versatile synthons for the construction of chiral porphyrins via palladium-
catalyzed amidation reactions with chiral amides.132 Considering the ready availability 
of chiral amides, these synthetic methodologies rendered ortho-bromophenyl 
porphyrins as a new class of synthons for the synthesis of chiral porphyrins. The 
quadruple carbon–nitrogen bond formation reactions have been accomplished in high 
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yields with different chiral amide building blocks under mild conditions, forming a 
family of D2-symmetric chiral porphyrins (Figure 8).  
The series of 5,15-bis(2,6-dibromophenyl)porphyrins, 61, containing different 
meso-aryl and -alkyl R groups at the 10,20-positions, were readily prepared by 
MacDonald [2+2] porphyrin synthesis using Lindsey’s condition using 5’-(2,6-
dibromophenyl)-dipyrrolmethane and the corresponding aryl or -alkyl aldehydes in the 
presence of boron trifluoride etherate in chloroform. Subsequently, the combination of 
Pd(OAc)2 and XantPhos effectively catalyzed the quadruple amidation reactions of 
synthons 61a-k with chiral amides 62a-f to deliver a the family of D2-symmetric chiral 
porphyrins 63a-u in high yields (Scheme 21 and Table 13). The near perpendicular 
arrangement between the meso-phenyl ring and the porphyrin plane, in combination 
with the trans-amide conformation, directs the ortho-chiral R* units toward the center 
of porphyrins. This is evidenced by both the observed large high-field NMR chemical 
shifts of the chiral R* units and X-ray crystallography of these structures. As a result, 
high asymmetric induction may be achieved for catalytic reactions with metal 
complexes of these chiral porphyrins. Through the combined use of the chiral R* and 
meso-R groups, it is possible to control the diastereoselectivity as well as the 
enantioselectivity of a variety of catalytic reactions.  
 
The results of these initial syntheses are reported as follows: Chen, Y.; Fields, 
K. B.; Zhang, X. P. Bromoporphyrins as Versatile Synthons for Modular 
Construction of Chiral Porphyrins: Cobalt-Catalyzed Highly Enantioselective 
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and Diastereoselective Cyclopropanation. Journal of the American Chemical 
Society, 2004, 126(45), 14718-9. 
 
Multiple batches of the D2-symmetric “Group of Six” porphyrins were 
synthesized and metallated to produce the cobalt catalysts needed to support various 
catalytic projects over the years. Every catalyst synthesized will not be included; 
however, the supporting information for the “Group of Six” that have provided the 
basis for much of the catalytic work reported in this dissertation are included below.  
The cobalt complexes of chiral porphyrins [Co(63)] were prepared in high 
yields from the free-base porphyrins via reflux with CoCl2 and 2,6-lutidine in THF. 
Recently, this catalytic family has expanded to include even more aryl groups and 
chiral amides for an expanded “toolbox” of possibilities. Although the synthesis of the 
“Group of Six” porphyrins is in this section, the results of the corresponding projects 
will be discussed in later chapters. 
 
Triflates 
Another project involved the use of the triflate porphyrins which served as 
pseudo-halides that could undergo palladium-catalyzed C-N amidation reactions. This 
is the first time porphyrins functionalized with triflates had been used as substrates for 
palladium-catalyzed cross-coupling cross-coupling reactions. Chelsea A. Huff, an 
undergrad in the Zhang laboratories during the summer of 2007 assisted in the arduous 
preparation of A3B porphyrin synthesis and the cross-couplig that followed.  
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Initial efforts involved the preparation and isolation of A3B bromoporphyrin 
synthons, a primary target were the 5-(2,6-dibromophenyl)-10,15,20-tris(3,5-di-t-
butylphenyl)porphyrin and 5-(2,6-dibromophenyl)-10,15,20-tris(4-t-butylphenyl) 
porphyrin. As a result of the waxy t-butyl groups, the porphyrins had limited solubility 
in hexanes; however, as a result of porphyrin-porphyrin pi-stacking it was difficult to 
get a concentrated solution. As a result of these two factors, a small amount could be 
carefully separated using a sizable quantity of both silica and solvent. 
There had to be a way around this situation, so we tried the 2,6-dibromophenyl 
with more polar groups and found that if the other aryl groups had methoxy groups, or 
they separated quite easily. After communicating the difficulties of the project, it was 
discovered that Dr. Guang-Yao Gao desired to make a similar porphyrin using phenyl 
as the aryl group while at the University of Tennessee – Knoxville. He found a paper 
on small molecule synthesis and he used that approach to triflate formation. The 
methodology adapted to porphyrins quite nicely. 
The premise was to start with a methoxy, deprotect it to form the hydroxy, and 
then convert that to a triflate. Once the triflate was formed, papers by Dr. Buchwald 
and Dr. Hartwig demonstrated that it was possible to do carbon-heteroatom cross 
coupling on small molecules using triflates as pseudo-halides. Chiral amides were then 
attached, which would direct the two chiral groups out over the porphyrin metal center 
both above and below the porphyrin plane. The end goal of the preparation of these 
porphyrins was to determine their ability as cobalt catalysts for use with larger 
substrates. The cobalt complexes were created, although they are not included in the 
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following article, and tested for asymmetric catalytic ability. The substrates tested must 
have structurally been of insufficient bulk to have sufficient asymmetric induction as 
the %ee was not of notable magnitude (<15%ee). The following prepared article 
contains both the porphyrins synthesized by Dr. Gao and those synthesized the summer 
and fall of 2007. 
 
The results of these syntheses will be reported as follows: Fields, K. B.; Gao 
G.-Y., Huff, C. A.; Zhang, X. P. Triflates as Synthons for Chiral Porphyrin 
Synthesis via Palladium-Catalyzed Carbon‒Heteroatom Bond Formation. 
Organic Letters, 2010-Ready for submission. 
 
Porphyrins and related tetrapyrrolic macrocycles have important applications in 
a number of fields, including catalysis1, polymer synthesis2, materials3, and 
photodynamic therapy.4 They play essential roles in biological system processes such as 
electron transfer, light harvesting, dioxygen transport, and substrate transformations.5 
The importance of these processes has stimulated intense interest in synthesizing novel 
porphyrin complexes that mimic these systems.  
Chiral porphyrins have found a wide range of useful applications in asymmetric 
catalysis, enzymatic mimicry, and chiral recognition/sensing.1i,6 Several approaches 
have been described for the syntheses of chiral porphyrins.1b,7 In the past, preparation of 
substituted porphyrins was limited by the acidic and oxidative reaction conditions 
which restricted substituent incorporation on the porphyrin macrocycle. These methods 
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have been typically associated with low yields and tedious purifications.8 As a result of 
these difficulties, the development and application of new synthetic strategies have been 
the focus of porphyrin research during the last several decades. 
In recent years, considerable progress has been achieved through the 
development of palladium-catalyzed cross-coupling reactions for the synthesis of 
chiral porphyrins. Smith and coworkers’ report described the first palladium-catalyzed 
cross-coupling of porphyrin substrates.9 Since then, reactions developed by Suzuki, 
Stille, Heck, Sonogashira, Buchwald-Hartwig, and others have been used to create new 
carbon‒carbon and carbon‒heteroatom bonds using palladium-mediated catalysis.10 
These systems allow for modular construction of a large number of functionalized 
derivatives from a single porphyrin precursor.11 The generation of suitable precursors 
has been the key to the success of these reactions, and research has centered on bromo- 
and iodo-porphyrins as the synthons for these cross-coupling reactions.10a,10b,12 
The use of triflates in organic and organometallic reactions is widespread 
because the conjugate base of the superacid, triflic acid, makes an excellent non-
nucleophilic leaving group. In addition to its use as a Lewis acid, its applications 
include SN2 nucleophilic substitutions and cross-coupling. Triflates are well-known aryl 
halide equivalents for palladium-catalyzed cross-coupling reactions, and they are 
typically accessed from phenols and enolates in high yields.13 They have high 
reactivity, good stability for room temperature storage, general ease of chromatography 
purification, and resistance towards hydrolysis.  
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Different halogenated porphyrin scaffolds with dissimilar symmetries have 
been cross coupled using palladium catalysis with a variety of boronic esters, amines, 
amides, alcohols, thiols, selenols, phosphanes, diphenylphosphines, and 
diphenylphosphine oxides, typically in high yields.14 Reported herein is the first 
extension of Buchwald-Hartwig type cross-coupling reactions15 to form porphyrin 
carbon-nitrogen bonds using triflates as pseudo-halides. The mild conditions employed 
for these palladium-catalyzed cross-coupling reactions allow for the use of chiral 
groups without loss of optical purity.16 
Lindsey’s [2+2] approach towards the formation of A2B2 porphyrin synthons 
requires very little chromatographic purification.8 Modification of the Lindsey method 
using a mixed aldehyde condensation additionally allows access to A3B 
tetraphenylporphyrins. This established methodology is useful for the preparation of 
halogenated A3B tetraphenylporphyrins with chromatographically distinct aryl 
substituents, in terms of sterics or polarity. However, when the halogenated aryl groups 
were mixed with other non-polar aryl substituents, the solubility profiles were very 
similar and purification became difficult regardless of quantity. 
A strategy, which employed triflates as pseudo-halides, provided access to the 
“halogenated” A3B tetraphenylporphyrin synthons with non-polar aryl substituents, and 
has allowed for their large scale production. The direct synthesis of triflate containing 
porphyrins resulted in side reactions despite the use of the mild conditions employed in 
the Lindsey method. The presence of triflates or alcohols afforded no or very low yields 
in the conditions required to prepare the porphyrin macrocycle. Conversely, robust 
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methoxy groups easily withstood the acidic and oxidative conditions employed in the 
porphyrin formation and were converted to alcohols then triflates post-cyclization.  
Preparation of the A3B porphyrins containing both methoxy substituted and non-
polar aryl groups using the mixed aldehyde method could be synthesized and separated 
on a gram scale. The total amount of porphyrin produced with this methodology was 
40-45% yields. By varying the ratio of the mixed aldehydes, the reaction conditions 
could be optimized, producing up to 15% of the desired A3B porphyrin. In addition, 
A2B2 porphyrins were produced in similar yields (Scheme 22).  
 
Scheme 22: A3B porphyrin synthesis via mixed aldehyde methodology 
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The methoxy groups were deprotected using boron tribromide to give hydroxy 
porphyrins in 85-99% yields (66a & 66b, Scheme 23). The hydroxy porphyrins were 
subsequently converted into triflates using triflic acid in 90-96% yields (67a & 67b 
Scheme 23). For both reactions, standard literature procedures were followed.13c-e 
 
Scheme 23: Conversion of A3B porphyrins from methoxy 64 to hydroxy 66 to triflate 
67 substituents 
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a Reaction conditions: a) BBr3 (2M in DCM) for 4 h, then slowly add H2O. b) Triflic anhydride (1.5 equiv per OH) 
was added to 1 equiv porphyin with pyridine (2.0 equiv per OH) in DCM at 0 °C to RT for 4-5 h. b Isolated yields. 
 
Palladium-catalyzed amidation reactions between A3B ditriflate porphyrins 5 
and chiral amides 68a-d produced amidoporphyrins 69a-f in low to good yields (Table 
71 
 
14). Amide 68c, which has both amide and alcohol groups, was selectively coupled 
almost exclusively to the amide functionality and didn’t require protection of the 
alcohol group. The quality of porphyrin purity and the dryness of the starting amide are 
both variables that may have contributed to the range of yields reported.  
Among different ligands and bases screened with the pre-catalytic palladium 
complexes Pd2(dba)3 and Pd(OAc)2, the optimal conditions were obtained using a 
combination of Pd(OAc)2, Xantphos and cesium carbonate in THF, which are similar to 
the optimal conditions for bromoporphyrin synthesis.   
During the mixed aldehyde preparation of A3B symmetric porphyrins, A2B2 
porphyrins are also produced and were isolated as well. Using 5,15-diphenyl-10,20-
bis(2,6-dimethoxyphenyl)porphyrin 65 as an example, the tetramethoxyporphyrin was 
deprotected to give the tetrahydroxy porphyrin 70 in 99% yield using the same 
conditions as previously used on the A3B counterparts (Scheme 24). Subsequently, the 
tetrahydroxy porphyrin was converted to the tetratriflate porphyrin 71 in 97% yield.   
The quadruple palladium-catalyzed cross coupling of A2B2 porphyrin triflate 71 
with amide 68c is an indicator of the efficiency of the cross-coupling process. 
Quadruple carbon‒nitrogen bond formation reactions can be accomplished in moderate 
yields under mild conditions with chiral amide building blocks, forming the D2-
symmetric chiral porphyrin 72 (Scheme 25).16a 
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Table 14: Palladium-Catalyzed Cross-Coupling of A3B Porphyrin Triflates with Chiral 
Amides 
entry Por-OTf yield (%)b
1
2c
33
N
HNN
NH
Ar
Ar
Ar
TfO
TfO
N
HNN
NH
Ar
Ar
Ar
HN
HN
*R
O
*R
O
amide
CH3
CH3
H
CH3
OH
N
H
CH3
Ph
H
67a
67a
67a
67b
67b
34
80
62
55H
[Pd]/L igand
Base/Solvent
H2N
*R
O
67 69
3
4c
5
O
H2N
O
O
H2N
H2N
68
product
69a
69e
69c
69b
69d
68a
68c
68b
59
CH3
OMe
H
67b6c
O
H2N
69f68d
 
a Reaction conditions: Porphyrin triflate, chiral amide (4 equiv per OTf), Pd(OAc)2 (5 mol 
% per OTf), Xantphos (10 mol % per OTf),  and Cs2CO3 (4 equiv per OTf) in THF (1 mL/ 
0.01 mmol OTf) at 100 °C for 20 h. b Isolated yields. c 48 h. 
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Scheme 24: Conversion of A2B2 porphyrins from methoxy 65 to hydroxy 70 to triflate 
71 substituents 
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aReaction conditions: a) BBr3 (2M in DCM) for 4 h, then slowly added H2O. b) Triflic anhydride (1.5 equiv per OH) 
was added to 1 equiv porphyin with pyridine (2.0 equiv per OH) in DCM at 0 °C to RT for 4-5 h.  b Isolated yields. 
 
In all cases, the free base porphyrins were directly employed in the palladium-
catalyzed cross-coupling reactions without the need for an “inorganic protecting group” 
for the porphyrins central NH units, avoiding the additional metallation and 
demetallation steps commonly employed by other groups cross-coupling 
methodologies.  
As a part of our program to develop cobalt metalloporphyrins as practical 
catalysts for atom/group transfer reactions,17 the relationship between those chiral 
porphyrins and the resulting selectivity in asymmetric catalytic reactions is currently 
being explored in our lab. New symmetries are being explored based on the hypothesis 
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that it is possible to control diastereoselectivity and enantioselectivity through the 
combined use of chiral R* and meso-aryl groups.16n The corresponding results will be 
published in future reports. 
 
Scheme 25: The quadruple palladium-catalyzed cross-coupling of A2B2 porphyrin 
triflate 71 with amide 68c 
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aReaction conditions: Porphyrin triflate, chiral amide (8 equiv per OTf), Pd(OAc)2 (10 mol % per OTf), Xantphos 
(20 mol % per OTf),  and Cs2CO3 (8 equiv per OTf) in THF (1 mL/ 0.01 mmol OTf) at 80 °C for 48 h. b Isolated 
yield. 
 
In summary, the first examples of triflate porphyrins undergoing cross-coupling 
are described herein. A general methodology has been developed for the palladium-
catalyzed synthesis of carbon‒heteroatom bonds to form amidoporphyrins and 
aryloxyporphyrins from the corresponding triflate porphyrin precursors with chiral 
amides and alcohols. This catalytic system operates efficiently under mild conditions, 
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can be applied to free base porphyrins, and is suitable for a variety of chiral substrates. 
Taking into account the ready commercial availability of a wide variety of chiral 
substrates and the versatility of porphyrin triflate synthons, this new methodology 
allows for the large scale production of non-polar porphyrin synthons with A3B and 
A2B2 symmetries. 
 
Experimental Section for Bromoporphyrins 
“Bromoporphyrins as Versatile Synthons for Modular Construction of Chiral 
Porphyrins: Cobalt-Catalyzed Highly Enantioselective and Diastereoselective 
Cyclopropanation” 
General Considerations. All cross-coupling reactions were carried out under a nitrogen 
atmosphere in oven-dried glassware following standard Schlenk techniques. 
Tetrahydrofuran (THF) and toluene were distilled under nitrogen from sodium 
benzophenone ketyl. Chiral amides were purchased from Aldrich Chemical Co. and 
Acros Organics, used without further purification. Anhydrous cobalt(II) chloride, cobalt 
acetate tetrahydrate, palladium(II) acetate, and 9,9-dimethyl-4,5-
bis(diphenylphosphino)xanthene (Xantphos) were purchased from Strem Chemical Co.. 
Cesium carbonate was obtained as a gift from Chemetall Chemical Products, Inc. 
 
General Procedures for Synthesis of Brominated Porphyrins. The brominated 
porphyrins were prepared according to the method described in literature.1,2 A mixture 
of meso-(2,6- dibromophenyl)dipyrromethane (1 mmol), aldehyde (1 mmol), and 
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molecular sieves (4A, 0.300g) in chloroform (150 ml) was purged with nitrogen for 10 
min. Boron trifluoride diethyl etherate (0.1 mL) was added dropwise via a syringe and 
the flask was wrapped with aluminum foil to shield it from light. The solution was 
stirred under a nitrogen atmosphere at room temperature for 3 h, and 2,3-dichloro-5,6-
dicyano-1,4-benzoquinone (DDQ) (1.2 mmol) was added as powder at one time. After 
30 min, 1 mL of triethylamine was added. The reaction solution was then directly 
poured on the top of a silica gel column that was packed with dichloromethane. The 
column was eluted with dichloromethane. The fractions containing product were 
collected and concentrated on a rotary evaporator. The residue was washed several 
times with hexanes to afford the pure compound. 
 
General Procedures for Amidation of Bromoporphyrin. The bromoporphyrin, chiral 
amide, Pd(OAc)2, Xantphos, and Cs2CO3 were placed in an oven-dried, resealable 
Schlenk tube. The tube was capped with a Teflon screwcap, evacuated, and backfilled 
with nitrogen. The screwcap was replaced with a rubber septum, and THF was added 
via syringe. The tube was purged with nitrogen for 2 min, and then the septum was 
replaced with the Teflon screwcap. The tube was sealed, and its contents were heated 
with stirring. The resulting mixture was cooled to room temperature, taken up in ethyl 
acetate and concentrated in vacuo. The crude product was then purified by flash 
chromatography. 
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General Procedures for Synthesis of Cobalt porphyrin complexes. Free-base porphyrin 
and anhydrous CoCl2 were placed in an oven-dried, resealable Schlenk tube. The tube 
was capped with a Teflon screwcap, evacuated, and backfilled with nitrogen. The 
screwcap was replaced with a rubber septum, 2,6-lutidine and dry THF were added via 
syringe. The tube was purged with nitrogen for 2 minutes, and then the septum was 
replaced with the Teflon screwcap. The tube was sealed, and its contents were heated 
with stirring. The resulting mixture was cooled to room temperature, taken up in ethyl 
acetate, and transferred to a separatory funnel. The mixture was washed with water 3 
times and concentrated in vacuo. 
 
Experimental Section and Spectra for Triflates 
“Triflates as Synthons for Chiral Porphyrin Synthesis via Palladium-Catalyzed 
Carbon‒Heteroatom Bond Formation”  
General Considerations. All cross-coupling reactions were carried out under a nitrogen 
atmosphere in oven-dried glassware following standard Schlenk techniques. All chiral 
building blocks and chemicals were purchased from Acros Organics or Aldrich 
Chemical Co. and used without further purification. Palladium(II) acetate, 
tris(dibenzylideneacetone)dipalladium(0), and 9,9-dimethyl-4,5-
bis(diphenylphosphino)xanthene (Xantphos) were purchased from Strem Chemical Co. 
Cesium carbonate was obtained as a gift from Chemetall Chemical Products, Inc. All 
ligands, palladium precursors, and bases were stored in desiccators filled with 
anhydrous calcium sulfate, and weighed in the air. Toluene and THF were distilled 
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under nitrogen from sodium benzophenone ketyl. Thin layer chromatography was 
performed on Merck TLC plates (silica gel 60 F254). Flash column chromatography 
was performed with ICN silica gel (60Å, 230-400 mesh, 32-63μm). 1H-NMR and 13C-
NMR were recorded on either a Bruker DPX 250 (250 MHz), aVarian Mercury 300 
(300 MHz) or a Varian Inova400 (400MHz) instrument with chemical shifts reported 
relative to residual solvent. HRMS data was obtained on an Agilent 1100 LC/MS 
ESI/TOF or Bruker Autoflex MALDI-TOF mass spectrometer. Porphyrin triflates were 
synthesized based on the procedures described below. 
 
General Procedure for the Synthesis of A3B Methoxy-Porphyrins.  Compounds SM-1a, 
SM-1b and SM-6 were prepared based on Lindsey’s methodology using mixed 
aldehydes with dipyrrolmethane. (Note: mixed dipyrrolmethanes do not give sufficient 
yield of the desired A3B product and the statistical condensation of aldehydes with 
pyrrole afforded only 5% yield of 64a). A 2L round bottom flask, containing 1L 
chloroform and a stir bar, was purged with nitrogen. To the flask, 1.0 equivalent 
(approx. 1 gram) of 5-phenyl dipyrrolmethane and a 1.0 equiv mixture of the two 
benzaldehydes (2,6-dimethoxybenzaldehyde: benzaldehyde=3:1) were added with 
stirring. The flask was wrapped in aluminum foil and 0.1 equivalents of BF3•OEt2 was 
added and stirred. Approximately 3 hours later, the mixture was oxidized with 1.5 
equivalents DDQ and stirred for another 2.5-3 hours, while being monitored by TLC. 
Triethylamine was then added to neutralize the Lewis acid. Then the stir bar was 
removed and the entire contents of the flask were poured onto a 1 L (12 inch x 40mm 
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frit) column packed with silica, topped with sand, and homogenized with methylene 
chloride. Once the contents of the flask reached the sand, the porphyrin product mixture 
was eluted with methylene chloride to give three bands, the first red band being the A4 
(TPP) product, the second band being the A3B product, and the third band being the 
A2B2 product. The fractions were then concentrated by rotary evaporation, added to a 
filter funnel, and rinsed with cold methanol to rinse away residual DDQ. 
N
HNN
NH
MeO
MeO
 
5-(2,6-Dimethoxy-phenyl)-10,15,20-triphenylporphyrin (SM-64a). For 64a, 1.0 
equiv of 5-phenyl dipyrrolmethane and a 1.0 equiv mixture of two benzaldehydes (2,6-
dimethoxybenzaldehyde: benzaldehyde=3:1) was used. Product SM-64a was obtained 
in 12% yield after flash chromatography (silica gel: methylene chloride). 1H NMR (300 
MHz, CDCl3): δ 8.80 (m, 8H), 8.20 (m, 6H), 7.72 (m, 10H), 7.01 (d, J = 8.4 Hz, 2H), 
3.51 (s, 6H), -2.71 (s, 2H); 13C NMR (75 MHz, CDCl3): δ 160.5, 142.4, 142.3, 134.5, 
130.2, 127.5, 126.6, 120.0, 119.7, 119.5, 112.1, 104.1, 56.0. UV–vis (CH2Cl2), λmax 
nm: 417, 514, 546, 590, 645. HRMS-EI ([M]+): calcd for C46H34N4O2, 674.2682; found: 
674.2690.  
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5-(2,6-Dimethoxy-phenyl)-10,15,20-tri(4-tert-butylphenyl)porphyrin (SM-64b). 
For SM-64b, 1.0 equiv of 5-(4-tert-butylphenyl)dipyrrolmethane and a 1.0 equiv 
mixture of two benzaldehydes (2,6-dimethoxybenzaldehyde: 4-tert-
butylbenzaldehyde=3:1) were used. Product SM-64b was obtained in 15% yield after 
flash chromatography (silica gel: methylene chloride). 1H NMR (400 MHz, CDCl3): δ 
8.82 (s, 6H), 8.75 (d, J = 4.4 Hz, 2H), 8.12 (d, J = 8.0 Hz, 6H), 7.73 (m, 7H), 7.00 (d, J 
= 8.4 Hz, 2H), 3.50 (s, 6H), 1.59 (s, 9H), 1.58 (s, 18H), -2.68 (s, 2H); 13C NMR (100 
MHz, CDCl3): δ 160.6, 150.3, 139.5, 139.3, 134.4, 130.1, 123.4, 120.2, 120.0, 119.5, 
111.7, 104.2, 56.0, 34.8, 32.4, 31.7, 30.9. UV–vis (CHCl3), λmax nm: 421, 520, 552, 
592, 648. HRMS-MALDI ([M+H]+): calcd for C58H59N4O2, 843.4641; found: 
843.4641.  
 
General Procedure for the Synthesis of A3B Hydroxy-Porphyrins. Compounds SM-66a, 
SM-66b and SM-70 were prepared based on standard demethylation methodology 
using boron tribromide as described in literature. To a solution of SM-64a, SM-64b, or 
SM-65 in anhydrous methylene chloride, BBr3 was added dropwise slowly under N2 
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until the concentration of BBr3 was 2M. The mixture was stirred under N2 at room 
temperature for 4-5 h. A small amount of water was then added dropwise – slowly and 
carefully – to quench. The product was extracted with ethyl acetate (or methylene 
chloride) and washed with water until neutral. The organic layer was concentrated until 
dryness. Product could be recrystallized in hexanes or purified by flash 
chromatography. 
 
N
HNN
NH
HO
HO
 
5-(2,6-Dihydroxy-phenyl)-10,15,20-triphenylporphyrin (SM-66a). Compound 
SM-66a was prepared according to the general procedure described above and the 
residue was recrystallized in hexanes to give the title compound as a purple solid 
(220mg, 99% yield). For SM-66a, 1H NMR (300 MHz, CDCl3): δ 8.91 (m, 4H), 8.87 
(m, 4H), 8.20 (m, 6H), 7.77 (m, 9H), 7.59 (t, J = 8.1 Hz, 1H), 6.96 (d, J = 8.1 Hz, 2H), 
4.72 (s, 2H), -2.74 (s, 2H); 13C NMR (75 MHz, CDCl3): δ 156.2, 141.8, 141.5, 134.5, 
130.9, 127.9, 126.8, 126.7, 122.0, 120.8, 115.5, 107.7, 103.2. UV–vis (CH2Cl2), λmax 
nm: 417, 514, 549, 588, 642. HRMS-EI ([M]+): calcd for C44H30N4O2, 646.2369; found: 
646.2362. 
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5-(2,6-Dihydroxy-phenyl)-10,15,20-tri(4-tert-butylphenyl)porphyrin. (SM-66b) 
Compound SM-66b was prepared according to the general procedure described above 
and was purified by flash chromatography to give the  title compound as a purple solid 
(240mg, 85% yield). For SM-66b, 1H NMR (400 MHz, CDCl3): δ 8.89 (m, 8H), 8.12 
(m, 6H), 7.75 (d, J = 8.0 Hz, 6H), 7.60 (t, J = 8.4 Hz, 1H), 6.98 (d, J = 8.4 Hz, 2H), 
4.73 (s, 2H), 1.60 (s, 27H), -2.71 (s, 2H); 13C NMR (100 MHz, CDCl3): δ 156.3, 150.8, 
138.9, 138.6, 134.5, 131.0, 123.7, 123.6, 122.3, 121.0, 115.7, 107.7, 106.4, 102.6, 67.6, 
67.4, 34.9, 32.4, 31.7, 31.0, 29.5. UV–vis (CHCl3), λmax nm: 421, 448, 517, 553, 590, 
646. HRMS-MALDI ([M+H]+): calcd for C56H55N4O2, 815.4320; found: 815.4324. 
 
General Procedure for the Synthesis of A3B Triflate-Porphyrins. Compounds SM-67a, 
SM-67b and SM-71 were prepared based on standard methodology using triflic 
anhydride as described in literature. To a solution of SM-66a, SM-66b, or SM-70 in 
anhydrous methylene chloride at 0 oC, pyridine (2.0 equiv per OH) and triflic anhydride 
(1.5 equiv per OH) were added dropwise successively. The mixture was allowed to stir 
at 0 oC for 0.5 hours, removed from the ice bath, and continued to stir at room 
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temperature for another 4-5 h. The solution was diluted with methylene chloride and 
washed with water until neutral. The methylene chloride solution was concentrated until 
dry. Product could be recrystallized in hexanes or purified by flash chromatography. 
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Trifluoro-methanesulfonic acid 3-trifluoromethanesulfonyloxy-2-(10,15,20-
triphenyl-porphyrin-5-yl)-phenyl ester (SM-67a). Compound SM-67a was prepared 
according to the general procedure described above and the residue was recrystallized 
in hexanes to give pure title compound as a purple solid (200mg, 96% yield). For SM-
67a, 1H NMR (300 MHz, CDCl3): δ 8.89 (d, J = 4.8 Hz, 2H), 8.85 (m, 4H), 8.64 (d, J = 
4.8 Hz, 2H), 8.19-8.25 (m, 6H), 8.02 (m, 1H), 7.86 (d, J = 8.1 Hz, 2H), 7.77 (m, 9H), -
2.72 (s, 2H); 13C NMR (75 MHz, CDCl3): δ 150.2, 141.9, 141.8, 134.7, 134.5, 131.3, 
131.0, 127.9, 127.8, 126.7, 121.3, 120.8, 102.3. 19F NMR (75 MHz, CDCl3): δ -75.0. 
UV–vis (CH2Cl2), λmax nm: 417, 514, 548, 589, 643. HRMS-EI ([M]+): calcd for 
C46H28F6N4O6S2, 910.1354; found: 910.1356.  
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Trifluoro-methanesulfonic acid 3-trifluoromethanesulfonyloxy-2-(10,15,20-
tri(4-tert-butylphenyl)-porphyrin-5-yl)-phenyl ester (SM-67b) Compound SM-67b 
was prepared according to the general procedure described above and the residue was 
purified by flash chromatography to give pure title compound as a purple solid (225mg, 
90% yield). For SM-67b, 1H NMR (400 MHz, CDCl3): δ 8.90 (d, J = 4.0, 2H), 8.87 (s, 
4H), 8.60 (d, J = 4.4, 2H), 8.14 (m, 6H), 8.01 (t, J = 8.2, 1H), 7.86 (d, J = 8.2, 2H), 7.75 
(d, J = 8.0, 6H), 1.60 (s, 27H), -2.69 (s, 2H); 13C NMR (100 MHz, CDCl3): δ 207.8, 
150.6, 150.2, ??, 138.8, 134.6, 134.4, 131.2, 123.6, 121.2, 120.4, 34.9, 31.7. 19F NMR 
(100 MHz, CDCl3): δ -75.1. UV–vis (CHCl3), λmax nm: 420, 516, 551, 591, 647. 
HRMS-MALDI ([M+H]+): calcd for C58H53F6N4O6S2, 1079.3305; found: 1079.3314. 
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General Procedures for Synthesis of Chiral Porphyrins via Palladium-Catalyzed C-N 
Bond Formation. (SM-69a-69f, SM-72) An oven-dried Schlenk tube equipped with a 
stirring bar was degassed on vacuum line and purged with nitrogen. The tube was then 
charged with palladium precursor (5 mol % per triflate), phosphine ligand (10 mol % 
per triflate), chiral building block (4 equiv per triflate), porphyrin triflate (0.03 to 0.05 
mmol), and base (4 equiv per triflate). The tube was capped with a Teflon screwcap, 
evacuated and backfilled with nitrogen. After the Teflon screwcap was replaced with a 
rubber septum, THF (1 mL/ 0.01 mmol triflate) was added. The tube was purged with 
nitrogen (1-2 min) and the septum was then replaced with the Teflon screwcap and 
sealed. The reaction mixture was heated in an oil bath with stirring at 100 °C for 20 
hours and monitored by TLC. After cooling to room temperature, the reaction mixture 
was diluted with ethyl acetate, washed with water (x 3) and concentrated to dryness. 
The solid residue was purified by flash chromatography to give the desired products. 
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Example 69a 
The general procedure was used to couple trifluoro-methanesulfonic acid 3-
trifluoromethanesulfonyloxy-2-(10,15,20-triphenyl-porphyrin-5-yl)-phenyl ester SM-
67a (0.05 mmol) with (S)-(+)-2,2-dimethylcyclopropanecarboxamide 68a (0.4 mmol). 
The title compound was isolated by flash chromatography (silica gel, methylene 
chloride: ethyl acetate (v/v) = 9:1) as a purple solid (14.0 mg, 34%). 1H NMR (300 
MHz, CDCl3): δ 8.89 (m, 6H), 8.81 (d, J = 4.8 Hz, 2H), 8.45 (s,bro., 2H), 8.20 (d, J = 
6.3 Hz, 6H), 7.73-7.83 (m, 10H), 6.51 (s, 2H), 0.85 (s, 6H), 0.63 (s, 2H), 0.13 (s, 6H), 
0.06 (m, 2H), -0.10 (s, 2H), -2.69 (s, 2H). 13C NMR (62.5 MHz, CDCl3): δ 169.6, 
141.7, 141.4, 139.4, 134.5, 130.2, 128.1, 126.9, 126.8, 122.0, 120.8, 106.5, 29.0, 26.2, 
22.2, 20.3, 18.3. UV–vis (CH2Cl2), λmax nm: 419, 515, 549, 590, 644. HRMS-EI 
([M+H]+): calcd for C56H49N6O2, 837.3872, found 837.3860. 
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Example 69b 
The general procedure was used to couple trifluoro-methanesulfonic acid 3-
trifluoromethanesulfonyloxy-2-(10,15,20-tri(4-tert-butylphenyl)-porphyrin-5-yl)-phenyl 
ester SM-67b (0.03 mmol) with (S)-(+)-2,2-dimethylcyclopropanecarboxamide 68a 
(0.23 mmol). The reaction was conducted for 48 h. The title compound was isolated by 
flash chromatography (silica gel, methylene chloride: ethyl acetate (v/v) = 9:1) as a 
purple solid (18mg, 62% yield). 1H NMR (400 MHz, CDCl3): δ 8.94 (d, J = 4.8 Hz, 
2H), 8.91 (s, 4H), 8.77 (d, J = 4.8 Hz, 2H), 8.46 (s, 2H), 8.12 (m, 6H), 7.79 (m, 7H), 
6.53 (s, 2H), 1.61 (s, 27H), 1.24 (m, 2H), 0.84 (s, 6H), 0.10 (m, 8H). 13C NMR (100 
MHz, CDCl3): δ 169.6, 150.9, 139.4, 138.8, 138.5, 134.5, 130.1, 123.8, 123.7, 122.2, 
121.0, 116.8, 106.0, 34.9, 32.4, 31.7, 30.9, 29.1, 26.2, 22.2. UV-vis(CHCl3), λmax nm: 
422, 452,517, 554, 591, 647. HRMS-EI([M+H]+): calcd for C68H73N6O2, 1005.5790, 
found 1005.5793. 
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Example 69c 
The general procedure was used to couple trifluoro-methanesulfonic acid 3-
trifluoromethanesulfonyloxy-2-(10,15,20-triphenyl-porphyrin-5-yl)-phenyl ester SM-
67a (0.05 mmol) with 1-[1’-(R)-α-methylbenzyl]-aziridine-2-(R)-carboxamide 68b 
(0.40 mmol). The title compound was isolated by flash chromatography (silica gel, 
methylene chloride: ethyl acetate (v/v) = 9:1) as a purple solid (39.0 mg, 80%). 1H 
NMR (300 MHz, CDCl3): δ 8.84 (t, J = 4.8 Hz, 4H), 8.78 (d, J = 4.8 Hz, 2H), 8.73 (d, J 
= 4.8 Hz, 2H), 8.62 (d, J = 8.1 Hz, 2H), 8.17-8.23 (m, 6H), 7.71-7.87 (m, 9H), 7.61-
7.69 (m, 1H), 5.80 (t, J = 7.5 Hz, 2H), 4.33 (t, J = 7.5 Hz, 4H), 3.78 (d, J = 7.2 Hz, 4H), 
1.52 (m, 4H), 1.22 (m, 2H), 0.57 (d, J = 7.2 Hz, 2H), 0.53 (d, J = 3.0 Hz, 2H), -0.76 (d, 
J = 6.3 Hz, 6H), -2.35 (s, 2H). 13C NMR (75 MHz, CDCl3): δ 168.2, 142.0, 141.5, 
140.9, 138.9, 134.3, 130.5, 127.8, 126.7, 125.9, 125.4, 124.2, 120.8, 120.7, 115.1, 
106.2, 66.7, 39.4, 33.7, 20.4. UV–vis (CH2Cl2), λmax nm: 418, 513, 547, 598, 643.  
HRMS-EI ([M]+): calcd for C66H54N8O2, 990.4370, found 990.4412. 
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Example 69d 
The general procedure was used to couple trifluoro-methanesulfonic acid 3-
trifluoromethanesulfonyloxy-2-(10,15,20-tri(4-tert-butylphenyl)-porphyrin-5-yl)-phenyl 
ester SM-67b (0.04 mmol) with 1-[1’-(R)-α-methylbenzyl]-aziridine-2-(R)-carboxamide 
68b (0.32 mmol). The reaction was conducted for 48 h. The title compound was 
isolated by flash chromatography (silica gel, methylene chloride: ethyl acetate (v/v) = 
9:1) as a purple solid (26.0 mg, 55% yield). 1H NMR (400 MHz, CDCl3): δ 8.87 (m, 
4H), 8.81 (d, J = 4.8 Hz, 2H), 8.70 (d, J = 4.4 Hz, 2H), 8.61 (d, J = 8.4 Hz, 2H), 8.18 (s, 
2H), 8.13 (d, J = 8.0 Hz, 4H), 7.84 (t, J = 8.4 Hz, 1H), 7.78 (m, 4H), 7.72 (d, J = 8.0 Hz, 
2H), 7.65 (d, J = 7.6 Hz, 2H), 5.79 (t, J = 7.2 Hz, 2H), 4.38 (t, J = 7.6 Hz, 4H), 3.80 (d, 
J = 7.6 Hz, 4H), 1.62 (s, 9H), 1.57 (s, 18H), -0.75 (d, J = 6.0 Hz, 6H), -2.32 (s, 2H). 13C 
NMR (100 MHz, CDCl3): δ 168.3, 150.8, 150.7, 140.9, 139.2, 139.0, 138.6, 134.2, 
134.3, 130.4, 126.0, 125.4, 124.2, 123.7, 122.0, 121.1, 120.9, 115.2, 105.8, 66.9, 39.5, 
34.9, 32.4, 31.7, 30.9. UV–vis (CHCl3), λmax nm: 421, 516, 551, 591, 647.  HRMS-EI 
([M+H]+): calcd for C78H78N8O2, 1159.6321, found 1159.6320.  
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Example 69e 
The general procedure was used to couple trifluoro-methanesulfonic acid 3-
trifluoromethanesulfonyloxy-2-(10,15,20-triphenyl-porphyrin-5-yl)-phenyl ester SM-
67a (0.05 mmol) with  (R)-(-)-lactamide 68c (0.4 mmol). The title compound was 
isolated by flash chromatography (silica gel, methylene chloride: THF (v/v) = 9:1) as a 
purple solid (13.0 mg, 33%). 1H NMR (300 MHz, CDCl3): δ 8.83 (m, 6H), 8.68 (d, J = 
4.8 Hz, 2H), 8.38 (d, J = 8.7 Hz, 2H), 8.13 (m, 6H), 7.67-7.82 (m, 10H), 7.55 (s, 2H), 
3.19 (m, 2H), 0.40 (d, J = 6.6 Hz, 6H), -2.69 (s, 2H). 13C NMR (75 MHz, CDCl3): δ 
172.1, 141.3, 138.4, 134.6, 134.4, 130.4, 128.0, 126.9, 126.7, 120.9, 117.4, 67.7, 20.1. 
UV–vis (CH2Cl2), λmax nm: 418, 515, 550, 589, 644. HRMS-EI ([M]+): calcd for 
C50H40N6O4, 788.3111, found 788.3127.  
 
 
91 
 
N
HNN
NH
HN
HN
O
O
H3CO H
HH3CO
 
Example 69f 
The general procedure was used to couple trifluoro-methanesulfonic acid 3-
trifluoromethanesulfonyloxy-2-(10,15,20- tri(4-tert-butylphenyl)-porphyrin-5-yl)-
phenyl ester SM-67b (0.04 mmol) with (S)-(-)-2-methoxypropanamide 68d (0.32 
mmol). The reaction was conducted for 48 h. The title compound was isolated by flash 
chromatography (silica gel, methylene chloride: THF (v/v) = 9:1) as a purple solid (39.0 
mg, 59%). 1H NMR (400 MHz, CDCl3): δ 8.89 (m, 6H), 8.73 (d, J = 4.8 Hz, 2H), 8.58 
(d, J = 8.4 Hz, 2H), 8.14 (m, 4H), 8.01 (m, 2H), 7.87 (t, J = 8.4 Hz, 1H), 7.76-7.81 (m, 
8H), 3.02 (q, J = 6.8 Hz, 2H), 1.61 (s, 9H), 1.60 (s, 18H), 1.24 (s, 6H), 0.61 (d, J = 6.4 
Hz, 6H), -2.61 (s, 2H). 13C-NMR (75 MHz, CDCl3): δ 171.3, 150.8, 138.9, 138.7, 
138.5, 134.4, 130.4, 123.8, 123.7, 122.3, 122.1, 120.9, 116.6, 105.6, 55.9, 34.9, 32.4, 
31.7, 30.9, 17.8. UV-vis (CHCl3), λmax nm: 421,517, 553, 592, 647. HRMS-EI 
([M+H]+): calcd for C64H69N6O4, 985.5375, found 985.5374. 
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5,15-bis(2,6-Dimethoxy-phenyl)-10,20-diphenylporphyrin (SM-65). Product 
SM-3 was obtained from the same reaction as SM-64a. Product SM-65 was obtained in 
12% yield after flash chromatography (silica gel: methylene chloride). (Note: If the 
A3B product is not desired, then this product is also easily accessed in 40% yield from 
the reaction of 5-phenyl dipyrrolmethane and 2,6-dimethoxybenzaldehyde (1:1) 
according to literature procedures). 1H NMR (300 MHz, CDCl3): δ 8.76 (s, 8H), 8.20 
(m, 4H), 7.71 (m, 8H), 6.98 (dd, J = 8.1, 1.8 Hz, 4H), 3.49 (s, 12H), -2.65 (s, 2H); 13C 
NMR (75 MHz, CDCl3): δ 160.5, 142.4, 134.5, 130.1, 127.4, 126.5, 120.0, 118.8, 
112.1, 104.1, 56.1. UV–vis(CH2Cl2), λmax nm: 417, 513, 547, 590, 643. HRMS-EI 
([M]+): calcd for C48H38N4O4, 734.2893; found: 734.2906. 
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5,15-bis(2,6-Dihydroxy-phenyl)-10,20-diphenylporphyrin (SM-70). Compound 
SM-8 was prepared according to the method described in the General Procedure for the 
Synthesis of A3B Hydroxy-Porphyrins using a solution of SM-65.The title compound 
was recrystallized in hexanes to give pure title compound as a purple solid (675 mg, 
85% yield). For SM-70, 1H NMR (300 MHz, CDCl3): δ 8.95 (d, J = 4.8 Hz, 4H), 8.92 
(d, J = 4.8 Hz, 4H), 8.17 (m, 4H), 7.78 (m, 6H), 7.61 (t, J = 8.1 Hz, 2H), 6.97 (d, J = 
8.7 Hz, 4H), 4.66 (s, 4H), -2.77 (s, 2H); 13C NMR (75 MHz, CDCl3): δ 156.2, 141.0, 
134.5, 131.2, 128.1, 126.9, 126.8, 121.3, 115.4, 107.9. UV–vis (CH2Cl2), λmax nm: 
417, 513, 548, 588, 642. HRMS-EI ([M]+): calcd for C44H30N4O4, 678.2267; found: 
678.2257. 
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Trifluoro-methanesulfonic acid 2-[15-(2,6-bis-trifluoromethanesulfonyloxy-
phenyl)-10,20-diphenyl-porphyrin-5-yl]-3-trifluoromethanesulfonyloxy-phenyl 
ester (SM-71).  Compound was prepared according to the method described in the 
General Procedure for the Synthesis of A3B Triflate-Porphyrins using a solution of SM-
70 The title compound was recrystallized in hexanes to give pure title compound as a 
purple solid (346mg, 97% yield). For SM-8, 1H NMR (300 MHz, CDCl3): δ 8.88 (d, J 
= 4.8 Hz, 4H), 8.65 (d, J = 4.8 Hz, 4H), 8.23-8.27 (m, 4H), 8.04 (m, 2H), 7.87 (m, 4H), 
7.77 (m, 6H), -2.79 (s, 2H); 13C NMR (75 MHz, CDCl3): δ 150.2, 141.5, 134.9, 134.5, 
131.5, 130.8, 127.9, 126.7, 121.5, 121.4, 121.2, 119.6, 115.4, 104.2. 19F NMR (75 
MHz, CDCl3): δ -74.9. UV–vis (CH2Cl2), λmax nm: 416, 512, 546, 589, 644. HRMS-EI 
([M]+): calcd for C48H26F12N4O12S4, 1206.0238; found: 1206.0235. 
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Example 72 
The general procedure was used to couple trifluoro-methanesulfonic acid 2-[15-
(2,6-bis-trifluoromethanesulfonyloxy-phenyl)-10,20-diphenyl-porphyrin-5-yl]-3-
trifluoromethanesulfonyloxy-phenyl ester 9 (0.05 mmol) with 1-[1’-(R)-α-
methylbenzyl]-aziridine-2-(R)-carboxamide 6b (1.6 mmol). The reaction was conducted 
in THF at 80 °C for 48 h. The title compound was isolated by flash chromatography 
(silica gel, methylene chloride: ethyl acetate (v/v) = 8.5:1.5) as a purple solid (73.0 mg, 
53%). 1H NMR (300 MHz, CDCl3): δ 8.89 (m, 8H), 8.58 (m, 8H), 7.94 (t, J = 8.1 Hz, 
2H), 7.54 (t, J = 7.5 Hz, 2H), 7.33 (t, J = 8.1 Hz, 4H), 6.72 (d, J = 7.8 Hz, 4H), 5.86 (t, 
J = 6.9 Hz, 4H), 4.54 (m, 12H), 1.61 (m, 8H), 1.23 (d, J = 3.0 Hz, 2H), 0.86 (m, 2H), 
0.55 (d, J = 6.0 Hz, 12H), 0.27 (m, 8H), -2.08 (s, 2H). 13C NMR (75 MHz, CDCl3): δ 
168.7, 141.5, 140.6, 138.9, 133.1, 130.9, 127.7, 126.2, 126.1, 125.2, 123.8, 121.8, 
120.2, 115.9, 108.6, 66.5, 39.4, 34.1, 23.6. UV–vis (CH2Cl2), λmax nm: 421, 515, 549, 
590, 645.  HRMS-EI ([M+H]+): calcd for C88H79N12O4, 1367.6342, found 1367.6330. 
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1H-NMR (300MHz)  5-(2,6-Dimethoxyphenyl)-10,15,20-triphenylporphyrin (SM-64a) 
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13C-NMR (75 MHz)  5-(2,6-Dimethoxyphenyl)-10,15,20-triphenylporphyrin (SM-64a) 
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1H-NMR (400MHz)  5-(2,6-Dimethoxyphenyl)-10,15,20-tri(4-tert-
butylphenyl)porphyrin (SM-64b) 
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13C-NMR (100 MHz)  5-(2,6-Dimethoxy-phenyl)-10,15,20-tri(4-tert-
butylphenyl)porphyrin (SM-64b) 
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1H-NMR (300MHz)  5,15-bis(2,6-Dimethoxy-phenyl)-10,20-diphenylporphyrin (SM-
65) 
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13C-NMR (75 MHz)  5,15-bis(2,6-Dimethoxy-phenyl)-10,20-diphenylporphyrin (SM-
65) 
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1H-NMR (300MHz)  5-(2,6-Dihydroxy-phenyl)-10,15,20-triphenylporphyrin (SM-66a) 
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13C-NMR (75 MHz)  5-(2,6-Dihydroxy-phenyl)-10,15,20-triphenylporphyrin (SM-66a) 
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1H-NMR (400MHz)  5-(2,6-Dihydroxy-phenyl)-10,15,20-tri(4-tert-
butylphenyl)porphyrin. (SM-66b) 
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13C-NMR (100 MHz)  5-(2,6-Dihydroxy-phenyl)-10,15,20-tri(4-tert-
butylphenyl)porphyrin. (SM-66b) 
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1H-NMR (300MHz)  Trifluoro-methanesulfonic acid 3-trifluoromethanesulfonyloxy-2-
(10,15,20-triphenyl-porphyrin-5-yl)-phenyl ester (SM-67a) 
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13C-NMR (75 MHz)  Trifluoro-methanesulfonic acid 3-trifluoromethanesulfonyloxy-2-
(10,15,20-triphenyl-porphyrin-5-yl)-phenyl ester (SM-67a) 
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19F-NMR (75MHz) Trifluoro-methanesulfonic acid 3-trifluoromethanesulfonyloxy-2-
(10,15,20-triphenyl-porphyrin-5-yl)-phenyl ester (SM-67a) 
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1H-NMR (400MHz)  Trifluoro-methanesulfonic acid 3-trifluoromethanesulfonyloxy-2-
(10,15,20-tri(4-tert-butylphenyl)-porphyrin-5-yl)-phenyl ester (SM-67b) 
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13C-NMR (100 MHz)  Trifluoro-methanesulfonic acid 3-trifluoromethanesulfonyloxy-
2-(10,15,20-tri(4-tert-butylphenyl)-porphyrin-5-yl)-phenyl ester (SM-67b) 
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19F-NMR (100MHz) Trifluoro-methanesulfonic acid 3-trifluoromethanesulfonyloxy-2-
(10,15,20-tri(4-tert-butylphenyl)-porphyrin-5-yl)-phenyl ester (SM-67b) 
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1H-NMR (300MHz)  Example 69a 
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13C-NMR (62.5 MHz)  Example 69a  
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1H-NMR (400MHz)  Example 69b 
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13C-NMR (100 MHz)  Example 69b 
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1H-NMR (300MHz)  Example 69c 
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13C-NMR (75 MHz)  Example 69c 
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1H-NMR (400MHz)  Example 69d 
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13C-NMR (100 MHz)  Example 69d 
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1H-NMR (300MHz)  Example 69e 
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13C-NMR (75 MHz)  Example 69e 
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1H-NMR (400MHz)  Example 69f 
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13C-NMR (100 MHz)  Example 69f 
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1H-NMR (300MHz)  5,15-bis(2,6-Dihydroxy-phenyl)-10,20-diphenylporphyrin (SM-
70) 
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13C-NMR(75 MHz) 5,15-bis(2,6-Dihydroxy-phenyl)-10,20-diphenylporphyrin (SM-70) 
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1H-NMR (300MHz)  Trifluoro-methanesulfonic acid 2-[15-(2,6-bis-
trifluoromethanesulfonyloxy-phenyl)-10,20-diphenyl-porphyrin-5-yl]-3-
trifluoromethanesulfonyloxy-phenyl ester (SM-71) 
 
N
NH N
HN
O
O
O
O
S
SS
S
CF3
O
O F3C
O
O
F3C O
O
CF3O
O
127 
 
13C-NMR (75 MHz)  Trifluoro-methanesulfonic acid 2-[15-(2,6-bis-
trifluoromethanesulfonyloxy-phenyl)-10,20-diphenyl-porphyrin-5-yl]-3-
trifluoromethanesulfonyloxy-phenyl ester (SM-71) 
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19F-NMR (75MHz) Trifluoro-methanesulfonic acid 2-[15-(2,6-bis-
trifluoromethanesulfonyloxy-phenyl)-10,20-diphenyl-porphyrin-5-yl]-3-
trifluoromethanesulfonyloxy-phenyl ester (SM-71) 
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1H-NMR (300MHz)  Example 72 
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13C-NMR (75 MHz)  Example 72 
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Palladium-Catalyzed C-O Coupling 
Porphyrins and metalloporphyrins that possess aryloxy and alkoxy groups have 
been shown to serve as catalysts, liquid crystal complexes, and photoinduced electron 
transfer agents.133-151 However, in comparison to the large numbers of synthetic 
porphyrins with carbon-based peripheral substituents, only a limited number of 
porphyrins with aryloxy- and alkoxy-substituents have been reported. 
Aryloxy- and alkoxyl-substituted porphyrins have been traditionally prepared 
via nucleophilic substitution of pyrroles.140-151 Considering the multiple steps and 
electronic requirements associated with alkoxypyrrole synthesis,140-142 the development 
of alternative methods to synthesize this class of porphyrin conjugates was necessary 
to exploit these compounds.140-151 The following section highlights recent 
advancements made in C–O bond formations via palladium-catalyzed cross-coupling. 
 
Meso-Etheration and Hydroxylation 
Zhang and co-workers explored the palladium-catalyzed etheration152-159 of 
meso-bromoporphyrins 2 and 3 for the versatile synthesis of meso-aryloxy- and 
alkoxyl-substituted porphyrins (Scheme 26).131,160 The reactions were performed under 
mild conditions with a host of alcohols, producing a family of novel porphyrins in 
moderate to high yields (Tables 15 and 16). In general, simple bidentate phosphine 
ligands, such as DPEphos (L7) and Xantphos (L9), worked best for these 
transformations. 
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Scheme 26: Palladium-catalyzed C-O cross-coupling at meso-position of porphyrin 
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Table 15: Synthesis of meso-Aryloxytetraphenylporphyrins via Palladium-Catalyzed 
C–O Bond Formations of meso-Bromotetraphenylporphyrins with Aromatic Alcohol 
 
entrya Br-porb alcohol time (h)c yield (%)d
2e OH
OH
OH
OH
OH
OHMeO
3
4e
6
8
10e
12e
18f
20f
[Zn(2)]
[Zn(2)]
[Zn(2)]
[Zn(2)]
[Zn(2)]
3
3
temp (ºC)
100
100
100
80
80
100
100
80 4 66
24 65
16 78
16 89
18 73
17 72
16 78
18 44
OH
Me2N
OH
OH
OH
OHF21e [Zn(2)] 100 17 78
14
15
16
3
3
3
100
100
100 21 58
21 62
21 54
OH
3 [Zn(3)]
5
7f
9g
11
13
3
3
3
3
3
100
100
100
100
100
80 5 44
69
23 61
48 59
48 45
25 50
19 [Zn(3)] 100 18 68
22e 3 80 4 55
1e [Zn(2)] 100 23 80
17e [Zn(2)] 100 17 93
a Reactions were carried out in toluene under N2 with 1 equiv of Br-por, 2-4 equiv of alcohol, 5 mol %
Pd2(dba)3, and 10 mol % DPEphos in the presence of 2 equiv of Cs2CO3 per Br. Concentration: 0.01 M Br-por
in toluene. b Structures of bromoporphyrins are shown in Figure 1. c Reaction times have not been optimized.
d Yields represent isolated yields of >95% purity as determined by 1H-NMR. e Pd(OAc)2 was used instead.
f Xantphos was used instead. g K3PO4 was used instead.
24
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Under the general reaction conditions, free-base and zinc complexes of both 
meso-monobrominated and meso-dibrominated 10,20-diphenylporphyrins 2, [Zn(2)], 
and 3 were effectively coupled with a variety of different alcohols. As summarized in 
Table 14, phenol and cresol isomers (entries 1-9, Table 15) were successfully 
employed to give the desired meso-monoaryloxyporphyrins in high yields. Sterically 
hindered 2-isopropylphenol gave the desired porphyrin in good yields (entries 12-13). 
 Electron- rich and electron-deficient phenol derivatives such as 4-
methoxyphenol (entries 17-19) and 4- fluorophenol (entries 21-22) were also 
efficiently coupled under the reported reaction conditions. In addition, electron-
deficient 3- and 4-nitrophenols, which failed to react with 3, could be successfully 
coupled with 5,15-dibromo-10,20-bis-(3,4,5-trimethoxyphenyl)porphyrin, a diaryl 
derivative of 3. The etheration methodology was also extended to a variety of aliphatic 
alcohols, including electron rich and electron deficient benzyl alcohol derivatives 
(entries 1-5, Table 16), linear primary and secondary alcohols (entries 6-14), cyclic 
primary alcohols (entries 15-16) and cyclic secondary alcohols (entries 17-18). 
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Table 16: Synthesis of meso-Alkoxytetraphenylporphyrins via Palladium-Catalyzed 
C–O Bond Formations of meso-Bromotetraphenylporphyrins with Aliphatic Alcohols 
 
a Reactions were carried out in toluene under N2 with 1 equiv of Br-por, 2-4 equiv of alcohol, 5 mol %
Pd2(dba)3, and 10 mol % DPEphos in the presence of 2 equiv of Cs2CO3 per Br. Concentration: 0.01 M Br-por
in toluene. b Structures of bromoporphyrins are shown in Figure 1. c Reaction times have not been optimized.
d Yields represent isolated yields of >95% purity as determined by 1H-NMR. e Xantphos was used instead.
entrya Br-porb alcohol time (h)c yield (%)d
1 3
2e
4e
5e
7
8e
13e
15
3
[Zn(3)]
3
[Zn(3)]
3
[Zn(3)]
[Zn(3)]
temp (ºC)
80
100
100
100
100
80
80
80 18 40
20 48
5 44
17 62
25 54
39 66
23 51
48 50
9
10e
11
3
3
3
100
100
100 47 50
39 30
48 33
OH
OH
F
OH
MeO
N
OH
OH
OH
OH
OH
F3C OH
OH
OH
3e 3 80 4 41
6e 3 80 17 51
14 3 80 48 62
12e 3 80 17 63
 
 
 In a follow-up report, Zhang and co-workers applied this methodology to di-
meso-bromo-diarylporphyrins using chiral alcohols (Table 17).131 A combination of 
Pd2(dba)3 and DPEphos (L7) could be used to perform the desired double C–O 
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coupling reactions. Secondary cyclic alcohol, (+)-dihydrocholesterol, formed the 
corresponding meso-chiral porphyrins in 45-82% yields (entries 1-4, Table 17). The 
aromatic alcohol (+)-estrone was used to produce the corresponding meso-chiral 
porphyrin in 98% yield (entry 5, Table 17). Only one set of resonances was observed 
in both 1H and 13C-NMR spectra of these compounds, suggesting free rotation around 
the C–O bond at ambient temperature. 
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Table 17: Synthesis of meso-Chiral Porphyrins 
O
O
H
H
H
OH
O
H
H
O
H
H
H
H
H
O
H
H
H
H
H
O
H
H
H
H
H
O
H
H
H
H
H
1
2
3
4
6
5
45
82
80
79
98
35
entrya *ROHAr group of 2 yield(%)b
a Reaction were performed in tolune at 100 °C for 17-40 h in the presence of Pd2(dba)3, DPEphos, and Cs2CO3.
b Yields represent isolated yields of >95% purity as determined by 1H-NMR.  
 
 When R-(+)-BINOL was used in excess, the double etheration reaction could 
be controlled to provide a meso-chiral porphyrin where only one of the two hydroxyl 
groups reacted (entry 6, Table 16). The observation of multiple 1H-NMR resonances 
suggested the product exists as a mixture of two atropisomers (α,α- and α,β-isomers), 
138 
 
presumably due to an increased rotation barrier around the C–O bond. Attempts to 
separate the atropisomers were unsuccessful. 
 The meso-chiral diphenylporphyrins in Table 17 were then chelated with cobalt 
and used as catalysts for the cyclopropanation of styrenes with ethyldiazoacetate. The 
desired cyclopropanes were produced in high to excellent yields with moderate trans-
selectivities, but low enantioselectivities. The authors speculated that the orientation 
and flexibility of the chiral appendages are likely responsible for the low 
enantioselectivities observed. For the R-(+)-BINOL-coupled cobalt(II) porphyrin 
catalyst, the existence of atropisomers created additional problems.  
In 2008, Zhang and co-workers extended their methodology to demonstrate that 
diporphyrins could be selectively synthesized from bromoporphyrin precursors via 
palladium-catalyzed cross-coupling.61 Using the diol as limiting reagent, a series of 
homo-diporphyrins containing different types of spacers were formed in high to 
excellent yields (Scheme 27, Table 18). The methodology developed was shown to be 
general for a number of diols and porphyrin compounds.  
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Scheme 27: Formation of porphyrin dimers using diol linkages 
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Table 18: Synthesis of Homo-Diporphyrins 
entrya diol yield (%)
HO
OH
HO OH
OHHO
OHHO
OH
HO
53
96
73
70
91
1
2
3b
4b
5b
a General reaction conditions 1 equiv of 2 in toluene at 100 ºC
under a N2 atmosphere with 2.5-4.5 equiv of alcohol, 10-12 mol
% Pd2(dba)3, 30-50 mol % DPEphos L7 in the presence of 4-6
equiv of Cs2CO3 per Br. Concentration: 0.01 M in toluene for 24-
28 h.
b In toluene at 80 ºC.  
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Using the same approach, chiral diporphyrins could be readily constructed 
through the use of optically active diols. As illustrated in Scheme 28, the meso-chiral 
diporphyrin 76 could be effectively prepared in 95% yield via palladium-catalyzed C–
O cross-coupling between meso-bromodiphenylporphyrin 2 and chiral diol (-)-2,3-O-
isopropylidene-D-threitol.161 
 
Scheme 28: Formation of chiral porphyrin dimers using chiral diol linkages 
N
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2
N
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O O
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The same strategy was used to provide access to hetero-diporphyrins and 
triporphyrins, including free-base and metalloporphyrin hetero-dimers. This 
methodology was also successfully employed for construction of hetero-diporphyrins 
with direct C–O–C linkages between two porphyrin units. For example, hetero-dimer 
78 was prepared from reaction of hydroxyphenyl porphyrin 77 and meso-
bromoporphyrin 2 in 45% yield (Scheme 29). To reach the optimized yield, 
bromoporphyrin 2 was used as the limiting reagent under the reaction conditions. 
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Scheme 29: Formation of heteroporphyrin dimer 78 
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A stepwise approach was applied to synthesize hetero-diporphyrins with 
different linkages via palladium-catalyzed etheration.161 For example, the etheration 
reaction of bromoporphyrin 2 with excess 1,6-hexanediol could be catalyzed to 
selectively form the mono-coupled product 79 in 64% yield (Scheme 30). Porphyrin 
79, which bears a pendant hydroxyl group, was then effectively coupled with 
bromoporphyrin 80, forming hetero-diporphyrin 81 in 72% yield (Scheme 30). This 
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stepwise approach also provided a straightforward route for the synthesis of homo- and 
hetero-triporphyrins with free-base or metalloporphyrin units. For example, coupling 
of dibromoporphyrin 83 with excess amount of hydroxyporphyrin 82 could furnish the 
hetero-triporphyrin 84 in 52% yield (Scheme 31). 
 
Scheme 30: Formation of heteroporphyrin dimer using a diol linkage 
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80
(i) 2:diol = 1:2.5; 5 mol % Pd2(dba)3; 25 mol % DPEphos; 2.0 equiv of Cs2CO3; toluene; 80 °C; 24 h.
(ii) 79:80 = 1.5:1; 5 mol % Pd2(dba)3; 25 mol % DPEphos; 3.4 equiv of Cs2CO3; toluene; 100 °C; 24 h.  
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Scheme 31: Formation of heteroporphyrin trimer using a diol linkage 
(i) 2:diol = 1:10; 5 mol % Pd2(dba)3; 25 mol % DPEphos; 4 equiv of Cs2CO3; toluene; 100 °C; 24 h.
(ii) 82:83 = 2:1; 10 mol % Pd2(dba)3; 40 mol % DPEphos; 4 equiv of Cs2CO3; toluene; 80 °C; 42 h.
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Palladium-catalyzed hydroxylation of bromoporphyrin was reported with 
nickel porphyrin [Ni(31)] by Arnold and co-workers in 2006 (Scheme 32).98 It was 
concluded that hydrated cesium carbonate was the potential nucleophile responsible for 
the hydroxylation, despite the fact that the experiments were conducted with the base 
that was rigorously dried. The resulting hydroxyporphyrin complex [Ni(85)] was 
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shown to be readily oxidized and deprotonated to give oxygen-centered radicals. 
However, [Ni(85)] could be “trapped” as the corresponding acetate upon treatment 
with acetic anhydride and pyridine. 
 
Scheme 32: Arnold’s meso-hydroxylated porphyrin 
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β-Etheration 
In 2007, Zhang and co-workers reported the efficient synthesis of a variety of 
β-substituted porphyrins by reacting β-bromotetraphenylporphyrin 22a with alkyl and 
aryl alcohols (Scheme 33).91 Palladium sources Pd(OAc)2 and Pd2(dba)3 were screened 
in combination with the bidentate phosphine ligands DPEphos L7, Xantphos L8, and 
BINAP L9 as potential catalysts.  
The C–O couplings of alkyl and aryl alcohols with 22a, could be successfully 
catalyzed using Pd2(dba)3 and DPEphos L7, forming the desired β-alkoxy/aryloxy-
substituted porphyrins in good yields (Table 19). Both aromatic and aliphatic alcohols 
were shown to be suitable substrates for the coupling although aliphatic alcohols 
required additional reaction time (Table 19). 
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Scheme 33: Formation of β-etherated porphyrins 86 
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Table 19: Synthesis of β-Aryloxy/Alkoxy-tetraphenylporphyrins via Palladium-
Catalyzed C–O Bond Formations of β-Bromotetraphenylporphyrin with Alcohols 
 
entrya alcohol time (h) yield (%)
a Reactions were carried out at 100 °C under N2 in toluene with 1 equiv of 22a; 4.0
equiv of alcohol, 10 mol % Pd2(dba)3; and 20 mol % DPEphos in the presence of 2
equiv of Cs2CO3. Concentration: 0.01 M 22a in toluene. b 4 equiv of Cs2CO3.
OH1
2b
3
24 66
26 65
24 77
4
26 79
5 40 71
OH
OH
OHF
OH
F
F
F
Br-por
22a
22a
22a
22a
22a
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C-O Etheration Projects and Spectra 
Porphyrin Dimers 
 There are two C-O palladium cross coupling projects. The first of these was 
almost completed at the University of Tennessee by Dr. Guan-Yao Gao. In addition to 
his work, the chiral linked dimer (76, Scheme 28) was set and the first flash 
chromatography column done by Dr. Joshua Ruppel at the University of South Florida 
to wrap up the project. Assistance in purification with an additional column was 
carried out to produce a publishable 1H-NMR and the optical rotation of the chiral 
dimer was taken on the Autopol IV polarimeter in Dr. Baker’s lab. Full UV-visable 
characterization was provided for all porphyrins reported using the Biomate UV-vis 
instrument in Dr. Ming’s lab (see below). The 1H-NMR spectra of the chiral dimer 
prepared is attached at the end of this section as well. The results detailed above were 
published as follows: 
 
Gao, G.-Y.; Ruppel, J. V.; Fields, K. B.; Xu, X.; Chen, Y.; Zhang, X. P. Efficient 
Synthesis of Diporphyrins and Triporphyrins via Palladium-Catalyzed C-O Bond 
Formation: Convenient Access to Chiral Diporphyrins. Journal of Organic 
Chemistry, 2008, 73(13), 4855-4858.  
 
CarboPhyrins 
 The second C-O palladium cross-coupling project was in collaboration with Dr. 
Nicole Snyder of Hamilton College, NY. Dr. Snyder has a great amount of experience 
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with carbohydrate chemistry and the protection of the sugar alcohols. This, of course, 
meshed well with our goals of porphyrin synthesis. The project was completed over 
two summers and involved the contributions of many individuals both in her lab at 
Hamilton College in New York as well as the Zhang laboratory at University of South 
Florida (USF). 
 The recent development of palladium-catalyzed cross-coupling reactions 
between mono-, di-, and tetrasubstituted bromo-porphyrins and amides, amines, 
alcohols, and thiols has allowed for the preperation of a number of chiral porphyrin 
analogs. Metalated derivatives of these chiral porphyrins have been used to catalyze a 
number of key functional group transformations with good diastereo- and 
enantioselectivity.   
Despite the progress that has been made in the development of these porphyrin 
catalysts, two key “problems” still exist. First, the hydrophobic nature of the porphyrin 
ring makes these systems insoluble (or poorly soluble) in most polar solvents, both 
limiting substrate scope and the ability to carry out reactions in water as solvent. In 
addition, the aromatic nature of the porphyrin ring facilitates pi stacking with some 
existing porphyrin catalysts, resulting in aggregation and decreased turnover. In an 
effort to address these problems, novel porphyrins bearing carbohydrate residues using 
a palladium-catalyzed cross-coupling approach were synthesized.  
While in New York, Dr. Snyder and her undergraduate students Taylor Adams 
and Peter Garrett made sugars with protective units on all but one alcohol for use in C-
O palladium cross-couplings in our lab. Concurrently, in the Zhang lab the synthesis of 
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the bromoporphyrin bases to which the sugars would be connected were being 
synthesized. Undergraduates Brian Davis and Mishka Peart made several grams of 
mono-bromodiphenylporphyrin 2 for use with this project.  
There were three glucose derivatives targeted for use: a 2’-OH, a 4’-OH, and a 
6’-OH. Dr. Snyder used mono-bromodiphenylporphyrin 2 to optimize the cross-
coupling conditions required to attach these glucose derivatives to the porphyrin 
framework. This generated three new porphyrins 87-89 (Scheme 34). The yield of the 
porphyrin syntheses were relatively low to moderate as the reactions suffered from the 
presence of water, which was difficult to avoid on hot, humid Florida afternoons. 
Many steps were taken to keep the starting materials and products dry, particularly 
since the use of a glove box was unavailable. 
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Scheme 34:  Glucose derivatives attached to porphyrin meso-position using palladium-
catalyzed cross-coupling 
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The 2’-OH and 4’-OH coupled products were generated in sufficient quantities 
for full characterization during Dr. Snyder’s visit. 1H-NMR were recorded on the 
Varian Innova 500MHz and required overnight acquisitions for the carbon spectra 
shown below. Both the initial NMRs to identify product formation, as well as the 
publishable spectra attached were taken for Dr. Snyder during her stay at USF. The 6’-
OH coupled porphyrin was particularly susceptible to hydrolysis and was very difficult 
to synthesize and isolate. As a result, only the mass was obtained for this compound by 
the end of the second summer (<1 mg sample). 
This process was also applied with limited success to para-BrTPP and using 
the 2,6-dibromophenyl porphyrin synthons. The original goal of making ortho-
substituted tetra-coupled porphyrins that could be used as catalysts for enantio- and 
diastereoselective reactions was not realized as a result of low yields and coupling sites 
that are potentially too sterically encumbered after the first cross-coupling. The 
preliminary results of our research were presented by Dr. Snyder at the spring 2010 
National ACS meeting in San Francisco. The spectra for the 2’ and 4’-coupled glucose 
derivatives are shown below. 
 
Snyder, Nicole L.; Zhang, X. P.; Adams, Taylor P.; Garrett, Peter F.; Fields, Kimberly 
B. Synthesis of carbohydrate-porphyrins conjugates via palladium-catalyzed 
cross-coupling approach. Abstracts of Papers, 239th ACS National Meeting, San 
Francisco, CA, United States, March 21-25, 2010  (2010), CARB-121.  
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Experimental Section and Spectra for Porphyrin Dimers and CarboPhyrins 
“Efficient Synthesis of Diporphyrins and Triporphyrins via Palladium-Catalyzed C-O 
Bond Formation: Convenient Access to Chiral Diporphyrins and Synthesis of 
carbohydrate-porphyrins conjugates via palladium-catalyzed cross-coupling approach” 
General Considerations. All cross-coupling reactions were carried out under a nitrogen 
atmosphere in oven-dried glassware following standard Schlenk techniques. 
Tetrahydrofuran (THF) and toluene were distilled under nitrogen from sodium 
benzophenone ketyl. Chiral alcohols were either purchased from Aldrich Chemical Co. 
or Acros Organics and used without further purification or synthesized in Dr. Snyder’s 
laboratory at Hamilton College. The Pd2(dba)3 and DPEphos were purchased from 
Strem Chemical Co. Cesium carbonate was obtained as a gift from Chemetall Chemical 
Products, Inc. 
 
General Procedures for Etheration of Bromoporphyrins. The bromoporphyrin, chiral 
alcohol, Pd2(dba)3, DPEphos, and Cs2CO3 were weighed in air and placed in an oven-
dried, resealable Schlenk tube. The tube was capped with a Teflon screwcap, evacuated, 
and backfilled with nitrogen. The screwcap was replaced with a rubber septum, and 
toluene was added via syringe. The tube was purged with nitrogen for 2 min, and then 
the septum was replaced with the Teflon screwcap. The tube was sealed, and its 
contents were heated to 100 °C with stirring for 48-72 hours. The resulting mixture was 
cooled to room temperature, taken up in ethyl acetate and concentrated in vacuo. The 
crude product was then purified by flash chromatography. 
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Chiral Diporphyrin 76. The general procedure was used to couple 5-bromo-10,20-
diphenylporphyrin 2 (0.25 mmol) with (−)-2,3-O-Isopropylidene-D-threitol (0.07 
mmol), using Pd2(dba)3 (0.005 mmol) and DPEphos (0.025 mmol) in the presence of 
Cs2CO3 (0.2 mmol). The reaction was conducted in toluene at 100 °C for 36 h. The title 
compound was isolated by flash chromatography [silica gel, methylene chloride: 
hexanes (v/v) = 8:2] as a purple solid (95%). 1H NMR (400 MHz, CDCl3): δ 10.05 (s, 
2H), 9.78 (d, J = 4.8 Hz, 4H), 9.23 (d, J = 4.8 Hz, 4H), 8.96 (d, J = 4.8 Hz, 4H), 8.87 (d, 
J = 4.8 Hz, 4H), 8.18 (m, 8H), 7.74 (m, 12H), 5.44 (m, 4H), 5.41 (m, 2H), 2.00 (s, 6H), 
-2.80 (s, 4H). 13C NMR (100 MHz, CDCl3):  142.0, 141.3, 137.7, 134.6, 131.5, 131.3, 
130.6, 127.7, 127.1, 126.8, 119.5, 110.9, 104.0, 83.9, 27.5; UV–vis (CHCl3), λmax nm 
(log ε): 412(5.61), 478(3.75), 509(4.37), 544(4.07), 585(3.89), 641(3.87). 
 
10-(2’-O-glucose)-5,15-diphenylporphyrin 87. The general procedure was used to 
couple 10-bromo-5,15-diphenylporphyrin 2 (0.25 mmol) with 2’OH – glucose (1.00 
mmol), using Pd2(dba)3 (0.005 mmol) and DPEphos (0.025 mmol) in the presence of 
Cs2CO3 (0.2 mmol). The reaction was conducted in toluene at 100 °C for 48-72 h. The 
pure compound was isolated by flash column chromatography as purple solids. 1H-
NMR (500 MHz, CDCl3): δ 9.94 (s, 1H), 9.57 (d, J = 4.5 Hz, 2H), 9.13 (d, J = 4.5 Hz, 
2H), 8.87 (d, J = 4.5 Hz, 2H), 8.78 (d, J = 4.5 Hz, 2H), 8.15 (m, 4H), 7.69 (m, 6H), 7.30 
(m, 12H), 7.10 (m, 3H), 5.14 (m, 2H), 5.03 (dd, J = 11.0, 15.0 Hz, 2H), 4.92 (d, J = 4.0 
Hz, 1H), 4.84 (dd, J = 11.5, 14.0 Hz, 2H), 4.73 (dd, J = 10.5, 11.5 Hz, 2H), 4.50 (m, 
1H), 4.21 (dd, J = 9.0, 9.5 Hz, 1H), 3.88 (dd, J = 9.0, 9.5 Hz, 1H), 3.78 (dd, J = 4.0, 9.5 
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Hz, 1H), 3.59 (s, 3H), −2.90 (s, 2H). 13C NMR (125 MHz, CDCl3): δ 146.81, 146.55, 
146.33, 142.17, 141.48, 138.74, 138.44, 138.19, 138.12, 134.69, 131.48, 131.27, 
130.30, 128.56, 128.45, 128.44, 128.19, 128.01, 127.98, 127.78, 127.75, 127.69, 
127.65, 127.45, 126.89, 119.41, 103.77, 98.37, 83.23, 82.47, 80.27, 78.23, 75.82, 75.22, 
73.49, 71.05, 55.60, 29.70.  
 
10-(4’-O-glucose)-5,15-diphenylporphyrin 88. The general procedure was used to 
couple 10-bromo-5,15-diphenylporphyrin 2 (0.25 mmol) with 4’OH – glucose (1.00 
mmol), using Pd2(dba)3 (0.005 mmol) and DPEphos (0.025 mmol) in the presence of 
Cs2CO3 (0.2 mmol). The reaction was conducted in toluene at 100 °C for 48-72 h. The 
pure compound was isolated by flash column chromatography as purple solids. 1H-
NMR (500 MHz, CDCl3): δ 9.91 (s, 1H), 9.56 (d, J = 4.5 Hz, 2H), 9.11 (d, J = 4.5 Hz, 
2H), 8.86 (d, J = 4.5 Hz, 2H), 8.77 (d, J = 4.5 Hz, 2H), 8.12 (m, 4H), 7.67 (m, 6H), 7.29 
(m, 12H), 7.10 (m, 3H), 5.11(m, 2H), 5.02 (dd, J = 11.0, 17.5 Hz, 2H), 4.91 (d, J = 3.5 
Hz, 1H), 4.83 (dd, J = 11.0, 15.5 Hz, 2H), 4.72 (dd, J = 8.5, 11.5 Hz, 2H), 4.49 (m, 1H), 
4.21 (dd, J = 9.0, 9.5 Hz, 1H), 3.87 (dd, J = 9.0, 9.5 Hz, 1H), 3.76 (dd, J = 3.5, 9.5 Hz, 
1H), 3.58 (s, 3H), −2.92 (s, 2H). 13C NMR (125 MHz, CDCl3): δ 146.78, 146.56, 
146.33, 142.16, 141.47, 138.74, 138.44, 138.19, 138.12, 134.69, 131.47, 131.27, 
130.30, 128.55, 128.45, 128.44, 128.18, 128.00, 127.97, 127.78, 127.75, 127.69, 
127.65, 127.45, 126.89, 119.41, 103.77, 98.37, 83.23, 82.47, 80.27, 78.23, 75.82, 75.22, 
73.49, 71.05, 55.59, 29.69. 
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UV-vis spectra for the Synthesis of Diporphyrins and Triporphyrins 
 
5-(10’,20’-Diphenyl-porphyrin-15’-yloxy)ethoxy-10,20-diphenyl-porphyrin (75, 
Scheme 27; Table 18, entry 1) UV–vis (CHCl3), λmax nm (log ε): 415(5.76), 478(3.95), 
510(4.54), 544(4.27), 586(4.09), 641(4.07) 
 
 
 
5-(10’,20’-Diphenyl-porphyrin-15’-yloxy)hexyloxy-10,20-diphenyl-porphyrin (75, 
Scheme 27; Table 18, entry 2) UV–vis (CHCl3), λmax nm (log ε): 412(5.66), 509(4.24), 
545(3.89), 587(3.72), 641(3.79) 
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5-[2-(10’,20’-Diphenyl-porphyrin-15’-yloxy)methyl]phenylmethoxy-10,20-
diphenyl-porphyrin (75, Scheme 27; Table 18, entry 3) UV–vis (CHCl3), λmax nm (log 
ε): 410(5.74), 510(4.54), 545(4.20), 587(4.02), 642(4.04) 
 
 
 
 
 
[3-(10’,20’-Diphenyl-porphyrin-15’-yloxy)methyl]phenylmethoxy-10,20-diphenyl-
porphyrin (75, Scheme 27; Table 18, entry 4) UV–vis (CHCl3), λmax nm (log ε): 
412(5.98), 510(4.57), 545(4.18), 587(4.07), 641(4.08) 
 
 
 
 
156 
 
5-[4-(10’,20’-Diphenyl-porphyrin-15’-yloxy)methyl]phenylmethoxy-10,20-
diphenyl-porphyrin (75, Scheme 27; Table 18, entry 5) UV–vis (CHCl3), λmax nm (log 
ε): 413(5.12), 510(3.85), 545(3.51), 587(3.33), 642(3.34) 
 
 
 
 
Chiral diporphyrin (76, Scheme 28) UV–vis (CHCl3), λmax nm (log ε): 412(5.61), 
478(3.75), 509(4.37), 544(4.07), 585(3.89), 641(3.87) 
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{5-[(10’,20’-Diphenyl-porphyrin-15’-yloxy)]phenyl-10,15,20-tritolyl-porphyrinato} 
zinc (78, Scheme 29) UV–vis (CHCl3), λmax nm (log ε): 413(5.63), 425(5.72), 
510(4.33), 549(4.42), 587(4.05), 641(3.60) 
 
 
 
 
 
 
5-(2-Hydroxyhexyloxyl)-10,20-diphenyl-porphyrin (79, Scheme 30) UV–vis 
(CHCl3), λmax nm (log ε): 412(5.46), 510(4.35), 545(4.05), 586(3.82), 642(3.89) 
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5-[10’,20’-Bis(3,4,5-trimethoxyphenyl)porphyrin-15’-yloxy]hexyloxy-10,20-
diphenylporphyrin (80, Scheme 30) UV–vis (CHCl3), λmax nm (log ε): 413(5.73), 
510(4.50), 546(4.22), 586(3.98), 642(4.05) 
 
 
 
 
 
 
5-(2-Hydroxyethoxyl)-10,20-diphenyl-porphyrin (82, Scheme 31) UV–vis (CHCl3), 
λmax nm (log ε): 412(5.35), 510(4.10), 545(3.81), 586(3.66), 641(3.64) 
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5,15-Bis(10’,20’-diphenyl-porphyrin-15’-yloxy)ethoxy-10,20-bis(3,4,5-
trimethoxyphenyl)-porphyrin (84, Scheme 31) UV–vis (CHCl3), λmax nm (log ε): 
412(5.58), 423(5.58), 511(4.64), 548(4.34), 587(4.10), 642(4.11) 
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1H-NMR (400 MHz) Chiral diporphyrin 76 
161 
 
1H-NMR (500 MHz) 10-(2’-O-glucose)-5,15-diphenylporphyrin 87 
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13C-NMR (125 MHz) 10-(2’-O-glucose)-5,15-diphenylporphyrin 87 
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1H-NMR (500 MHz) 10-(4’-O-glucose)-5,15-diphenylporphyrin 88 
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13C-NMR (125 MHz) 10-(4’-O-glucose)-5,15-diphenylporphyrin 88 
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Palladium-Catalyzed C-S, C-Se, and C-P Coupling 
In their 2004 paper, Zhang and co-workers extended their synthetic strategy to 
palladium-catalyzed C–S bond formation162-167 for porphyrin synthesis. They reported 
a general method for the synthesis of meso-arylsulfanylporphyrins from reaction of 
bromoporphyrins with thiols (Scheme 35, Table 20). In the same report, it was noted 
that when an excess amount of propane-1,3-dithiol was used, the coupling reaction 
could be controlled to take place with only one of the thiol groups, affording a 
porphyrin with an appended free thiol functionality (entry 22, Table 20). 
Considering the results obtained from the synthesis of meso-diporphyrins via 
C–O bond formation,161 this novel functional thioporphyrin might be useful for the 
construction of unsymmetric diporphyrins or triporphyrins upon further reaction with 
brominated porphyrins.168-169 In view of the commercial availability of dithiols with 
varied chain lengths, this methodology should provide convenient access to thiol-
derivatized porphyrins, which have found interesting applications for sensors, optics, 
and information storage.170-178  
Under similar conditions, a meso-seleno-substituted porphyrin was also 
prepared using a selenol via palladium-mediated C–Se bond formation.168 This 
represents the first synthesis of a meso-seleno-substituted porphyrin. 
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Scheme 35: Palladium-catalyzed C-S cross-coupling at the meso-position of porphyrin 
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Table 20: Synthesis of meso-Mercaptotetraphenylporphyrins via Palladium-Catalyzed 
C–S Bond Formations of meso-Bromotetraphenylporphyrin with Thiols 
 
 
entrya thiols time (h) yield (%)b
1
11
14
temp (ºC)
100
80
80
100
100
100
100
100 20 64
24 79
24 75
24 75
24 38
48 52
24 81
24 61
22g
23
100
100
60
20
25
12
77
70
49
ligand
L5
SH
SH
SHMeO
SHCl
SH
C7H15 SH
SH
SHHN
O
N
S
SH
HS SH
SeH
L7
L7
L7
L9
L8
L9
L7
L7
L7
Br-por
[Zn(2)]
2
2
[Zn(2)]
2
[Zn(2)]
[Zn(2)]
2
2
2
2
100 20 68L72
100 27 71L73
100 27 873
100 21 94L52
100 20 71L72
100 25 72L73
100 23 66L92
100 24 74L73
100 24 75SH L73
100 24 77L9[Zn(2)]
100 32 64L9[Zn(2)]
100 32 54L7[Zn(2)]
3
2
4c
L7
L7
6
7c
5
9
8
10
13
12
16
15d
17
18d,e
19f
20
21
a Reaction conditions Br-por 2: reactions were carried out in toluene under N2 with 1 equiv of Br-por, 3 equiv of
thiol, 5 mol % Pd2(dba)3 and 20 mol % of ligand in the presence of 4 equiv of Cs2CO3.
Reaction conditions Br-por [Zn(2)]: same as 2 except for 4 equiv of thiol and used 2 equiv of Cs2CO3.
Reaction conditions Br-por 3: same as 2 except for 8 equiv of thiol and 10 mol % Pd2(dba)3.
Concentration: 0.01 M Br-por in toluene. b Isolated yields. c 40 mol % of ligand. d 4.0 equiv of thiol and 2.0 equiv
Cs2CO3. e 5 mol % Pd(OAc)2. f 10 mol % of ligand. g 8.0 equiv of thiol and 2.5 mol % of Pd2(dba)3.  
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In 2007, Zhang and co-workers reported the efficient synthesis of a variety of 
β-mercaptoporphyrins from reactions of β-bromotetraphenylporphyrin 22a, with alkyl 
and aryl thiols via palladium-catalyzed sulfonylation(Scheme 36, Table 21).91 Low to 
moderate yields were obtained, but the catalytic system was capable of sulfonylation 
with sterically hindered ortho-methyl thiophenol, electron donating para-methoxy 
thiophenol, and propanethiol, an alkyl thiol. 
 
Scheme 36: Palladium-catalyzed C-S cross-coupling at the β-position of porphyrin 
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Table 21: Synthesis of β-Mercaptotetraphenylporphyrins via Palladium-Catalyzed C–
S Bond Formations of β-Bromotetraphenylporphyrin with Thiols 
 
entrya thiol time (h) yield (%)
a Reactions were carried out at 100 °C under N2 in toluene with 1 equiv of 22a; 4
equiv of thiol, 10 mol % Pd2(dba)3; and 20 mol % BINAP in the presence of 2 equiv
of Cs2CO3. Concentration: 0.01 M 22a in toluene. b 4 equiv of Cs2CO3.
1b
2
40 35
28 24
3 28 32
SH
SHMeO
SH
Br-por
22a
22a
22a
 
 
Hirao and co-workers reported the first palladium-catalyzed C–P bond 
formation in 1980.179 Since then, this methodology has been expanded to generate 
various phosphonates, phosphites, phosphine oxides, and phosphines65,180 and has been 
applied to the functionalization of porphyrins. 
 
Conclusions 
Over the last twenty years, palladium-catalyzed carbon–heteroatom cross-
coupling reactions have been developed into practical, reliable synthetic methods for 
functionalization of porphyrins. The scope of catalytic reactions has evolved 
significantly to include borylation, amination, amidation, etheration, sulfanylation, 
selenation, and phosphoration of halogenated porphyrins and metalloporphyrins. 
 Early efforts using Suzuki-Miyaura cross-coupling reactions for the preparation 
of functionalized porphyrins led to the production of borylated porphyrins, which 
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could be subsequently employed as coupling partners for further Suzuki-Miyaura 
coupling reactions to form C–C bonds.  
The majority of the efforts in applying palladium-catalyzed carbon–heteroatom 
bond formation reaction for porphyrin synthesis have been focused on amination and 
amidation reactions. Developments in palladium-catalyzed C–N cross-couplings have 
led to successful synthesis of a diverse array of amino- and amido-substituted 
functional porphyrins via mono, double, triple and even quadruple 
amination/amidation reactions. The practicality and utility of these palladium-
catalyzed reactions are highlighted by the stepwise formations of more complex 
porphyrin systems, such as dimers, trimers, and even higher arrays.  
Palladium-catalyzed etheration has proven to be a powerful method for the one-
pot production of aryloxy- and alkoxy-substituted porphyrins, which were previously 
accessed only through often difficult and low-yielding multi-step preparations. It has 
been demonstrated that a broad range of alcohol substrates can be successfully coupled 
with a variety of halogenated porphyrins to produce the desired porphyrins in moderate 
to high yields.  
The reliability and diversity of palladium-catalyzed carbon–heteroatom cross-
coupling reactions will continue find practical applications in porphyrin synthesis as 
highlighted by recent developments in functionalization of porphyrins via C–S, C–Se, 
and C–P bond formations. Further advancements in this field will continue to provide 
valuable synthetic tools for the construction of a diverse array of porphyrins for 
applications in catalysis, energy transfer, and medicine, among other areas. 
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CHAPTER 2:  CATALYTIC APPLICATIONS OF PORPHYRINS AND RELATED 
MACROCYCLES 
 
Introduction  
Metalloporphyrins have been shown to catalyze many fundamental and 
practically important chemical transformations in biological systems and in the 
chemical laboratory.  The most notable examples have been accomplished using 
metalloporphyrins complexes inspired by biology.  These complexes have been used to 
perform atom/group transfer reactions including oxene, nitrene, and carbene transfers, 
which in turn have provided chemists with direct access to complex and functionally 
diverse compounds from abundant and inexpensive alkenes and alkanes. 
In an effort to improve the catalytic ability and specificity of these “synthetic 
enzymes”, researchers have focused on the synthesis of “designed” complexes that are 
based on well defined biological/chemical scaffolds. These complexes, which 
incorporate chiral peripheries into the metalloporphyrin framework, have provided 
researchers with better control over the reaction system. Three methodologies for 
synthesizing these derivatives have been developed: 1) porphyrins formed through the 
classical condensation of chiral aldehydes with pyrrole; 2) porphyrins formed through 
substitution of amino- and hydroxy-substituted tetraphenylporphyrins with chiral 
building blocks; and 3) bridging of the enantiotropic faces of prochiral porphyrins to 
afford a chiral environment. The porphyrins prepared by these three methods have 
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provided important information regarding the type of chiral environment required to 
induce enantioselectivity when used as catalysts. The trends indicate that the more rigid 
the chiral environment, the greater the catalytic stability and the slower the 
intramolecular decomposition. This in turn provides for a longer catalytic lifetime and 
higher turnover numbers (TON). On the other hand, more flexible substituents are more 
vulnerable to degradation, such as oxidation of the porphyrin periphery, and produce 
products with decreased enantioselectivity.  
Another trend observed concerns the proximity of the chiral units to the active 
center. Chiral units that are far away provide less chiral induction as the approach of the 
incoming substrate is not substantially affected by the peripheral chiral environment. 
On the other hand, chiral units that are too close to the metal center often suffer from 
decomposition as the chiral environment itself becomes the substrate and is then 
decomposed.  
Chiral proximity also plays a role in determining enantioselectivity in substrates 
of different sizes and shapes, though the specific requirements are not as well defined or 
easy to define. This constraint has led some research groups to incorporate a modular 
design with steric environments that can be systematically modified to best suit each 
type of substrate. 
The modification and design of porphyrin ligands to create chiral environments 
has led to a diverse array of catalysts.  To categorize these chiral ligands we will use the 
classification system outlined in the 1993 report by Collman and co-workers.1 In this 
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system, porphyrin ligands are categorized by class: “picket fence”, “strapped”, and 
“basket handle” (Figure 10). 
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Figure 10: Examples of “picket fence”, “strapped”, and “basket handle” type porphyrin 
scaffolds. 
 
The picket fence class contains porphyrin ligands with chiral units around the 
perimeter of the porphyrin ring, but without connections between adjacent or opposite 
functionalities. Chiral groups can be connected directly to the meso- or beta-positions 
or attached to the meso-aryl positions in a wide range of orientations.   
The strapped and basket handle classes are categorized by the positions of the 
chiral units bridged around the porphyrin perimeter above and below the porphyrin 
plane. The major difference between the two classes is the orientation of the chiral 
bridge. Chiral bridges that connect adjacent positions (for example the 5,10-positions) 
are considered strapped.  Chiral bridges connecting opposite positions (for example the 
10,20-positions) are categorized as basket handle.  
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This chapter will review the major advancements in asymmetric atom/group 
transfer reactions utilizing metalloporphyrin catalysts. Specifically, asymmetric 
epoxidation, cyclopropanation, and aziridination of alkenes, as well as several reports of 
various forms of C-H functionalization will be discussed. These works will be 
organized by ligand class and cover the literature through July of 2009.1 
 
Cyclopropanation Using Metalloporphyrins 
Background of Enantioselective Cyclopropanation 
Metal-catalyzed cyclopropanation of olefins with diazo reagents has attracted 
interest due to the fundamental and practical importance of the resulting cyclopropyl 
units.2-5 Cyclopropane rings are recurrent motifs in biologically important molecules 
and can serve as versatile precursors in organic synthesis.6-9 Currently, the metal-
mediated decomposition of diazo reagents in the presence of olefins constitutes the 
most direct route to the synthesis of these systems. These systems provide the 
advantage of using achiral reagents with the induction of chirality occurring as a direct 
result of the chiral catalysts.  Prior to the development of catalytic systems capable of 
decomposing diazo reagents, the Simmons-Smith Reaction was the predominate 
method for cyclopropanation,4 and chiral starting materials or chiral auxiliaries were 
required  for asymmetric induction.   
In the last twenty years, a number of metal-mediated asymmetric 
cyclopropanation systems incorporating copper, ruthenium, cobalt, rhodium and various 
ligands have been developed.10-17 Copper bisoxaline and di-rhodium complexes are 
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examples of some of the more general and selective catalysts that have been prepared.  
For example, Doyle’s use of di-rhodium carboxamates as catalysts for the general and 
selective asymmetric intramolecular cyclopropanation with diazo reagents has achieved 
broad use in the chemical literature.16-23  
Among the wide variety of catalytic systems, metalloporphyrin-based ligand 
designs are unique, owing to their excellent selectivities and high catalytic turnover 
numbers. Metalloporphyrins were first used as catalyst for cyclopropanation by Callot 
utilizing rhodium porphyrins.24-25 Rhodium catalyzed cyclopropanation was 
significantly expanded by Kodadek.26-32  Woo showed that osmium porphyrins could 
also catalyze the cyclopropanation of alkenes, although with less efficiency.33 
Subsequently, Kodadek and Woo collaborated to report that iron porphyrins were 
effective catalysts for the shape-selective and stereoselective cyclopropanation of 
alkenes.34 The development of highly diastereoselective and enantioselective catalysts 
soon followed. 
In the following section, the asymmetric cyclopropanation of alkenes using 
metalloporphyrins will be examined.  The very robust Halterman porphyrin 93, 
examined in various systems for the epoxidation of alkenes, has historically been one of 
the most widely studied chiral porphyrin ligands for cyclopropanation (Figure 11). 
More recently, the development of a new family of D2-symmetric chiral cobalt-catalysts 
capable of extremely high levels of stereocontrol over an expansive substrate scope has 
broadened the use of porphyrin catalysts for asymmetric cyclopropanation. 
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Figure 11: Halterman’s D4-symmetric porphyrin ligand.  
 
Chiral Picket Fence Porphyrins  
Inspired by Doyle18,19,23 and Callot’s24-25 previous reports using rhodium 
complexes for the cyclopropanation of olefins, O’Malley and Kodadek employed their 
“Chiral Wall” porphyrin (94, Figure 12) as a ligand for rhodium-catalyzed asymmetric 
cyclopropanation.30,32  Based on Callot’s work,  they believed that the use of the bulky 
“Chiral Wall” ligand would favor cis cyclopropane isomers, which are normally the 
minor products in most catalytic cyclopropanations. As anticipated, the cis-isomer was 
generated when the rhodium(III) iodide complex of 94 was employed for asymmetric 
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cyclopropanation using styrene, cis-β-methylstyrene, and allyl benzene in the presence 
of ethyl diazoacetate (EDA). The turnover numbers for this system were outstanding, 
up to 4,500 TON in the case of cis-β-methylstyrene. In all the cases examined, the cis 
isomer was favored over the trans, although the trans product exhibited significantly 
higher enantioselectivity (Table 22). 
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Figure 12: “Chiral Wall” Porphyrin Ligand. 
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Table 22: Asymmetric Cyclopropanation of Olefins Catalyzed by [Rh(94)I]  
 
5 mol % [Rh(94)I]
EDA
DCM, 0 °C
Ar
entrya
ee (%)
1 -
2 50
3 60
a Reactions were performed with 5 mol % of catalyst, 1 equiv of substrate, and 1
equiv of EDA in DCM at 0 °C. EDA was added in 0.25 equivalent portions over the
course of the reaction.
Ar
substrate
styrene
cis-β−methylstyrene
allylbenzene
cis/trans cis t rans
2.3
7.8
4.3
10
20
45
R R
TON
2000
4500
550
CO2Et
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Figure 13 :”Chiral Fortress” porphyrin.   
 
Kodadek and O’Malley designed and synthesized a new chiral porphyrin ligand 
termed the “Chiral Fortress” (95, Figure 13) incorporating bulkier aromatic rings in an 
effort to enhance the formation of the cis-cyclopropanated products.  The rhodium 
complex of 95 was used for the cyclopropanation of olefins. In comparison to the 
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“Chiral Wall” the cis:trans ratio was only slightly improved for styrene and a decrease 
in selectivity was observed for all other substrates (Table 23). The authors concluded 
that the active site was too sterically hindered in comparison to the “Chiral Wall.” 
 
Table 23: Asymmetric Cyclopropanation of Olefins Catalyzed by [Rh(95)I]  
Ar
entrya
ee (%)
a Reactions were performed with [Rh(86)I] as catalyst, 1 equiv of substrate, and 1
equiv of EDA in DCM at rt. EDA was added in 0.25 equivalent portions over the
course of the reaction.
Ar
substrate cis/trans cis t rans
R R
TON
CO2Et
[Rh(95)I]
EDA
DCM, rt
1 -
2 20
3 10
styrene
cis-β-methylstyrene
allylbenzene
2.5
5.1
1.0
15
25
10
1600
770
420
4 10ethoxyethane 0.83 15 130
 
 
In 1997, Simonneaux and co-workers reported the first successful use of 
ruthenium porphyrins for the asymmetric cyclopropanation of olefins with EDA.35 
Previous studies using this system reported complex mixtures of products with EDA 
dimerization identified as the major product of the reaction. The employment of a slow-
addition technique to introduce the EDA over several hours minimized the formation of 
these side products and produced the desired cyclopropane derivatives in good yields 
(Scheme 37). This technique ultimately proved useful for most rhodium, iron, and 
ruthenium systems.  
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Scheme 37: Simonneaux’s asymmetric cyclopropanation using ruthenium porphyrin 
 
CO2Et
CO2Et
+
trans cis
N2
H
O
OEt+
trans:cis = 1:9
34% ee (t rans), 14% ee (cis)
NN
N N HN
HN
NH
NH
O
O
M
O
O
CF3
OMe
MeO
F3C
CF3 MeOOMe F3C
[Ru(96)(O)2]
96
 
 
Che and co-workers expanded on their previous work by using ruthenium 
complexes [Ru(93)(CO)] and [Ru(93)(CPh2)] of the Halterman porphyrin 93 (Figure 
11) as catalysts for the cyclopropanation of styrene derivatives with diazo reagents 
(Table 24 and 25).36-37 Overall, [Ru(93)(CO)] complexes generated higher yields and 
greater diastereo- and enantioselectivities with a range of aromatic olefins. In addition, 
the turnover numbers associated with both of these complexes were shown to be 
outstanding, providing upwards of 1,200-1,700 TON 
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Table 24: Asymmetric Cyclopropanation of Aromatic Olefins Catalyzed by 
[Ru(93)(CO)] 
 
0.05 mol% [Ru(93)(CO)]
EDA
DCM, rt, 20 h
Ar
entrya
ee (%)
1 4
2 35
4 3
a Reactions were performed with 0.05 mol % of catalyst, 1 equiv of EDA, and 5 equiv of substrate
in DCM at room temperature for 20 h.
Ar
substrate
styrene
α-methylstyrene
4-fluorostyrene
trans/
cis trans cis
18
3.0
19
87
87
87
CO2Et
yield (%)
5 9
6 8
4-methylstyrene
4-methoxystyrene
18
15
81
85
83
69
83
78
61
TON
3 44-chlorostyrene 23 9066
1700
1400
1700
1600
1200
1300
 
 
Table 25: Asymmetric Cyclopropanation of Aromatic Olefins Catalyzed by 
[Ru(93)(CPh2)] 
 
0.05 mol% [Ru(93)(CPh2)]
EDA
DCM, rt, 20 h
Ar
entrya
ee (%)
1 7
2 25
4 12
a Reactions were performed with 0.05 mol % of catalyst, 1 equiv of EDA, and 5 equiv of
substrate in DCM at room temperature for 20 h.
Ar
substrate
styrene
α-methylstyrene
4-fluorostyrene
trans/
cis trans cis
11
5.6
8.4
83
66
85
CO2Et
yield
(%)
5 -
6 9
4-methylstyrene
4-methoxystyrene
4.1
12
71
71
36
72
71
62
75
TON
3 404-chlorostyrene 5.2 8861
720
1400
1400
1200
1500
1200
 
 
 The ruthenium carbonyl complex of the Halterman porphyrin, [Ru(93)(CO)], 
was also examined as a potential catalyst for intramolecular cyclopropanation to 
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produce cyclopropyl fused ring products (Table 26). Although the yields and 
enantioselectivities reported for these valuable synthetic intermediates are low to 
moderate, this example is important because it illustrates one of the first reports of 
asymmetric intramolecular cyclopropanation utilizing a metalloporphyrin complex.   
 
Table 26: Intramolecular Asymmetric Cyclopropanation Catalyzed by [Ru(93)(CO)] 
0.6 mol% [Ru(93)(CO)]
DCM, rt, 20 h
entrya ee (%)
1
2
a Reactions were performed with 0.6 mol % of catalyst and 1 equiv of substrate
in DCM at room temperature for 20 h.
Rt
Me
24 (1R,5S)
36(1R,5S)
yield (%)
3 Me 41
45
65
65
Rc
4 Ph 25 (1S,5R)60
Me
Rt
Rc
O
O
N2
OO
Rt Rc
H H
H
H
 
 
Che and co-workers continued work on the Halterman porphyrin 93 led to the 
investigation of ruthenium and rhodium complexes for both inter- and intramolecular 
asymmetric cyclopropanation.38 As presented in Table 27 and 28, their research showed 
that both systems generated higher diastereo- and enantioselectivities using the 
ruthenium complexes of 93. Despite using catalysts with the same ligand environment, 
the authors observed an “enantiomeric switch” for one of the substrates when the metal 
was exchanged from rhodium to ruthenium (entry 4, Table 28). These results led the 
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authors to theorize that these two metal complexes may cyclopropanate via different 
mechanistic pathways to generate the two different enantiomers.   
 
Table 27: Asymmetric Cyclopropanation of Aromatic Olefins Catalyzed by Rhodium 
and Ruthenium Complexes of 93  
 
0.05 mol % [M(93)]
EDA
DCM, rt, 20 h
Ar
entrya
ee (%)
1 36
2 46
3 33
a Reactions were performed with 0.05 mol % of catalyst, 1 equiv of EDA, and 5 equiv of substrate in DCM at room
temperature for 20 h.
Ar
substrate
styrene
α-methylstyrene
4-f luorostyrene
trans/cis
trans cis
1.5
1.0
0.9
61
46
62
CO2Et
yield (%)
4 42
5 44
4-methylstyrene
4-methoxystyrene
1.2
1.6
49
68
66
75
72
71
83
2 204-chlorostyrene 1.2 6281
ee (%)
4
35
3
trans/cis
trans cis
18
3.0
19
86
87
87
yield (%)
9
8
18
15
81
85
83
69
83
78
61
423 9066
[Rh(93)I] [Ru(93)(CO)]
 
 
Table 28: Intramolecular Asymmetric Cyclopropanation Catalyzed by Rhodium and 
Ruthenium Complexes of 93  
0.6 mol % [M(93)]
DCM, rt, 20 h
entrya ee (%)
1
2
a Reactions were performed with 0.6 mol % of catalyst and 1 equiv of substrate in DCM at room temperature for
20 h.
Me
20 (1R,5S)
37 (1R,5S)
yield (%)
3 Me 24 (1R,5S)
23
81
79
4 Ph 49 (1R,5S)59
Me
R1
R2
O
O
N2
OO
R1 R2
H H
H
H
ee (%)
24 (1R,5S)
36 (1R,5S)
yield (%)
41 (1R,5S)
48
65
65
25 (1S,5R)60
R3
R3
R3
H
H
H
H
5 Ph 24 (1R,5S)33H 28 (1R,5S)67H
R1 R2
[Rh(93)I] [Ru(93)(CO)]
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Che and co-workers also reported the use of ruthenium complexes of 93 
encapsulated in mesoporous molecular sieves for intramolecular cyclopropanation.39 
Although the report provides only one example, shown in Scheme 38, the authors noted 
that the catalyst generated respectable enantioselectivities and was reusable up to four 
times. The result from this heterogeneous system demonstrated a significant 
improvement in enantioselectivity over their previous report in Table 28.  
 
Scheme 38: Che’s ruthenium complexes of 93 encapsulated in mesoporous molecular 
sieves for intramolecular cyclopropanation  
 
[Ru(93)(CO)]
MCM-48
Ph O
O
N2
O
O
Ph
85 %ee
TON: 1500  
 
 Iron complexes of 93 were also reported by Che and co-workers in 2006. The 
use of the iron(III) chloride complex of 93 for asymmetric cyclopropanation with ethyl 
diazoacetate gave results similar to that of the rhodium and ruthenium complexes 
mentioned previously (Table 27).40 However, the iron complex produced the 
cyclopropanes with lower turnover numbers in comparison to the ruthenium complex. 
Continued investigation of the iron catalyzed system showed that the use of nitrogen-
based axial ligands could improve the diastero- and enantioselectivity across a range of 
substrates as shown in Table 29. However, the use of excess axial ligand resulted in 
even greater diminished turnover numbers as shown in Table 30.   
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Table 29. Asymmetric Cyclopropanation of Aromatic Olefins Catalyzed by [Fe(93)Cl]  
0.5 mol % [Fe(93)Cl]
EDA
DCM, rt, 5 h
Ar
entrya
1
2
3
a Reactions were performed with 0.5 mol % of catalyst, 1 equiv of EDA, and 5 equiv
of substrate in DCM at rt. 4 h slow addition is followed by 1 h of stirring in DCM,
b Z isomer.
Ar
substrate
styrene
4-chlorostyrene
4-methylstyrene
t rans:
cis
trans
ee (%)
12:1
18:1
12:1
80
75
79
CO2Et
TON
368
284
424
4
5
6
4-methoxystyrene
α-methylstyrene
1,1-diphenylethane
13:1
3:1
-
74
81
83b
416
390
410
yield (%)
71
57
56
65
68
72
 
 
Table 30: Asymmetric Cyclopropanation of Styrene Catalyzed by [Fe(93)L]  
0.5 mol % [Fe(93)L]
4 mol % axial ligand (L)
EDA
DCM, rt, 5 h
Ar
entrya
1
2
3
a Reactions were performed with 0.5 mol % of catalyst, 4 mol % of axial ligand (L),
1 equiv of EDA, and 5 equiv of substrate in DCM at rt. 4 h slow addition is followed
by 1 h of stirring in DCM.
Ar
axial
Ligand (L)
pyridine
DMAP
t rans:
cis
trans
ee (%)
12:1
33:1
24:1
80
82
81
CO2Et
TON
368
307
321
4
5
6
1-methylimidazole
1-methylpyrrolidine
4-phenylpyridine N-oxide
26:1
27:1
23:1
83
86
83
275
293
209
Cl
7 DMSO 17:1 82 385
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Berkessel and co-workers evaluated ruthenium complexes of their derivatives of 
the Halterman porphyrin 93 (Figure 14)41 as catalysts for the cyclopropanation of 
aromatic olefins using the slow addition method for the introduction of EDA (Table 
31). Excellent diastereo- and high enantioselectivities were observed with all ligand 
derivatives when styrene was used as the olefin (entries 1-5, Table 31). Results showed 
that the derivatization of the para-phenyl position of the meso-aryl group with electron-
donating or -withdrawing groups did not have a pronounced effect on the diastereo- and 
enantioselectivity in comparison to the metal complexes of the Halterman porphyrin.  
 
N
N N
N
M
N
N N
N
M
Y Y
Y
Y
Y
Y
Y
Y
93: Y = H
97: Y = OCH3
98: Y = CH3
99: Y = CF3
 
Figure 14: Halterman ligand 93 and its derivatives. 
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Table 31: Asymmetric Cyclopropanation of Olefins Catalyzed by [Ru(93)(CO)] and  
[Ru(97-99)(CO)] 
 
0.1 mol % [Ru(Por*)(CO)]
EDA
DCE, 25 °C
R
entrya
1 87 (1S,2S)
2 90 (1R,2R)
3 89 (1R,2R)
a Reactions were performed with 0.1 mol % of catalyst, 1 equiv of substrate, and 1 equiv of EDA in DCE at 0 °C.
Diazo was added by means of a syringe pump over 2 hours. b See Figure 6 for structures. c [Ru(84)PF3] used as
catalyst.
Ar
substrate trans:cis ee cis (%)ee trans (%)
96:4
96:4
96:4
14 (1S,2R)
31 (1R,2S)
11 (1R,2S)
CO2Et
Por*b conversion (%)
4 89 (1S,2S)
5 87 (1S,2S)
97:3
96:4
<1
14 (1S,2R)
93
ent-97
ent-98
99
93c
80
81
83
94
81
6 90 (1S,2S)
7 91 (1R,2R)
8 91 (1R,2R)
66:34
68:32
67:33
38 (1S,2R)
43 (1R,2S)
46 (1R,2S)
9 91 (1S,2S)
10 90 (1S,2S)
69:31
66:34
36 (1S,2R)
38 (1S,2R)
93
ent-97
ent-98
99
93c
79
76
81
>98
78
11 46 (1S,2S)
12 40 (1R,2R)
13 39 (1R,2R)
86:14
85:15
82:18
9
<2
<2
14 46 (1S,2S)
15 32 (1S,2S)
85:15
99.5:0.5
4
6
93
ent-97
ent-98
99
93c
20
15
20
30
42
n-hexyl
 
 
Simonneaux and co-workers reported the use of the first water-soluble 
Halterman porphyrin derivative (100, Scheme 39) and its iron and ruthenium complexes 
for the cyclopropanation of styrene with EDA.42 While both the iron and ruthenium 
catalysts displayed very similar diastereo- and enantioselectivities, the iron complex 
provided superior yields (Scheme 39). The authors also noted that the iron complex was 
recyclable up to four times, with no significant decrease in enantioselectivity, while 
retaining excellent diastereoselectivity. In comparison, the enantioselectivity and yield 
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of the cyclopropanated product generated by the ruthenium complex decreased 
significantly after the first cycle. 
 
Scheme 39: Simonneaux’s water-soluble Halterman porphyrin derivatives 
0.5 mol % catalyst
EDA
H2O, rt, 24 h
Ph
Ph
CO2Et
[Fe(100)Cl]: 85% yield
trans:cis = 92:8
trans ee = 83%
N
N N
N
MNaO3S SO3Na
SO3Na
SO3Na
100
[Ru(100)(CO)]: 52% yield
trans:cis = 96:4
trans ee = 83%
 
 
Simonneaux and co-workers continued developing new asymmetric 
cyclopropanation systems, and in 2005 they introduced the use of a heterogeneous 
polymer-based Halterman porphyrin system as a catalyst for the cyclopropanation 
olefinic substrates (Figure 15). Halterman ligand complexes of iron and ruthenium were 
incorporated into the backbone of the polymer-based system,43 and the use of an 
alternate diazo reagent, trifluorodiazoethane (Table 32), was employed for the first 
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time.44  The diastereoselectivities reported for his new system was excellent, as with 
most Halterman porphyrin-based cyclopropanation systems; however, the yield and 
enantioselectivity were only moderate. 
N
N N
N
MR R
R
R
L
101: R =
heterogeneous
catalyst
 
Figure 15: Polymer-based Halterman ligand. 
 
Table 32: Asymmetric Cyclopropanation with Trifluorodiazoethane Catalyzed by 
[Fe(93)Cl] and [Ru(101)(CO)]   
 
0.5 mol % catalyst
trif luorodiazoethane
DCM, rt, 2h
Ph
entrya
1 61
2 58
3 56
a Reactions were performed with 0.5 mol % catalyst, 1 equiv of diazo, and 5 equiv of
substrate in DCM at rt for 2 h.
Ph
catalyst trans:cis ee (%, trans)
99:1
98:2
97:3
4 6199:1
CF3
yield (%)
50
32
52
33
[Fe(93)Cl]
[Ru(93)(CO)]
[Fe(101)Cl]
[Ru(101)(CO)]
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 Simmonneaux and coworkers report using trifluorodiazoethane led them to 
explore the use of bulkier diazo reagents for asymmetric cyclopropanation. In a separate 
report, the diazo reagent 2,6-di-tert-butyl-4-methylphenyl diazoacetate (Scheme 40) 
was employed  in the cyclopropanation of styrene with [Ru(93)(CO)].45 Although the 
results reported by Simonneaux and co-workers showed that excellent 
diastereoselectivity could be achieved with this system, the yield and enantioselectivity 
was low.  The authors speculated that the slower reaction rate responsible for the poor 
yield and enantioselective outcome was a consequence of the formation of a stable 
carbene intermediate. Acquisition of a crystal structure of the carbene intermediate 
supported this claim.  
 
Scheme 40: Simonneaux’s use of alternate diazo reagent 2,6-di-tert-butyl-4-
methylphenyl diazoacetate  
 
[Ru(93)(CO)]
toluene
t rans
N2
H+
62% yield
tr ans:cis = 100:0
60% ee (t rans)
O
O
O
CH3
tBu
tBu
O
tBu CH3
tBu
 
Further studies on the expansion of diazo substrate scope, led Simonneaux and 
co-workers to the use the ruthenium Halterman complex for the asymmetric 
cyclopropanation of styrene with diisopropyl diazomethylphosphonate (DAMP).46 The 
results, shown in Table 33, demonstrate that this diazo reagent was capable of 
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producing excellent diastereo- and enantioselectivities while achieving high product 
yields.   
 
Table 33: Asymmetric Cyclopropanation of Styrene with DAMP using [Ru(93)(CO)] 
as Catalyst 
 
0.5 mol% [Ru(93)CO]
DAMP
DCM, rt, 2h
entrya
ee (%)
1 34
2 23
3 23
a Reactions were performed with 0.5 mol % of catalyst, 1 equiv of DAMP, and 5
equiv of EDA in DCM at room temperature for 2 h.
R=
4-methyl
4-methoxy
t rans:cis trans cis
96:4
99:1
97:3
90
87
90
P
yield (%)
4 5
5 27
4-trifluoro
4-chloros
95:5
97:3
92
88
97
93
96
90
92
R R
H
O
Oi-Pr
Oi-Pr
 
 
Simonneaux and co-workers also reported the design and synthesis of a new 
porphyrin ligand. The incorporation of a mixture of two rigid, bulky groups onto the 
porphyrin ring generated the four porphyrin ligands shown in Figure 16. These 
Halterman-like ligands, bearing 1 – 4 chiral appendages (4 chiral appendages being the 
Halterman ligand (84) itself) were employed as catalysts for the cyclopropanation of 
styrene with EDA and DAMP (Table 34). Catalysts bearing only three chiral groups 
displayed high levels of asymmetric induction, although ligands having only one or two 
chiral groups led to a significant reduction. For both the EDA and DAMP, the steric 
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bulk of the chiral and non-chiral groups produced products with high 
diastereoselectivity with all of the ligands examined. 
 
≡≡
93 102
103 104
 
Figure 16: Schematic representation of the chiral porphyrin ligands 93-95.   
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Table 34: Asymmetric Cyclopropantion of Styrene with DAMP Catalyzed by 
Ruthenium Complexes of Halterman Porphyrin 93 and its Derivatives 102-104  
 
0.5 mol% [Ru(Por*)(CO)]
DAMP
DCM, rtPh
entrya ee (%)
1
2
3
a Reactions were performed with 0.5 mol % of catalyst, 1 equiv of DAMP, and 5 equiv of
diazo in DCM at room temperature for 2 h for EDA and 48 for DAMP.
b See Figure 32 for structures of ligands.
Ph
Por*b
93
102
trans:
cis
t rans
95:5
96:4
93:7
87
90
65
P
yield (%)
4
5 103
96:4
90:10
77
41
96
97
95
65
94
diazo
6 95:5 66
7
8
104 90:10
90:10
25
33
55
96
13
EDA
DAMP
EDA
DAMP
EDA
DAMP
EDA
DAMP
O
Oi-Pr
O i-Pr
 
 
In 2006, Cenini and co-workers reported the use of ligand 105 for the ruthenium 
catalyzed cyclopropanation of α-methyl styrene using EDA (Scheme 41).47 In 
comparison to the Halterman porphyrin-based catalysts, this system produced 
significantly lower selectivities. They also reported the use of a cobalt complex of 105 
for the cyclopropanation of styrene using EDA. In this example, the cobalt complex of 
105 generated slightly greater diastereoselectivities (trans:cis = 4.4:1) than ruthenium-
catalyzed system. Enantioselectivities of the cobalt-catalyzed system was not reported. 
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Scheme 41: Cenini’s [Ru(105)(CO)] cyclopropanation 
[Ru(105)(CO)]
benzene, 1 h CO2Et
CO2Et
+
trans cis
3.2:1
72.5% yield
10% ee
16.5% yield
5% ee
N2
H
O
OEt+
N N
NN
M
105  
 
 Independently of Cenini, Zhang and co-workers  also reported some of the first 
examples of cobalt porphyrins as asymmetric catalysts for cyclopropanation (Figure 
17).48-49 One of the distinct advantages of cobalt over the existing metal catalyzed 
systems was that the slow addition of the diazo reagent was no longer necessary to 
minimize the formation of the dimerization side-product. 
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N
NN
N
OO
H
H
H
H
H
H
H
H
Co
N
NN
NOH
O
HO
OCo
ON
O
O N
O
N
NN
N
Co
N
NN
N
OO
O
H
H
H
O
H
H
H
Co
N
N N
N
O
O
O
O
O O
O
O
*R
*R R*
R*
R*
R**R
*R
O
O
CH3
O
CH3H3C
110: R*=
106 107
108
109
Co
 
Figure 17: Chiral cobalt porphyrin complexes. 
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In the initial report by Zhang and co-workers, cobalt complexes of several chiral 
porphyrin ligands (Figure 17) were prepared and evaluated for the asymmetric 
cyclopropanation of styrene with EDA (Table 35). Their initial findings demonstrated 
that chiral groups directed toward the metal-center, as in ligand 110, provided the 
highest selectivities. Continued development of these ligand systems with chiral groups 
in close proximity to the cobalt metal center has led to improved selectivities.   
 
Table 35: Asymmetric Cyclopropanation of Styrene Catalyzed by Cobalt Porphryin 
Complexes  
 
2 mol % [Co(Por*)]
EDA
toluene,80 °C,12 h
Ph
entrya
1 62
2
a Reactions were performed with 2 mol % catalyst, 1.2 equiv of diazo, and 1 equiv. of
styrene at 80 °C for 12 h. b See Figure 33 for structures.
Ph
cis:
trans trans
64:36
CO2Et
yield (%)
73
Por*b cis
% ee
77110
3
9
4
1
28:72
32:68
97
99
1
1
106
107
5
1
6
36:64
34:66
79
80
1
6
109
108
 
 
 Zhang and co-workers prepared a series of D2-symmetric chiral ligands for use 
in cyclopropanation (Figure 18).50-51 One notable feature of these systems is the 
modular design of the porphyrin ligand. This synthetic strategy reported by Zhang and 
co-workers provides for the direct installation of select chiral amides from a common 
precursor or set of precursors. Through selection of the appropriate chiral groups, each 
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diastereomer of the cyclopropanated product could be accessed with excellent 
enantioselectivity (Scheme 42).   
 
N
NN
N
Ph
Ph
N
N
N
N
H
H
H
H
R*
O
R*
O
*R
O
*R
O
MeO
N
H
O
H
N
H
O
HH
Me
Me N N
H
O
HH
H
Me
H
Me
MeO
N
H
O
HMe
H
62d: R = [S]-(-)62c: R = [R]-(+)
62a: R = [S]-(+) 62b: R = [R,R]-(+)
M
N
N
N
N
HN
HN
O
O
NH
NH
O
O
H
HH
H
M
63o  
Figure 18: D2-Symmetric porphyrins.  
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Scheme 42: D2-symmetric cobalt porphyrin catalyst with different chiral amides 
selectively produces each of the four cyclopropane enantiomers 
 
 
N
N N
N
NH
NH
HN
HN
O
O
O
O
R* *R
*RR*
Co
+ t-BDA
CO2t-Bu CO2t -Bu
CO2t-BuCO2t-Bu
cis-(1S,2R)
cis-(1R,2S)
trans-(1R,2R)
tr ans-(1S,2S)
H
H
H
H
H
H
H
H
(S)
O
H2N
(R)
O
H2N
(R)
O
H2N
OMe
(S)
O
H2N
OMe
>99:1 dr
95% ee
37:63 dr
96% ee
38:62 dr
96% ee
t-Bu t-Bu
t-Bu t -Bu
(S) 63o(R) 63p
(S) 63q not availableat time of
publishing
 
 
The resulting ligands (selected examples are shown in Table 36) were evaluated 
for the cyclopropanation of styrene with EDA and tert-butyl diazoacetate (t-BDA). The 
use of the axial ligand, 4-N,N-dimethylaminopyridine (DMAP), was found to 
significantly increase diastereo- and enantioselectivity without diminishing the yields 
(entries 1 and 5, Table 36).  Further improved were achieved by lowering the reaction 
temperature (entries 8 and 9, Table 36).   
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Table 36: Asymmetric Cyclopropanation of Styrene Catalyzed by [Co(63)] 
2 mol % [Co(Por*)]
EDA
toluene, rt, 20 h
Ph
entrya
1 31 1R,2R
2 35 1S,2S
a Reactions were carried out at room temperature in toluene for 20 h under N2 with 1.0 equiv of styrene, 1.2
equiv of diazo reagent and 1 mol % 63 in the presence of 0.5 equiv of additive. Concentration: 0.25 mmol
styrene/1 mL toluene. b Determined by GC. Yields in parentheses represent isolated yields. c ee of major
diastereomer determined by chiral GC. d Absolute configuration of major enantiomer determined by optical
rotation. e Carried out at -20 ºC for 8 h. f 5 mol % 4 was used. See Scheme 21, Table 13, and Figure 8 for
structures.
Ph
trans:cisb ee (%)c
87:13
66:34
CO2R
yield (%)b
92
77
3 48 1S,2R
4 51 1R,2S
32:68
32:68
92
95
5 67 1R,2R
8 78 1R,2R
96:04
97:03
91
86(82)
additivediazoPor*
9 95 1R,2R>99:188(84)
10e 98 1R,2R
11 92 1S,2R
>99:1
31:69
84(85)
65(59)
63a EDA -
63b EDA -
63c EDA -
63d EDA -
63a EDA DMAP
63o EDA DMAP
63o t-BDA DMAP
63o t-BDA DMAP
63p EDA DMAP
6 88 1R,2R44:5652
7 89 1R,2R42:5857
63c EDA DMAP
63d EDA DMAP
13 95 1R,2S30:7068
14f 95 1R,2S38:6276
15 59 1R,2R
16 78 1R,2R
96:04
99:01
80
73
63q EDA DMAP
63q t-BDA DMAP
63t EDA DMAP
63t t-BDA DMAP
12f 96 1S,2R37:6378(75)63p t-BDA DMAP
configd
 
 
Further investigations into these ligand systems by Zhang and co-workers 
focused on the uniqueness of the cobalt in performing catalytic cyclopropanations.52 
When the cobalt complex was synthesized and subjected to the same reaction 
conditions as the iron complex, it generated superior results. Given the low cost of 
cobalt, the ‘one-pot’ process practicality, and the yield and enantioselectivity generated, 
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chiral cobalt complexes presented themselves as desirable alternatives to other 
cyclopropanation systems.  
 Zhang and co-workers continued to focus their attention on increasing the 
substrate scope of their cobalt based system (Table 37).53 The cobalt D2-symmetric 
porphyrin 63o was shown to be a suitable catalyst for the asymmetric cyclopropanation 
of aromatic olefins (entries 1-5, Table 37). However the most notable feature of this 
catalytic system was its ability to tolerate electron-deficient olefins, normally shown to 
be inactive in most cyclopropantion systems (entries 6-9, Table 37). 
 
Table 37: Asymmetric Cyclopropanation of Olefins with t-BDA Catalyzed by 
[Co(63o)] 
 
R
CO2t -Bu
1 mol % [Co(63o)]
0.5 equiv DMAP
t-BDA
entrya olefin yield (%)
t rans:
cis
ee (%,
t rans)
1
2
3
4
a Reaction conditions: 1 mol % of catalyst, 1.0 equiv of olefin, 1.2 equiv of t-BDA, and 0.5
equiv of DMAP in toluene at 25 oC under N2 for 20 hrs. b Chlorobenzene was used as solvent.
84 >99:1 95
69 98:2 91
86 98:2 96
74 97:3 84
Olefin
6b 92 99:1 91
7b 77 99:1 97
8b 81 99:1 94
9b 83 76:24 93
styrene
4-chlorostyrene
4-methoxystyrene
pentafluorostyrene
ethyl acrylate
acrylamide
pent-1-en-3-one
acrylonitrile
5 84 99:1 982-vinylnaphthalene
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 In 2008, Zhang and co-workers reported the use of diazosulfones as alternative 
diazo reagents for cobalt catalyzed cyclopropanation.54 During the course of this study 
it was discovered that a new porphyrin ligand would be required to obtain high 
enantioselectivities (Figure 8). The results shown in Table 38 demonstrated that the 
porphyrin ligands examined in the previous cyclopropanation system (63o &p) did not 
produce adequate levels of stereoselectivity.  Therefore, ligands 63r and 63l were 
designed and synthesized in an effort to increase the rigidity and polarity of the chiral 
environment, thereby enhancing enantioselectivity. The more sterically demanding 
ligand 63l, of the “group of six” (Figure 8), was shown to be the best cobalt catalyst for 
diazosulfones (entry 7, Table 38).  
 
Table 38: Asymmetric Cyclopropanation of Styrene with Diazosulfone Catalyzed by 
Cobalt Complexes of the “Group of Six” Porphyrins  
 
Ph
+
N2
H S
Ph
S
O
[Co(Por*)]
entrya [Co(Por*)]b yield (%)
ee (%)
trans
[Co(63j)]
[Co(63p)]
[Co(63k)]
[Co(63r)]4
60
99 61
5 78 56
[Co(63l)] 99
6
7
3
1 [Co(63o)] ~6 3
30 54
23
92
a Reaction conditions: Performed at 25 oC for 48 h with DCM as solvent using 1 mol % [Co(Por*)]
with 1.0 equiv of styrene and 1.5 equiv of N2CHTs; [styrene] = 0.25 M. b See Figure 8 for structures.
additive
DMAP
-
-
-
-
-
t rans:
cis
>99:01
>99:01
>99:01
>99:01
>99:01
>99:01
O
CH3
O O
CH3
2 [Co(63o)] 86 14- >99:01
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With the cobalt complex of ligand 63l identified as the catalyst of choice, the 
substrate scope was examined (Table 39). Similar to diazoacetates, the cobalt-catalyzed 
cyclopropanation system could tolerate a broad range of olefins including aromatic and 
electron-deficient olefins, to generate products with high levels of diastereo- and 
enantioselectivity. 
 
Table 39: Asymmetric Cyclopropanation of Olefins with Diazosulfone Catalyzed by 
[Co(63l)]  
 
entrya yield (%)
ee (%)
t rans
1 99 92
a Reaction conditions: Performed at 25 oC for 48 h with DCM as solvent using 1 mol % [Co(92)] with 1.0 equiv
of styrene and 1.5 equiv of N2CHTs; [styrene] = 0.25 M.
tr ans:
cis
>99:01
2 57 94>99:01
80 97>99:013
72 95>99:014
5
6
77 95>99:01
81 93>99:01
7
8
9
10
96 8996:04
72 90>99:01
93 8999:01
81 6179:21
substrate
styrene
4-t-butylstyrene
4-methoxystyrene
4-trifluoromethylstyrene
3-nitrostyrene
2-vinylnaphthalene
ethyl acrylate
acrylonitrile
but-3-en-2-one
methyl acrylate
R +
N2
H S
R
S
O
[Co(63l)]
O
CH3
O O
CH3
 
 
 The use of succinimidyl diazoacetate as a carbene source was examined by 
Zhang and co-workers for the cobalt-catalyzed cyclopropanation of both aromatic and 
electron-deficient olefins (Table 40).55  Both ligands 63o and 63j from the “group of 
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six” (Figure 8) provided excellent diastereo- and enantioselectivities. Although the 
yields associated with the cyclopropanation of electron-deficient olefins were 
diminished in this system, the stereoselectivities were still very high.  The products of 
these reactions, cyclopropyl succinimidyl esters, are valuable intermediates for the 
synthesis of cyclopropyl carboxamide derivatives. 
 
Table 40: Asymmetric Cyclopropanation of Olefins with Succinimidyl Diazoacetate 
Catalyzed by [Co(63o)] and [Co(63j)]  
 
entrya yield (%)
ee (%)
tr ans
70 962b
1 86 92
a Reaction conditions: Performed at 25 oC for 48 h with toluene as solvent using 5 mol % [Co(63o)]
with 1.0 equiv of styrene and 1.5 equiv of N2CHCO2Suc in the presence of 0.5 equiv of DMAP;
[styrene] = 0.25 M. b [Co(63j)] used as catalyst.
tr ans:
cis
>99:01
>99:01
4b
3
71 96
90 95>99:01
98:02
81 98
80 97>99:01
>99:016b
5
75 97
71 95>99:01
99:018b
7
10b
9
12b
11
48 92
66 90>99:01
>99:01
30 94
77 90>99:01
>99:01
13
14
15
16
17
18
71 91>99:01
50 92>99:01
33 9199:01
57 89>99:01
52 96>99:01
55 91>99:01
substrate
styrene
4-methylstyrene
4-t-butylstyrene
4-methoxystyrene
4-chlorostyrene
4-trifluoromethylstyrene
4-vinylphenyl acetate
3-nitrostyrene
2-vinylnaphthalene
ethyl acrylate
N,N-dimethylacrylamide
but-3-en-2-one
R +
N2
H
O
O
N
O
O R
O
O N
O
O
[Co(63o)]
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Zhang and co-workers also reported on the use of an acceptor/acceptor type 
diazo reagent, α-nitrodiazoacetate, which was shown to be a suitable diazo source for 
use by many of the cobalt-catalyzed systems.56-57  The results generated by the “group 
of six” (Figure 8) in the cyclopropanation of styrene with ethyl α-nitrodiazoacetate 
(ENDA) is shown in Table 41. Similar to other diazoacetate systems, ligand 63o 
generated high diastereo – and enantioselectivities (Table 41). One notable feature of 
this system was the preferred solvent, hexanes, which generated the highest 
enantioselectivity while maintaining high yield and diastereoselectivity (entry 2, Table 
41). Research also showed that aromatic and electron-deficient olefins, as well as 
aliphatic olefins, were suitable substrates for cyclopropanation with ENDA (Table 42).   
 
Table 41: Asymmetric Cyclopropanation of Styrene with ENDA Catalyzed by Cobalt 
Complexes of the “Group of Six” Porphyrins  
 
Ph +
N2
O2N Ph
[Co(Por*)]
entrya Por*b yield (%) ee (%) Z
[Co(63j)]
[Co(63p)]
[Co(63k)]
[Co(63r)]4
20
69 47
5 99 58
[Co(63l)] <5
6
7
3
1 [Co(63o)] 99 81
31 -23
33
nd
a Reaction conditions: Performed at 25 oC for 48 h with DCM as solvent using 1 mol %
[Co(Por*)] with 1.0 equiv of styrene and 1.2 equiv of ENDA; [styrene] = 0.25 M.
b See Figure 8 for Structures.
solvent Z:E
91:09
91:09
67:33
81:19
66:34
85:15
2 [Co(63o)] 87 89n-C6H14 92:08
OEt
O
NO2
CO2Et
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
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Table 42: Asymmetric Cyclopropanation of Olefins with α-Nitrodiazoacetate 
Catalyzed by [Co(63o)]  
 
R +
N2
O2N
R
[Co(63o)]
OEt
O
NO2
CO2Et
entrya yield (%) ee (%) Z
1 93 92
a Reaction conditions: Performed at 25 oC for 24 h with hexane as solvent using 5 mol %
[Co(63o)] with 1.0 equiv of styrene and 1.2 equiv of ENDA; [styrene] = 0.25 M. b DCE used as
solvent. c Reaction performed neat.
Z:E
92:08
2 86 9093:07
82 9091:093
88 9092:084
5 81 9593:07
6b
7b
8b
9c
42 8853:47
62 8856:44
92 7563:37
45 8092:08
substrate
styrene
4-methylstyrene
4-chlorostyrene
4-trifluoromethylstyrene
3-nitrostyrene
ethyl acrylate
1-hexene
N ,N-dimethylacrylamide
methyl acrylate
 
 
Chiral Strapped Porphyrins  
In 1998, Simonneaux and co-workers used the threitol-strapped ligand 111, 
previously reported by Gross and co-workers for epoxidation58-59, for the asymmetric 
cyclopropanation of aromatic olefins (Scheme 43). The ruthenium complex of 111 was 
used in conjunction with ethyl diazoacetate to generate cyclopropane products with 
excellent yields and moderate diastereo- and enantioselectivities (Table 43).60 
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Scheme 43: Simonneaux’s threitol-strapped ligand 111 
P
P +
trans cis
N2
PH
O O iPr
+
92% yield
t rans:cis = 97:3
33% ee trans
O iPr
O
O iPr
OiPr
O
OiPr
O iPr
DAMP
[Ru(111)(CO)]
N
N N
NM
O
O
O
O
O O
O
O
R
R
R
R
O
O
R =
111
 
 
Table 43: Asymmetric Cyclopropanation of Aromatic Olefins Catalyzed by 
[Ru(111)(CO)] 
1 mol % [Ru(111)(CO)]
EDA
rt, 8 h
Ar
entrya
1 46
2 47
3 46
a Reactions were performed with 1 mol % catalyst, 1 equiv of diazo, and substrate neat
at rt for 8 h.
Ar
trans:
cis
ee (%)
trans
4:1
6.1:1
9.9:1
CO2Et
4 528.6:1
yield
(%)
85
95
92
93
5 457.1:1
6 5011.0:1
93
92
substrate
styrene
4-methoxystyrene
4-methylstyrene
4-chlorostyrene
4-bromostyrene
4-fluorostyrene
 
 
In 2003, Simonneaux and co-workers continued their work with threitol-
strapped ruthenium catalysts and reported the use of an alternative diazo reagent, 
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diisopropyl diazomethylphosphonate (DAMP) for the cyclopropanation of styrene.61 
The yield and diastereoselectivities produced by [Ru(111)(CO)] with DAMP were 
excellent, and comparable to the results generated by the ruthenium complex of the 
Halterman porphyrin 93. However, unlike the Halterman ligand system, the 
enantiomeric excess was shown to be significantly lower.  
Rose and Cenini collaborated to develop a cobalt-catalyzed asymmetric 
cyclopropanation system utilizing the binaphthyl-strapped porphyrin ligands seen in 
Figure 19.62 These ligands, first developed by Collman and Rose and employed in 
asymmetric epoxidation, were evaluated for the cyclopropanation of various styrene 
derivatives with EDA (Table 44). Although the yields were consistently excellent 
across a range of substrates, the diastereo- and enantioselectivities reported were not as 
high as the cobalt-catalyzed cyclopropanation systems developed by Zhang and co-
workers.50 
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N
N
N
N
M
HN
NH
O
O
HN
O
NH
O
MeO
OMe
OMe
MeO
112 113
N
N
N
N
M
HN
NH
O
O
HN
O
NH
O MeO
OMe
OMe
MeO
 
Figure 19:  Rose’s modified Collman catalyst. 
 
Table 44: Asymmetric Cyclopropanation of Aromatic Olefins EDA Catalyzed by 
[Co(112)] and [Co(113)] 
 
0.5 mol % [Co(Por*)]
EDA
benzene, rt
Ar
entrya
ee (%)
1 10
2c 46
4 8
a Reactions were performed with 0.5 mol % of catalyst, 1 equiv of EDA, and 10 equiv of substrate in benzene at room
temperature. b See Figure 18 for structures. c N-methylimidazole (20 equiv) was added to reaction mixture.
Ar
substrate
styrene
styrene
4-chlorostyrene
cis:trans
cis t rans
27:33
16:84
29:71
60
50
61
CO2Et
yield
(%)
5 10
6
4-methylstyrene
1,1-diphenylethylene
27:33 62
92
89
90
90
93
3 31α-methylstyrene 27:33 7695
ee (%)
42
31
21
cis/ trans
cis trans
25:75
18:82
17:83
57
66
8
yield
(%)
-
22
- -
96
93
85
-
93
2228:72 3994
[Co(113)]b [Co(112)]b
time
(h)
time
(h)
36
60
24
36
72
20
48
60
24
-
72
16
56
 
222 
 
 In 2002, Rose and Woo published a report using the Halterman porphyrin 
derivative 114 and Collman’s bis-binaphthyl strapped ligand 115 for the iron(II) 
catalyzed asymmetric cyclopropanation of styrene with EDA.63 The iron(II) complex of 
the Halterman porphyrin derivative, [Fe(114)], generated excellent yields and 
diastereoselectivities, however it afforded only a modest 45% ee (Scheme 44). The 
iron(III) bis- binaphthyl strapped complex, [Fe(115)], showed decreased selectivities. 
 
N N
NNM
HNNH
NH HN
MeO
OMe
OMe
MeO
O
O
O
O
115
N
N N
N
R
R
R
R M
D4-TpAP-114
R=
 
Figure 20. Kodadek’s Halterman-like D4-symmetric porphyrin ligand 105 and a 
binaphthyl-derived catalyst by Collman and Rose 115. 
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Scheme 44: Rose and Woo’s iron-catalyzed cyclopropanation    
[Fe(Por*)]
EDA CO2Et
CO2Et
+
trans cis
99% yield
21:1 t rans:cis
45% ee (trans), 21% ee (cis)
N2
H
O
OEt+
[Fe(114)]:
95% yield
5.8:1 trans:cis
27% ee (trans), 25% ee (cis)
[Fe(115)]:
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Enantioselective Cyclopropanation with Cobalt(II) Chiral Porphyrin Project 
In 2004, at the University of Tennessee – Knoxville highly enantioselective and 
diastereoselective cyclopropanation was communicated in the Journal of the American 
Chemical Society. The bromoporphyrin “toolbox” synthetic approach related to this 
project was already covered under the projects section of the C-N amido cross-coupling 
portion. Originally mentored in the Zhang group by Dr. Ying Chen, this 2004 summer 
project was actually a result of the progression of three years of research in this area. 
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Dr. Peter Zhang and his first two post-docs, Dr. Ying Chen and Dr. Guan-Yao 
Gao, began looking to cobalt porphyrins for cyclopropanation diastereo- and 
enantioselectivity. Initial approaches included the use of vitamin B12 in hopes that the 
natural chiral environment would provide the chiral environment necessary to generate 
high selectivity. Encouraged by the production of an enantioselective product formation 
and little EDA dimer formation, they continued efforts to improve the chiral 
environment led to the bio-mimetic approach of meso- and beta-porphyrin coupling 
projects. The idea was that by using larger chiral units and attaching them directly to the 
porphyrin ring using different symmetries that they could improve the chiral 
environment near the metal center and generate higher enantioselectivity. 
That led to the use of meso- and beta-bromoporphyrins being used as synthons 
for the production of a variety of porphyrins to be used as catalysts to test this theory. 
With only moderately enantioselective results, again the group sought to employ a 
chiral center closer to the metal center of the porphyrin. This was the beginning of the 
2,6-disubstituted porphyrins. 
It was found that 2,6-dibromophenyl units attached to the porphyrin were 
suitable synthons for the cross-coupling of a variety of chiral substrates; however, it 
happened that the amide coupling displayed a trans-orientation that directed the chiral 
units out over the metal center. Three chiral amides that were commercially available at 
the time were coupled to a variety of frameworks in an attempt to optimize the cobalt 
catalyzed diastereo- and enantioselectivity of the cyclopropanation reaction. Dr. Chen 
and Gao were now accompanied by a few graduate students, one of which was Dr. 
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Joshua V. Ruppel. These chiral amides became nicknamed as the Chen amide 62a, the 
Gao amide 62b, and the Ruppel amides 62c & d based on the original developer and 
user of the catalyst. These created the original chiral frameworks that served our group 
well until 2008 paper on diazosulfones by Dr. Shifa Zhu, who coined the Zhu amide 
62e. Since then our “toolbox” has expanded considerably and will probably be the 
source of the group’s ability to customize the ligand environment for a great variety of 
substrates for many years to come. 
The catalysis was also well underway. The GC method was well established and 
standardized as a result of previous papers that determined the diastereo and 
enantioselectivity of the cyclopropanation reaction. That left the solvent, time and 
temperature to optimize and then the use of additives. The cobalt(II) complexes of these 
chiral porphyrins were shown to be active catalysts for highly enantioselective and 
diastereoselective cyclopropanation under a practical one-pot protocol. Alkenes could 
be used as limiting reagents and the typical slow-addition of diazo reagents was not 
required as a result of the minimal amount of EDA dimer formation. 
Using 1 mol % of the new Co[63] catalysts, the cyclopropanation reactions 
proceeded effectively at room temperature in one-pot with styrene as the limiting 
reagent, producing the desired cyclopropanes in high yields (Table 34). Each of the four 
possible stereoisomers (trans-(1R,2R), trans-(1S,2S), cis-(1S,2R), or cis-(1R,2S)) could 
be produced as the dominant product when 63a, 63b, 63c, or 63d was used as the 
catalyst, respectively, (entries 1-4, Table 34). These results signify a high dependence 
of catalytic selectivity on the structure of the chiral R* units. The moderate 
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enantioselectivities were doubled when 0.5 equivalent of 4-dimethylaminopyridine 
(DMAP) were added (entries 5-7, Table 34), suggesting significant trans influence of 
potential coordinate ligands on the metal center. The DMAP additive also boosted the 
production of the trans isomer (entries 5-7, Table 34). Further improvements in 
diastereoselectivity and enantioselectivity were observed when 63a was replaced with 
63l where the two meso-groups are 3,5-di-tert-butylphenyl instead of phenyl (entry 8, 
Table 34). When t-BDA was used, the same catalyst produced trans-(1R,2R)-isomer as 
the only diastereomer in 95% ee, which was further improved to 98% ee at –20 ºC 
(entries 9 and 10, Table 34).12 The same structure modification resulted in 96% ee for 
cis-(1S,2R)-isomer with 63m and 95% ee for cis-(1R,2S)-isomer with 63n (entries 11-
14, Table 34). The results obtained with 63o bearing meso-n-heptyl groups (entries 15 
and 16, Table 34) further underline the importance of the R group of the chiral 
porphyrins 63 in achieving high selectivities.  
During that first summer, some repetition of Dr. Chen’s initial results were done 
to ensure reproducability. The new porphyrins were characterized with UV-vis before 
publishing and Dr. Ying Chen was assisted with the dilutions and the UV-vis 
measurements of all the porphyrins. Several other attempts were made to further 
functionalize the porphyrin framework, including meso-bromination after chiral 
attachment which was determined to be unproductive.  
 
Chen, Y.; Fields, K. B.; Zhang, X. P. Bromoporphyrins as Versatile Synthons 
for Modular Construction of Chiral Porphyrins: Cobalt-Catalysed Highly 
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Enantioselective and Diastereoselective Cyclopropanation Journal of the American 
Chemical Society, 2004, 126(45), 14718-9. 
 
After the initial results were published, the substrate scope was explored using 
styrene derivatives and competition experiments began, which led to other papers 
suthored by Dr. Chen. After assisting in the determiniation of the Hamilton plot for the 
styrene derivatives, it was time to embark on the solo iridium(III) cyclopropanation 
project (Section C). 
In summer 2008, (R)-62a became commercially available and it was time to 
demonstrate that the expected enantiomer for the cyclopropanation reaction could be 
produced. High school teacher Paul Goodland and his student Armani Tavares assisted 
in demonstrating that the (R)-62a or R-Chen amide would in fact give the same 
cyclopropane product diastereoselectivity, but the opposite enantiomer (Scheme 45). 
The R-Chen amide was purchased and the corresponding cobalt(II) 3,5-di-t-
butylChenPhyrin was synthesized. As a result of the GC becoming inoperable due to an 
overheating diffusion pump, that summer we made due with showing the opposite 
enantiomer was formed through optical rotation measurements.  
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Scheme 45: Zhang’s catalyst with different chiral amides selectively produces each of 
the four cyclopropane enantiomers 
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Co[63o] was synthesized with both the R and S amides. Both catalysts were 
employed for the cyclopropanation of styrene with EDA. The two products were 
isolated and then diluted using volumetric glassware. Using the Autopol IV polarimeter 
in Dr. Baker’s lab at University of South Florida, the optical rotation of both samples 
was taken. It was demonstrated that the light was rotated in the opposite direction, 
which confrmed the other enantiomer was catalytically produced.  
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Diastereoselective Cyclopropanation with Iridium(III) Tetraphenylporphyrins 
Project  
 
In late 2004, a project began using iridium porphyrins for the catalytic 
cyclopropanation of styrene using diazoreagents as carbene sources. Using the same 
techniques as were used on the cobalt cyclopropanation system, efforts were made to 
optimize yield, minimize dimer formation, and improve the regioselectivity of the 
trans:cis toward either pair of isomers. Three different porphyrin frameworks were used 
as part of this project:  tetraphenylporphyrin 1, octaethylporphyrin 116, and 
tetramesitylporphyrin 117 (Figure 21). 
N
N N
N
M
N
N N
N
M
116 117  
Figure 21: Octaethylporphyrin (OEP) 116 & tetramesitylporphyrin (TMP) 117. 
 
At the time, it was the first iridium-based system for cyclopropanation using 
diazo reagents as carbene sources; however, it had many drawbacks over the cobalt(II) 
catalytic system. Upon screening various metal porphyrins, it was found that in addition 
to cobalt, other metals including iron, rhodium, ruthenium, and iridium could all 
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cyclopropanate styrene using diazo reagents as the carbene source (entries1-6, Table 
45).  
 
Table 45: Cyclopropanation with Iridium (III) Porphyrin Complexes  
[M(TPP)] SM:DM:CP Trans:CisTemp
Fe(TPP)Cl
Ru(TPP)(CO)
Rh(TPP)I
Co(TPP)
23
23
23
23
80
28:30:42
46:38:16
28:17:55
20:07:73
02:01:97
88:12
94:06
64:36
75:25
70:30
N2
H O
O
R
+
1 mol % catalyst
COORH
Co(TPP)
23 35:05:55 81:19Ir(OEP)(CO)Cl
a) Styrene = 0.25M; b) AgPF6, 1 eqiv.; c) AgClO4, 1 equiv.; d) DMAP 0.5 eqiv.; e) slow additon, 1 h, diluted in
0.5 ml solvent.
Styrenea : EDA Solvent Time
20 h
20 h
20 h
20 h
20 h
1 h
10 : 1
10 : 1
10 : 1
1 : 1.2
1 : 1.2
5 : 1
1
2
3
4
5
6
7b
8c
80 45:11:33 81:19Ir(OEP)(CO)Cl 1 h5 : 1
entry
80 48:12:28 80:20Ir(OEP)(CO)Cl 1 h5 : 1
80 55:09:27 80:20Ir(OEP)(CO)Cl 1 h5 : 1
80 49:10:31 80:20Ir(OEP)(CO)Cl 40 h5 : 1
23 45:12:31 80:20Ir(OEP)(CO)Cl 1 h5 : 1
9d
10
Ir(OEP)(CO)Cl -78 53:07:33 80:2016 h5 : 1
Ir(OEP)(CO)Cl -78 69:06:19 83:171 h5 : 1
14
15
80 73:03:21 84:16Ir(OEP)(CO)Cl 1 h
80 83:02:13 78:22Ir(OEP)(CO)Cl 1 h5 : 1
5 : 1
23 48:11:30 81:19Ir(OEP)(CO)Cl 5 min5 : 1
11
12
13
80 95:02:01 --:--Ir(OEP)(CO)Cl 1 h5 : 1
16
17e
toluene
toluene
toluene
toluene
toluene
toluene
toluene
toluene
toluene
toluene
toluene
toluene
toluene
acetonitrile
THF
toluene
toluene
 
 
One of the major side reactions to cyclopropanation is the dimerization (DM) of 
the diazo reagent. This is a common known side reaction that plagues many catalytic 
systems. The lack of dimerization is also one of the many benefits of the cobalt system; 
however, for those systems that suffer from dimerization, it can be mediated through 
the use of excess styrene, dilute conditions, and the slow addition of diazo reagents.  
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Initial results indicated that the trans:cis ratio was more favorable to the trans 
product than cobalt, so efforts were made to optimize the regioselectivity of the 
reaction. In order to improve the yield, it would be necessary to decrease the amount of 
dimer product (DM) formed, so additives were used. Silver salts were added in attempts 
to further activate the Ir(116)(CO)Cl (entries 7-8, Table 45). Unfortunately, neither of 
the silver salts influenced the reaction, so the dissociation of the chloride ion must have 
been a fast step at the beginning of the catalytic cycle. The additive DMAP that 
improved the cobalt-based system coordinated too strongly to the iridium and blocked 
the coordination site from reaction (entry 9, Table 45). 
Another step to improve the yield was to vary the time and temperature of the 
reaction. Increasing the reaction time from 1 hour to 40 hours, led to no improvement as 
the reaction that occurred was completed within the hour at 80 °C (entry 10, Table 45). 
Since the reaction was very fast, lower temperatures were attempted. The reaction was 
set at room temperature for an hour and then 5 minutes, generating the same results 
(entries 11-12, Table 45). Therefore, lower temperature reactions were set in hopes that 
the dimer formation could be ameliorated at -78 °C (entries 13-14, Table 45). While the 
much lower temperature slowed the cyclopropanation and slightly ameliorated the 
dimer formation, it wasn’t a significant enough difference to continue with low 
temperature runs. Different anhydrous solvents were used, which further decreased the 
yield (entries 15-16, Table 45). 
 The slow addition of diazo reagent over 1 hour at room temperature did have an 
effect of the product distribution (entry 17, Table 45). Continued experiments using 
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slow addition of EDA were further improved by diluting the EDA prior to addition 
(entry 1, Table 46). The 1 electron reductant cobaltocene Co(cp*)2 was added which 
improved the trans:cis ratio slightly (entry 3, Table 46). When anhydrous THF was used 
as solvent, the trans:cis ratio improved further (entry 3, Table 46) and the addition of 
cobaltocene with the use of THF as solvent maintained the trans:cis ratio and further 
improved the yield (entries 4-5, Table 46). 
 
Table 46: Cyclopropanation with Iridium (III) Porphyrin Complexes using Slow 
Addition 
 
[M(TPP)] SM:DM:CP Trans:Cis
52:06:36
51:03:43
51:05:39
36:16:32
91:09
90:10
93:07
84:16
N2
H
O
O
R
+
1 mol % catalyst
COORH
35:05:55 81:19
Ir(OEP)(CO)Cl
a Styrene = 0.25M; b cobaltocene = 1.2 mol%; c slow additon, 1 h, diluted in 0.5 ml solvent; d slow additon,
6 h, diluted in 0.5 ml solvent and using syringe pump; e 7 hour reaction time.
5 equiv. : 1 equiv.
1c
2b
3b
4b,c
5b,c
6c
7b,d,e
8c 48:04:44 78:22
entry
06:09:76 90:10
57:01:41 81:199c
10c 51:21:07 76:24
toluene
neat
toluene
toluene
toluene
Ir(TMP)(CO)Cl
Ir(TMP)(CH3)
Ir(OEP)(CO)Cl
Ir(OEP)(CO)Cl
Ir(OEP)(CO)Cl
Ir(OEP)(CO)Cl
Ir(OEP)(CO)Cl
47:13:27 84:16
THF
THF
THF
THF
Ir(TMP)(CO)Cl THF
Ir(OEP)(CO)Cl
Solvent
1 h, RT
 
 
 The reaction was also attempted in neat styrene, in hopes that it would improve 
the reaction product ratio; however, the dimerization product was substantially 
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increased (entry 6, Table 46). As hindsight, one more reaction that would have been 
interesting to note would have been to dilute the EDA in additional styrene before 
addition to the catalyst dissolved in the styrene. The best result of the study was entry 7, 
where the cobaltocene was used in THF as solvent for an hour at room temperature with 
a 6 hour addition of diluted EDA using a syringe pump and allowing an hour at the end 
of the addition for complete reaction. Other iridium complexes were tested using slow 
addition in toluene and THF, the top results are shown as entries 8-10 on Table 46. 
 Using the same optimized conditions, the substrate scope of the catalyst was 
explored with styrene derivatives. A variety of styrene derivatives were used as 
cyclopropanation substrates. It was found that there was an electronic and steric 
component to the reaction. In entry 1-2, the increased steric bulk as styrene was 
replaced with mesitylene and it had a substantial decrease on yield and the trans:cis 
ratio became nearly 1:1. The addition of electron withdrawing groups also decreased 
the yield, although the trans:cis selectivity was slightly improved (entries 3-4, Table 
47). The use of a methoxy electron donating group also had diminishing effects on yield 
and led to less selectivity of the trans:cis ratio (entry 5, Table 47). 
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Table 47: Substrate Scope of Ir(OEP)(CO)Cl as a Cyclopropanation Catalyst 
SM:DM:CP Trans:Cis
+
1 mol % catalyst
COORH
Reactions were run in THF, using 1 mol% of Ir(OEP)(CO)Cl with 1.2 mol% cobaltocene at room temperature.
Styrene : diazo = 5 : 1; styrene = 0.25M in THF; slow additon, 1 h, diluted in 0.5 ml solvent; a) extra slow
additon, 6 h, diluted in 0.5 ml solvent using syringe pump; b) double cyclopropanated product forms and
single cyclopropanation forms at short reaction times in very low yields.
Styrene Diazo
1
entrya
06:09:76 90:10
29:01:69 79:21
71:01:27 --:--
63:02:33 93:07
R
N2
H
O
O
Et
F3C
Br
MeO
N2
H O
O
Et
N2
H O
O
Et
N2
H
O
O
Et
2
3
4
49:03:45 95:05
N2
H O
O
t-Bu
5
59:01:40 55:45
6
N2
H O
O
Et
--:--:-- --:--
N2
Ph O
O
Me7
--:--:-- --:--8
95:00:05* --:--
N2
H O
O
Et
9
10b
N2
O
O
MePh
--:--:-- --:--
N2
H
O
O
t -Bu
t -Bu
Diazo
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 Again, using the optimized conditions, the diazo reagent substrate scope was 
examined. The reaction proceded with t-BDA as diazo reagent with improved trans:cis 
ratio; however, the larger diazo reagent also was provided lower yields (entry 6, Table 
47). Several other diazo reagents were attempted; however, they did not react and all 
the starting material remained even after additional time (entries 7-9, Table 47). Finally, 
if an alkyne was used instead of the alkene, short reaction times gave a very small 
amount of the single cyclopropanation product. After extended reaction time was 
provided in hopes of improving the yield, the double cyclopropanation product formed 
albeit in very low yield as well. (entry 10, Table 47). 
 This work was never published, however. The results were not outstanding. The 
catalytic process suffered from the need for slow addition, dilute conditions, and the 
need for additives as well as a very limited substrate scope which achieved only 
moderate to high yields. Katsuki’s iridium salens later provided excellent yields, cis-
diastereoselectivity, and good enantioselectivity of the cis isomers. The Zhang group’s 
cobalt porphyrins were already shown to offer excellent trans-diastereoselectivity and 
excellent enantioselectivities. 
 
Diastereoselective Cyclopropanation with Various Cobalt(II) and Cobalt(III) 
Macrocycles Project 
 
 Cobalt complexes of N-confused porphyrins and benziphthalocyanine, which 
both feature organometallic bonds at the macrocycle cores, catalyze the 
cyclopropanation of styrene with a higher trans-selectivity than the corresponding 
porphyrin and phthalocyanine complexes. 
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 The metal complexes of porphyrins and phthalocyanines are frequently used as 
catalysts for organic transformations.1 These metallomacrocycles were initially 
employed as oxygen transfer catalysts, inspired by heme-based enzymatic catalysis 
such as that seen in Cytochrome P-450.2 More recently, metalloporphyrins and 
metallophthalocyanines have been used to catalyze other organic transformations, 
including carbene and nitrene transfer reactions.3 During the past few years, Zhang et 
al. have reported that cobalt porphyrin complexes are effective catalysts for the 
stereoselective cyclopropanation of alkenes with unique reactivity profiles.4  
There are many inherent advantages in using porphyrin or phthalocyanine based 
catalysts, ranging from their robustness to their facile steric and electronic modification. 
Recent development in the synthesis of porphyrin and phthalocyanine variants has lead 
to new metal complexes where the skeleton of the macrocycle is perturbed relative to 
their parent molecules.5 Not surprisingly, there has been increasing interest in 
investigating the catalytic properties of porphyrin and phthalocyanine analogues, in 
particular with regard to oxidations.6 In this report, we present the first catalytic study 
on a series of cobalt carbaporphyrinoids which have an observed selectivity for trans 
products, a direct result of the presence of a metal-carbon bond in the complex.  
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N
NH
N
N
N
HN
N
N
N
NR
HC
NNH
NNH
N
N
N NH
H
N
N HN
NNH
118 119 (R=H), 120 (R=CH3)
121 122  
Figure 22: Structures of porphine (118, top left), N-confused porphines (119 & 120, 
top right), phthalocyanine (121, bottom left), and benziphthalocyanine (122, bottom 
right) 
 
 
Carbaporphyrins are porphyrin analogues and isomers that have one or more 
carbon atoms in place of nitrogen atoms at the core of the ring.7 The carbaporphyrin 
family of macrocyles includes the porphyrin isomer N-confused benziphthalocyanine.9 
These macrocycles are shown along with normal porphyrin and phthalocyanine in 
Figure 22. N-confused porphyrin has the same skeleton as normal porphyrin, but with 
one of the four pyrrole rings inverted. Benziphthalocyanine is a phthalocyanine 
analogue with one of the isoindoline rings replaced with a benzene ring. We have 
recently developed the synthetic metal chemistry of both macrocycle types. The metal 
complexes of the carbaporphyrins have not been extensively studied as catalysts for 
organic transformations, although there has been some work in the catalytic chemistry 
of N-confused porphyrin.10 
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a   b  
  c   d  
Figure 23: The structures of CoII(NCP)py (a)†, CoII(N-MeNCP)py (b)†, 
CoIII(NCP)py2 (c)11, and CoII(bzpc)py (d)9 with 35% thermal ellipsoids. Hydrogen 
atoms have been omitted for clarity with the exception of those on the external nitrogen 
positions. 
 
Previously, several cobalt complexes of the carbaporphyrin N-confused 
porphyrin11 as well as the carbaphthalocyanine benziphthalocyanine9 have been 
generated. For the benziphthalocyanine, Co2(CO)8 in pyridine solution was used to 
insert the metal ion into the macrocycle, which first resulted in the complex 
CoII(bzpc)py and then, upon air oxidation, CoIII(bzpc)py2. The metalation of N-
confused porphyrin with cobalt can be achieved using Co(NO3)2 to produce Co(III) 
complexes; alternatively, Co2(CO)8 can be used to afford the Co(II) adducts.12 
CoII(NCTPP)py and CoII(N-CH3NCTPP)py can be readily generated via this latter 
method, and the structures elucidated from single crystals are shown in Figure 23 along 
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with our previously elucidated cobalt carbaporphyrinoids. Both N-confused porphyrin 
complexes resemble each other as well as the corresponding CoII(bzpc)py complex.  
The internal C-H bonds of the N-confused porphyrins have been activated, 
resulting in direct Co-C bonds. The compounds are five coordinate with pyridines 
occupying the axial positions. In the case of CoII(NCTPP)py, air oxidation in the 
presence of pyridine produces the Co(III) complex Co(NCTPP)py2, which indicates that 
the N-confused porphyrin macrocycle stabilizes higher valent oxidations states than 
normal porphyrin. Directly analogous chemistry is observed with benziphthalocyanine. 
However, the presence of the methyl group on the external nitrogen position in CoII(N-
CH3NCTPP)py effectively prevents the formation of a trivalent N-confused porphyrin 
ligand, and thus is more similar to normal porphyrin.  
The catalytic cyclopropanation of styrene with ethyl diazoacetate (EDA) using 
the above cobalt complexes was investigated and compared to normal cobalt porphyrin 
and phthalocyanine. To probe the effect of ligand environment on the Co-catalyzed 
cyclopropanation, these catalytic reactions were carried out under the same conditions 
in toluene at 80 ºC with styrene as the limiting reagent using only 1 mol% catalyst 
loading. The results of this initial study are shown in Scheme 41 and are remarkably 
consistent across the series.  
Both the normal porphyrin and phthalocyanine complexes exhibited higher 
product yields than the corresponding carbamacrocycle complexes, and the differences 
were as much as a factor of two. The reduction in yield most likely results from the 
stabilization of higher valent oxidation states in the carbamacrocycles versus the 
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divalent preference seen in normal porphyrin and phthalocyanine. Consequently, the 
putative cobalt carbene intermediates of carbaporphyrinoids are more electrophilic in 
nature other than the radical carbenes associated with cobalt(II) porphyrins.13  
The observed high percentages of dimerization side products from EDA in the 
reactions catalyzed by cobalt carbaporphyrinoids are consistent with this hypothesis. 
This hypothesis is further substantiated with the result from catalytic cyclopropanation 
by cobalt N-methylated N-confused porphyrin, which can less readily form the Co(III) 
oxidation state. As can be seen in the data in Scheme 46, the N-methylated N-confused 
porphyrin complex exhibits an appreciably higher cyclopropanation yield of 51%. The 
yield was further increased to 85% when the reaction was carried out at room 
temperature.  
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Scheme 46: Cobalt (II) and (III) cyclopropanation catalysts with different macrocycles 
N2
H
O
O
Et
+
1 mol % catalyst
toluene, 80 °C, 20 h
COOEt
H
N
N N
N
N
N
N
N
N
N
N
N
Co
yield= 67 %
cis:trans = 26:74
dimer = 1.1%
Co
yield= 13 %
cis:trans = 23:77
dimer = 0%
N
N
NH
N
Co
N
yield= 35 %
cis:trans = 2:98
dimer = 19%
yield= 44 %
cis:trans = 8:92
dimer = 8%
using styrene:EDA 5:1
N
N
N
N
Co
yield= 51 %
cis:trans = 2:98
dimer = 11%
Me
N
N
N
N
N
N
H
NHCo
yield= 24 %
cis:trans = 41:59
dimer = 0%
N
yield= 12 %
cis:trans = 22:78
dimer = 0%
N
N
N
N
N
N
H
NHCo
N
N
1 equiv 1.2 equiv
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Another notable aspect of the observed catalysis can be seen in the 
benziphthalocyanine compelxes. Both the Co(II) and Co(III) complexes produced the 
cyclopropane product in essentially identical yields and selectivity. This implies that the 
active intermediates for both compounds are identical, therefore the Co(III) complex is 
reduced to the Co(II) complex during reaction.  
All of the cobalt carbamacrocycle complexes exhibit a higher 
diastereoselectivity for the trans isomer over the cis isomer in product formation. In the 
case of the cobalt N-confused porphyrins, the difference is striking, with a 98:2 
selectivity for the trans isomer (Table 48). Since the normal cobalt porphyrinoid and the 
cobalt carbaporphyrinoid have minimal or no differences in steric bulk, the current 
effects are entirely electronic in nature.  
 
Table 48: N-Methylated N-Confused Tetraphenylporphyrin Results 
entry Styrene:EDA 
catalyst 
(mol%) conc. 
temp 
(°C) 
yield 
(%) trans:cis dimer 
1 1:1.2 1 0.025 80 51 98:2 9% 
2 1:1.2 1 0.025 RT 85 93:7 15% 
3 5:1 1 0.025 80 76.5 91:9 3% 
4 1:1.5 5 0.0125 80 64 92:8 13% 
__________________________________________________________________ 
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In rhodium-based cyclopropanation reactions, more covalently bound ligands 
tend to favor the formation of trans products.14 Similarly, in the cobalt complexes of the 
carbaporphyrins, there is a greater degree of covalency than in normal 
metalloporphyrins or phthalocyanines due to the presence of the metal-carbon bond at 
the core of the ring. Previously, this change in electronic structure at the metal center in 
carbaporphyrin complexes has been observed spectroscopically,15 but the present 
observations are rare examples of how this change in bonding affects reactivity and 
selectivity, specifically via the stabilization of specific transition state pathways. 
In conclusion, we have carried out a preliminary investigation into the catalysis 
of cyclopropanation reactions using a series of cobalt carbaporphyrinoids. While the 
overall yields of cyclopropanation are lower than observed in normal porphyrin and 
phthalocyanine, a notable increase in selectivity for the trans isomer was observed 
across the carbaporphyrin series. Since the sterics for these carbaporphyrinoids are 
identical to their normal porphyrin and phthalocyanine parents, the difference in 
product selectivty results from electronic factors. Work in this area on the catalytic 
chemistry of the metal complexes of the porphyrinoids will continue. 
 
† Crystal data for CoII(NCTPP)py (CoC54H35N6): Monoclinic, space group P21/n, a = 
21.6684(15), b = 17.1353(12), c = 22.1912(15) Å, 90.00°, β = 98.6680(10), γ = 90.00°, 
V = 8145.4(10) Å3, Z = 8, ρ = 1.348 g cm-3, M = 826.81, Rint= 0.0435, R1=0.0492, 
wR2 = 0.1164 (for 17762 reflections, 68252 observed reflections Io>2s(Io)). Crystal 
data for CoII(2-N-CH3-NCTPP)py (CoC55H40N6): Triclinnic, space group P-1, a = 
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11.6749(13), b = 13.2874(15), c = 14.1474(16) Å, 97.019(2)°, β = 93.666(2)°, γ = 
107.317(2)°, V = 2067.8(4) Å3, Z = 2, ρ = 1.355 g cm-3, M = 843.86, Rint=0.0524, 
R1=0.0755 wR2 = 0.1629 (for 8810 reflections, 17072 observed reflections Io>2s(Io)). 
Data were collected at 100(2) K (Bruker-AXS SMART CCD diffractometer with 
MoKα radiation, λ = 0.71073 Å) and corrected for absorption (empirical SADABS). 
The structures were solved by direct methods and refined by full-matrix least-squares 
procedures (SHELX97). CCDC-790334 & 790335 contain the supplementary 
crystallographic data for this paper. This data can be obtained free of charge from the 
Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
 
These results are being submitted as follows:  Fields, K. B., Engle, J. T., Sripothongnak, 
S., Kim, C., Zhang, X. P. Cobalt carbaporphyrin-catalyzed cyclopropanation Chem. 
Comm. 2010, Accepted, proofs submitted - C0CC03894F. 
 
Cyclopropanation Experimental Project and Spectra  
General Considerations for all Three Publications 
 All catalytic reactions were carried out under a nitrogen atmosphere in oven-
dried glassware following standard Schlenk techniques. Toluene and THF were distilled 
under nitrogen from sodium benzophenone ketyl. Styrene and ethyl diazoacetate (EDA) 
were purchased from Sigma-Aldrich and used without further purification. Proton and 
carbon nuclear magnetic resonance spectra (1H-NMR and 13C-NMR) were recorded on 
a Varian Inova 400 spectrometer and referenced with respect to residual solvent. GC 
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measurements were carried out on a Hewlett-Packard G1800B GC-MS or a Shimadzu 
GC-MS QP2010S system equipped with a G-TA column. 
 
General Procedures for Cyclopropanation of Styrene, Characterization, and Spectra 
 Catalyst (1 mol %) was placed in an oven-dried, resealable Schlenk tube. The 
tube was capped with a Teflon screwcap, evacuated, and backfilled with nitrogen. The 
screwcap was replaced with a rubber septum, and 1.0 equivalent (unless otherwise 
noted – Ir(OEP)(CO)Cl project) of styrene (0.25 mmol) was added via syringe, 
followed by toluene (0.5 mL) were added and allowed to stir 1 minute until the 
porphyrin dissolved. Then, 1.2 equivalents of ethyl diazoacetate was added in one 
portion (unless otherwise noted – Ir(OEP)(CO)Cl project) and toluene again (0.5 mL to 
rinse the walls) was added to rinse the walls of the tube. The tube was purged with 
nitrogen for 1 minute while its contents were stirred at room temperature, then the 
rubber septum was replaced with a Teflon screwcap and typically placed in an 80 °C oil 
bath  (unless otherwise noted) and allowed to stir. After 20 hours, the resulting mixture 
was given an internal standard (tridecane = 0.50 equivalent) and injected into the gas 
chromatograph (GC-MS). Peaks were standardized based on isolated cis and trans 
cyclopropanes purified by flash silica gel chromatography (Hexanes: Ethyl acetate = 
9:1), diethyl maleate (cis-EDA dimer), and the starting styrene and noting their 
corresponding mass peaks. All yields reported are GC yields based on this process. 
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O
OEt
 
Ethyl 2-phenylcyclopropane-1-carboxylate cis-isomers: 1H-NMR (400 MHz, 
CDCl3): δ 7.18-7.28 (m, 5H), 3.88 (q, J = 7.2 Hz, 2H), 2.59 (m, 1H), 2.08 (ddd, J = 9.0, 
7.8, 5.6 Hz, 1H), 1.72 (ddd, J = 6.3, 4.9, 4.4 Hz, 1H), 1.32 (ddd, J = 8.9, 7.9, 5.0 Hz, 
1H), 0.97 (t, J = 7.2 Hz, 3H). 13C-NMR (75 MHz, CDCl3): δ 170.9, 136.5, 129.2, 127.8, 
126.6, 60.1, 25.4, 21.7, 14.0, 11.1. 
O
OEt
 
Ethyl 2-phenylcyclopropane-1-carboxylate trans-isomers: 1H-NMR (400 MHz, 
CDCl3): δ 7.09-7.31 (m, 5H), 4.17 (q, J = 7.2 Hz, 2H), 2.52 (ddd, J = 9.3, 6.6, 4.2 Hz, 
1H), 1.90 (ddd, J = 8.7, 5.4, 4.5 Hz, 1H), 1.60 (ddd, J = 9.0, 5.1, 4.2 Hz, 1H), 1.30 (ddd, 
J = 8.4, 6.6, 4.8 Hz, 1H), 1.28 (t, J = 7.2 Hz, 3H). 13C-NMR (75 MHz, CDCl3): δ 173.4, 
140.1, 128.4, 126.4, 126.1, 60.7, 26.2, 24.2, 17.1, 14.3. 
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1H-NMR (400MHz) Ethyl 2-phenylcyclopropane-1-carboxylate cis-isomers 
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13C-NMR (400MHz) Ethyl 2-phenylcyclopropane-1-carboxylate cis-isomers 
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1H-NMR (400MHz) Ethyl 2-phenylcyclopropane-1-carboxylate trans-isomers 
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13C-NMR (400MHz) Ethyl 2-phenylcyclopropane-1-carboxylate trans-isomers 
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GC Trace of N-methyl-N-confused porphyrin catalyzed cyclopropanation 
H
N2
O
O
Et+
H
COOEt
1 mol % catalyst
toluene, 80o, 20h
N
N
NN
Ph
Ph Ph
Ph
Co
N
CH3
Yield = 51%
cis:trans = 2:98  
 
 
Note: GTA column - The starting styrene appears around 5.14 minutes; the 0.5 eqiv. tridecane standard corresponds 
to the 13.10 retention time; the diethyl maleate (cis-EDA dimer) appears at 16.50; the cyclopropanated products 
appear at 21.39 (trans) and 20.38 + 20.71 (cis). All yields based on starting 1 equiv of styrene. 
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C-H Amination of Sulfonylazides Using Cobalt(II) Chiral Porphyrins 
Background of C-H Amination 
Introduction 
 Carbon-hydrogen bond functionalization by atom/group transfer reactions is a 
direct way to functionalize hydrocarbons to produce valuable intermediates previously 
inaccessible by classic synthetic means.52,154,178-184 Many of these systems were 
developed in conjunction with epoxidation, cyclopropanation, and aziridination 
systems.  
C-H amination describes the process of singlet monovalent nitrogen (nitrene) 
inserting into a saturated C-H bond. The synthetic importance of C-H insertion is that it 
allows for access to non-traditional sites of activation. Functional groups can now be 
added to a molecule where none existed before. This provides chemists with a new 
strategy for synthesis. In the past, organic synthesis has been limited to the 
transformation of existing, reactive functional groups. Now chemists are equipped with 
a powerful synthetic tool as the field of developing selective modifications to saturated 
C-H bonds emerges. 
 
C-H Functionalized 
 Vs.  
 Traditional 
 
Figure 24: Typical sites for C-H modification versus traditional sites for modification. 
Br
O
N
O
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 Saturated C-H bonds are ubiquitous in organic chemisty. These are strong bonds 
that are typically chemically inert. There is very little difference in reactivity between 
the various C-H bonds, so targeting a specific bond with so many C-H bonds present 
appears unlikely. As a result, C-H bonds usually need to be “activated”. Selectivity 
occurs through the activation of certain C-H bonds adjacent to activating groups (Figure 
24). These activating groups result in partial positive charge build-up on activated 
carbons. These carbons are then susceptible to attack by transition metal complexes 
(Scheme 47). 
 
Scheme 47: General action of C-H amination  
 
C
X
HC
HLnM=X + LnM
C-H Insertion
X=NR or CRR'
+
"Amination"  
 
 The reactivity of these transition metal complexes can be tuned in two different 
ways. First, the structure of the metal and ligand environment can be adjusted to 
modulate the reactivity. Di-rhodium complexes using bulky ligand environments are 
very popular and have been demonstrated as capable of effecting these transformations. 
Although not as extensively studied, other transition metals including copper, silver, 
manganese, cobalt, and iron have proven capable as well.  
Secondly, the nitrene, or nitrene precursor, can be altered. The nitrene source 
requires an electron withdrawing group which creates the electrophilicity on the 
nitrogen needed for reactivity (Scheme 48). A variety of electron withdrawing groups 
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have been utilized successfully with particular emphasis on sulfamate esters, phosphate 
esters, and carbonate esters. 
 
Scheme 48: Proposed C-H amination intermediate  
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Figure 25: Catalytic cycle showing the use of the three different nitrene precursors. 
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 The first step of the catalytic cycle involves the coordination of the nitrene 
precursor and formation of the metal nitrene and the elimination of byproduct. There 
are three basic types of nitrene sources: 1) hypervalent aryliminophenyliodinane 
species, 2) Chloramine-T/ Bromamine-T, and 3) azides (Figure 25). These highly 
reactive nitrene precursors are able to make the amination process energetically 
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favorable through the discharge of very stable by-products. The second step of the 
catalytic cycle involves the coordination of the substrate and the elimination of the C-H 
aminated product. 
 This section will briefly highlight several examples of carbon-hydrogen bond 
functionalization reactions that have been developed and will be organized 
chronologically by nitrene source. 
 
Nitrene Source – Aryliminophenyliodanes 
 By far the most widely studied nitrene precursors are the hypervalent iodinanes. 
They were first developed in 1975 by Yamada and co-workers. The drawback to this 
method is lack of atom economy from the stoichiometric production of phenyliodinanes 
as by-products. They have been successfully generated in situ through the reaction of a 
diacetoxyiodoarene 124 in the presence of para-toluenesulfonamide 123 with an 
oxidant in methanol to give the iodonium ylide N-tosyliminophenyliodinane 125, or 
PhI=NTs (Scheme 49).1  
 
Scheme 49: Yamada’s generation of PhI=NTs in situ 
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 The first example of C-H amination was the tosylamidation of cyclohexane by 
Breslow and Gellman in 1982.2 The successful hydroxylation or insertion of oxygen 
into hydrocarbons by iron tetraphenylporphyrin, modeled after the mono-oxidase 
enzyme Cytochrome P-450, inspired Breslow to attempt the insertion of a tosylimide 
group in exchange for the oxygen. He used iron and manganese tetraphenylporphyrins 
(1, TPP) to successfully insert nitrogen into cyclohexane C-H bonds. The Mn(TPP) was 
shown to be catalytic and produced 6.8% yield of the nitrogen inserted product, which 
is analogous to the 8% hydroxylation product by Mn(TPP) previously reported by 
Groves.3 The Fe(TPP) demonstrated that it could insert nitrogen as well, albeit in a 
3.1% yield.  
 They followed up that study in 1983 with an intramolecular study utilizing 2,5-
diisopropylbenzenesulfonylamide 126 (Scheme 50).4 They generated the nitrene 
precursor imidoiodobenzene derivative 127 in an isolated 89% yield. They then used 
Fe(TPP)Cl as catalyst in acetonitrile to give an 85% yield of the benzylic inserted 
product 128 in 1 hour. The by-product was 1.5% unsaturated sulfonamide 129 and 13% 
of the original sulfonamide 127 remained. Other iron complexes, Mn(TPP)Cl, and 
Rh2(OAc)4 were tested for catalytic ability. Of these, only Rh2(OAc)4 provided the 
inserted product 128 selectively with excellent catalytic ability as 94% of the product 
mixture. In 1985, Breslow finally demonstrated that purified cytochrome P-450-L3,4 
from rabbit livers was able to perform catalytic C-H insertions on both the 
intramolecular and intermolecular systems noted above.5 
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Scheme 50: Breslow’s intermolecular C-H amination 
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 In 2000, Breslow successfully preformed C-H insertion on the steroid derivative 
equilenin acetate in 57% yield. The amination had complete regioselectivity at the 
benzylic 11-β position of the steroid without any detectable amination at the 6 position 
(Scheme 51).6  
 
Scheme 51: Breslow’s C-H insertion on the steroid derivative equilenin acetate 
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 Since these first examples of inter and intramolecular C-H amination there has 
been great efforts toward finding a system that can asymmetrically insert into the C-H 
bond. The first asymmetric C-H amination is attributed to Muller and coworkers for the 
di-rhodium catalyzed C-H amination of indane 132. Using chiral ligands created by 
Ikegami tetrakis[p-(S)-N-phthaloylphenylalaninato-01,01]dirhodium(II) (134) and 
Pirrung {p-(R)-[l,l'-bi(naphthalene)]-2,2'-diylphosphato-O,O}dirhodium(II) (135), the 
benzylic positions of indane were effectively amidated with NsN=IPh, where Ns is a 
nosyl group. The results of this experiment showed that Ikegami’s di-rhodium catalyst 
could give product in 77% yield and 7% ee. Pirrung’s di-rhodium catalyst gave 71% 
yield with an even better 31% ee (Scheme 52).7 
 
Scheme 52: Muller’s di-rhodium catalyzed asymmetric C-H amination of indane 132  
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Rh Rh
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 Other spectacular examples of asymmetric C-H insertion are seen in the 
synthesis of natural products by DuBois and coworkers. This group has successfully 
used in situ generated iminophenyliodinanes from amines to provide the sulfamate ester 
nitrene precursors. The resulting di-rhodium nitrenes undergo highly diastereoselective 
intramolecular insertions into saturated secondary or tertiary C-H bonds. This 
methodology is demonstrated in the critical asymmetric synthetic steps for the 
production of the marine alkaloid manzacidin A 136, the ion channel blocker (+)-
saxitoxin 137, the marine poison (±)-tetrodotoxin 138, and (+)-aconitine 139 (Scheme 
53).8-11 Through the careful choice of substrates, these transformations were possible in 
the presence of a wide range of functional groups in high yields and often yielding a 
single diastereomer. 
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Schemes 53a-d: DuBois’s use of C-H insertion in the synthesis of natural products 
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 An interesting twist on this type of chemistry is the work done by Lebel and co-
workers utilizing N-tosylcarbamates 140 instead of N-tosyloxyamides. This 
methodology allows for intramolecular C-H insertions that no longer produce 
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stoichiometric PhI as a by-product.12 Initially, Lebel’s group had hoped to use 
azidoformate type substrates; however, after getting no reaction they decided to try a 
less coordinating species, such as an ester or sulfamate group. The reaction generally 
proceeds in good to high yields (Scheme 54). When the N-tosyloxycarbamate’s C-H 
amination carbon is chiral, the configuration about the carbon is conserved and provides 
the oxazolidinone without racemization.  
 
Scheme 54: Lebel’s intermolecular C-H amination using N-tosylcarbamates 140 
R2
O
O
H
N
OTs HN O
O
Ph
H
R1 Rh2(triphenylacetate)4 6 mol%
K2CO3 2-3eq, DCM, 25oC
64-95% yield
140 141
 
 
 PhI(OAc)2-mediated C-H amination has been shown to be catalyzed using 
ruthenium and manganese porphyrin complexes by Che13 and Breslow2,4,5,6; rhodium 
complexes by DuBois8,9,10,11,14, Davies, and Lebel12; copper complexes by Dauban15; 
and silver complexes by He16. The ability to create many of these nitrene precursors in 
situ makes them valuable synthetic resources. The reactivity and selectivity of these 
catalytic systems can be modulated using a variety of sulfonamides, sulfamates, 
carbamates, and chiral-sulfonimidamides as nitrene precursors. Selectivity typically 
chooses benzylic positions over all others; however, vinylic, tertiary > secondary > 
primary structural isomers may be selectively produced as well. Adjacent functional 
groups often direct this process to form highly selective product ratios and chiral metal-
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ligand complexes have been demonstrated to provide transitions with high 
enantioselectivities as well.  
In 2002, during the course of their study into the asymmetric aziridination of 
olefins with metal complexes of the Halterman ligand 93, Che and co-workers also 
reported the asymmetric amination of hydrocarbons.174 Che’s research group explored 
the use of the ruthenium complex of 93 with PhI=NTs and various benzylic substrates. 
Although moderate to low enantioselectivities were initially produced (Table 49), Che 
and co-workers were able to improve these results through the in situ generation of the 
nitrene source with a sulfonyl amide in the presence of PhI(OAc)2 (Table 50). This 
system allowed for the production of moderate enantioselectivities across a variety of 
benzylic substrates. Research also showed that the manganese complex 93 was able to 
induce higher levels superior to the ruthenium complex, as shown in entries 3 and 4 of 
Table 50. 
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Table 49: Asymmetric Amination of Benzylic Hydrocarbons Catalyzed by 
[Ru(93)(CO)]  
  
1.3 mol % [Ru(93)(CO)]
PhI=NTs
DCM
Ar R
entrya yield (%)b ee (%)
1 82(29) 22
substrate
3 85(22) 28
4 84(23) 47
a Reactions were performed using 1.3 mol % of catalyst, 2 equiv
of PhI=NTs, and 1 equiv of substrate in DCM at 40 °C for 2 h.
b Values in parenthesis represent conversion.
Ar R
NHTs
MeO
2 92(32) 3
 
 
 
Table 50: Asymmetric Amination of Benzylic Hydrocarbons with in situ Generation of 
Nitrene Source catalyzed by [Mn(93)(CO)]   
 
1 mol % [Mn(93)OH]
PhI(OAc)2, NH2SO2Me
DCM
Ar R
entrya yield (%)b ee (%)
1 84(26) 50
substrate
2 84(22) 46
3 92(21) 56
a Reactions were performed using 1 mol % of catalyst, 1 equiv
of PhI(OAc)2, 1.25 equiv of sulfonyl amide, and 1.5 equiv of
substrate in DCM at 40 °C for 2 h.
b Values in parenthesis represent conversion.
c Catalyzed by [Ru(93)(CO)].
Ar R
NHSO2Me
MeO
4c 90(34) 40
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Nitrene Source -  Chloramine-T / Bromamine-T 
 Chloramine-T and bromamine-T are another class of nitrene precursors. One 
major benefit is that the byproducts of the reaction are NaCl and NaBr, respectively. 
These reactions are more ecologically friendly and have greater atom economy and than 
their phenyliodinane releasing counterparts. However, both chloramine-T and 
bromamine-T are both very hygroscopic which leads to difficulties with moisture 
sensitive reactions. Furthermore, they are explosive at high temperatures. As a result, 
the benefits of the benign byproducts are outweighed by the difficulties in working with 
these reagents and few groups have focused on utilizing these nitrene sources. 
  In 1998, Komatsu and coworkers were the first group to show that chloramine-
T could be utilized as a transition metal nitrene precursor for aziridination and 
amination using copper (I) chloride. Since Komatsu’s focus was on aziridination he 
only recognized the formation of the allylic C-H inserted product as the major side 
reaction with no mention as to the yield. 17  There are a few other references that deal 
with chloramine-T and bromamine-T as nitrene sources for aziridination; however, C-H 
amination is considered a byproduct and little information is given. 
 In 2007, Zhang and coworkers utilized bromamine-T for the purpose of 
selective C-H amination. They used indan as a model substrate and found that electron 
withdrawing porphyrin ligands around a cobalt metal center could give high 
chemoselectivity for benzylic C-H bonds at room temperature (Scheme 55). 18 Yields 
ranged from 15-75% as a wide variety of substrates were screened. Heteroatoms in the 
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ring were well tolerated; however, sterically hindered benzylic positions generally had 
decreased yields. 
 
Scheme 55: Bromamine-T as an alternative nitrene source for selective amination 
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Nitrene Source – Azides 
 Azides are a particularly interesting nitrene precursor as the only by-product is 
chemically stable and environmentally benign molecular nitrogen, N2. This is in 
alignment with the goals of performing “green chemistry”. Although TsN3 is less easily 
decomposed by a variety of metals than the corresponding PhI=NTs, compounds such 
as PhI=N-R can be obtained only from the corresponding sulfonamides (R-SO2NH2). 
Azides represent a broad class of compounds with commercial availability and 
relatively simple syntheses. Despite their great potential, few catalytic systems have 
been developed that can effectively decompose the azide into a nitrene.  
 In 2000, Cenini and coworkers were the first to demonstrate intermolecular C-H 
insertion with aryl azides.19 Specifically, para-substituted electron withdrawing aryl 
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azides, such as p-nitrophenyl azide, could be utilized by cobalt (II) porphyrins for the 
benzylic C-H amination of isopropylbenzene and sec-butylbenzene (Scheme 56 & 57). 
When the substrate had two hydrogens available at the benzylic position, the imine was 
formed and a second equivalent of azide was reduced to the amine in the process 
(Scheme 57). Yields were low-moderate with a portion of product as dimer formation. 
 
Scheme 56: Cenini’s intermolecular C-H amination using aryl azides 
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Scheme 57: Cenini’s intermolecular C-H amination using aryl azides to produce 
imines and amines 
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 As a result of their kinetic studies, the mechanism was investigated.20 As a result 
of the type of azide used, they found that arylazides reversibly coordinated to the cobalt 
porphyrin center to form an unstable adduct. This adduct will either react with the 
hydrocarbon in a rate-determining step or “decompose” into the nitrene complex that 
reacts with a second equivalent of azide to form the diaryldiazene byproduct (Scheme 
58).  
 
Scheme 58: Cenini’s kinetic studies provide mechanistic insight  
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 Arylazides with electron-withdrawing substituents reacted at a faster rate giving 
greater product selectivity and higher yields. Tosylazide is reported to have a much 
slower C-H insertion reaction rate. Admittedly, this is counter-intuitive as the sulfonyl 
group should have strong electron-withdrawing characteristics and should be expected 
to react even faster. There is speculation that the decrease in rate may be attributed to 
competitive coordination of the sulfonyl group to the metal center which inhibits the 
catalytic reaction. It should also be noted that the selectivity of this reaction results in 
no/ trace production of the dimer byproduct readily formed using arylazides. PhI=NTs 
274 
 
was also attempted, giving trace amounts of C-H inserted product and the reduced 
tosylamide. In the proposed transition state for C-H amination by cobalt porphyrins, 
Cenini reports the formation of an adduct rather than a true “nitrene” intermediate 
(Figure 26).  
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Figure 26: The proposed transition state for C-H amination by cobalt porphyrins. 
 
 Ruthenium salen complexes [(R,R)-Ru(salen)CO] have been demonstrated to 
perform allylic C-H aminations. Using the chiral ligand in Scheme 59, an enantiomeric 
excess of 80% and 17% yield was obtained for the C-H amination of toluenesulfonyl 
azide 147 with 2-ethyl-1-indene 149 and a 57% ee and 36% yield was obtained for 1-
phenylcyclohexene 148.21,22 
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Scheme 59: Katsuki’s C-H aminations utilizing a ruthenium salen complex 
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 In 2007, Driver and coworkers demonstrated that dirhodium(II) nitrenoids could 
be used to selectively C-H aminate vinyl azidoacrylates into indoles or other N-
heterocycles with high yields and >95:5 selectivity in most cases.23 The dirhodium 
catalytic system strongly preferred electron-deficient carboxylate ligands, such as 
perfluorobutyrate, and regioselectively preferred the 5-member indole ring (Scheme 
60). 
 
Scheme 60: Driver’s C-H amination of vinyl azidoacrylates 
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 The mechanism is believed to be similar to that of other rhodium catalysed C-H 
bond functionalizations. The azide coordinates to the rhodium through the α-nitrogen 
and forms the nitrene as molecular nitrogen is released. The C-N bond formation step is 
believed to be a stepwise electrophilic aromatic substitution via the formation of an 
arenium ion as shown in Scheme 61. 
 
Scheme 61: Proposed rhodium-catalyzed C-H amination mechanism 
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 Cobalt porphyrins have been demonstrated as capable catalysts for the 
intramolecular C-H amination with a broad range of arylsulfonylazides.24 This 
methodology provides high yielding syntheses of the corresponding benzosultams with 
low catalyst loadings and mild conditions. Benzosultams have great synthetic interest as 
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they are used as chiral auxiliaries, HIV-1 reverse transcriptase inhibitors, and potential 
COX-2 inhibitors. One of the projects of Dr. Joshua Ruppel, while he was a member of 
the Zhang lab, was an investigation of the ability of Co(TPP) to C-H aminate 
intramolecular substrates to form benzosultams. Many metallo-tetraphenylporphyrins 
(TPPs) were screened including V(IV), Cr(III), Mn(III), Ni(II), Cu(II), Zn(II), Fe(III)Cl, 
Ru(II)CO, and Co(II). Of these, only Fe(III)Cl, Ru(II)CO, and Co(II) produced more 
than a trace of the C-H inserted product, with Co(II) tetraphenylporphyrin 
outperforming the others by giving an excellent 96% yield.  
 Co(II)TPP was then tested on a collection of arylsulfonyl azides where it proved 
an effective catalyst for C-H insertion into tertiary, secondary, and even primary C-H 
bonds. The five membered benzosultams were preferentially formed and the reactivity 
followed the expected pattern of tertiary > secondary > primary C-H bonds (Table 51). 
 When sulfonylazides 141 and 144 contained two different secondary carbons, 
such as a benzylic position and a non-benzylic position, both the five 142 and 145 as 
well as six membered rings 143 and 146 were formed, respectively. The 
thermodynamic product is believed to be the five-membered product as a result of a 
slight increase in distribution at elevated temperatures (entries 1-3 and 4-6, Table 52). 
The choice of porphyrin ligand environments also affected the product ratio (entries 1 
and 7-9, Table 52).  
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Table 51: [Co(TPP)]-Catalyzed Intramolecular C-H Amination 
S
O O
N3
S
O O
NH
S
O O
N3
S
O O
NH
S
O O
N3
S
O O
NH
S
O O
N3
S
O O
NH
S
O O
N3 S
O O
NH
S
O O
N3
S
O O
NH
S
O O
N3 S
O O
NH
S
O O
N3
S
O O
NH
S
O O
N3
S
O O
NH
O2N
O2N
Br Br
S
O O
N3
S
O O
NH
80
40
23
80
40
23
80
40
23
80
40
23
80
40
23
96
32
18
91
58
37
95
79
47
99
85
69
93
77
46
80
40
23
80
40
23
80
40
23
80
40
23
80
40
23
91
57
40
90
54
19
94
82
72
96
95
91
87
33
23
Azide Sultam Temp (°C) Yield (%)
Performed in chlorobenzene for 18 hours under N2 with 2 mol % [Co(TPP)] in the presence of 5A
molecular sieves; [azide] = 0.20 M; temperature in celcius, yield is the % isolated yield.
entry
1
2
3
4
5
6
7
8
9
10
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Table 52: Five and Six Member Ring Formation via Intramolecular C-H Amination 
S
N3
O
O
S
NH
O O S
NH
O O
chlorobenzene
MS, 80 °C, 18 h
+
Co(II)porphyrin
S
N3
O
O
S
NH
O O S
NH
O O
chlorobenzene
MS, 80 °C, 18 h
+
Co(II)porphyrin
154 155 156
157 158 159
entrya azide Co[Por] temp (oC) sultam distributionb yield (%)c
1
2
3
4
5
6
7
8
9
154
154
154
157
157
157
157
157
157
Co(TPP)
Co(TPP)
Co(TPP)
Co(TPP)
Co(TPP)
Co(TPP)
Co(TMP)
Co(TMeOPP)
Co(OEP)
80
40
23
80
40
23
80
80
80
155 + 156
155 + 156
155 + 156
158 + 159
158 + 159
158 + 159
158 + 159
158 + 159
158 + 159
72 + 28
68 + 32
67 + 33
56 + 44
56 + 44
54 + 46
55 + 45
59 + 41
73 + 27
91
41
25
94
56
33
77
97
92
a Performed in C6H5Cl for 18 h under N2 with 2 mol % [Co(Por)] in the presence of 5 Å MS; [azide] ) 0.20 M.
b Ratio of 5- to 6-membered ring products determined by NMR. d Combined isolated yields of 5- and 6-
membered ring products.  
 
Conclusions 
 The synthetic importance of C-H insertion is that it allows for access to non-
traditional sites of activation. Functional groups can now be added to a molecule where 
none existed before providing chemists with a new strategy for synthesis. Now chemists 
are equipped with a powerful synthetic tool as the field of developing selective 
modifications to saturated C-H bonds emerges. Intense efforts to find broadly 
applicable enantioselective, regioselective, and chemoselective transition metal-
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mediated catalytic systems are necessary in order for C-H amination to become a useful 
tool for chemists.  
 In the same manner that cross-coupling chemistry has been rapidly developed 
into a blossoming field that is full of general methods, it is hoped that general C-H 
insertion systems of broad applicability can be found and then utilized by all synthetic 
chemists. 
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C-H Amination Project Summary 
 Cyclic sulfonamides (sultams) are found in many drugs and are important in the 
future of drug research. A variety of aryl sulfonylazides have undergone intramolecular 
enantioselective amination using chiral cobalt(II) porphyrins as catalysts to provide aryl 
sultams in up to 99% yields and up to 93% ee. 
 
Regioselectivity Studies 
Cyclic sulfonamide (sultam) containing compounds are one of the most 
important pharmacophores in current medicinal chemistry discovery. Sultams (cyclic 
sulfonamides) are useful heterocycles and hold excellent promise for future drug 
research. Several polycyclic sultams show biological activity as COX-2 inhibitors, 
glucokinase activators for type II diabetes, and anti-HIV properties.24  Sultams are also 
valuable chiral auxiliaries, for a variety of chemical transformations such as 1,4-
cycloadditions, Diels-Alder reactions, and reductions.  
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Several transition metal methodologies have been developed to synthesize 
sultams. Metal catalyzed approaches include: manganese, iron, rhodium, ruthenium, 
copper, palladium, silver, and cobalt. Of these strategies, metal mediated nitrene 
transfer reactions allow for the selective conversion of hydrocarbons to nitrogen 
containing compounds via C‒N bond formation.  
Much work has involved the use of hypervalent iodine reagents such as 
PhI=NTs and its derivitives. Despite overall success, disadvantages of this method 
include instability of the iminoiodane species, the use of terminal oxidants, and the 
generation of ArI derivatives as by-products. In recent years, alternative nitrene sources 
have been actively pursued to improve catalytic features. Readily available, easily 
synthesized, environmentally friendly, stable, and producing only nitrogen gas as a by-
product, azides as a class could be considered the ideal source for metal-mediated 
nitrene reactions. However, few systems can effectively catalyze the decomposition of 
azides for use in nitrene transfer reactions. 
Recent developments in our cobalt catalyzed system using chiral porphyrin 
ligands have led to the formation of regioselective and enantioselective products. Our 
approach uses arylsulfonyl azides for intramolecular C‒H amination and is one of the 
most atom economical routes to the synthesis of benzosultam derivatives.  
Previously, the Co(TPP)-catalyzed reaction of a broad range of arylsulfonyl 
azides was reported which could proceed at room temperature in various solvents in as 
little as 0.5 mol %. Varying the porphyrin ligand environment created changes in the 
distribution of the reaction chemoselectivity. Encouraged by these results, the effect of 
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the porphyrin macrocycle and cobalt oxidation state on the distribution of the products 
was explored. Solvent screenings revealed that non-polar, halogenated, anhydrous 
solvents produced the highest yields and minimized side products. Coordinating 
solvents and additives diminished the catalytic yield. Higher temperatures generally 
gave increased yields, bu decreased selectivity. The ideal temperature was demonstrated 
to be 80 °C to glean the highest yields and the best selectivities. 
Isoelectronic cobalt(II) and ruthenium(III) tetraphenylporphyrins displayed very 
different reactivity profiles (Table 53). In a comparison using dipropylbenzene 
sulfonylazide 154, the cobalt(II) TPP gave high yield (94%) and little chemoselectivity 
between the two secondary carbons, the benzylic and non-benzylic positions (155:156 = 
56:44). In contrast, the ruthenium(III) TPP gave low yield (7%) and showed 
chemoselectivity for the six member sultam (155:156  = 11:89). The catalytic results 
generated from ruthenium(III)TPP were very similar to cobalt(II) pentafluoroTPP with 
low yield (8%) and six member sultam selectivity (155:156  = 37:63). The catalytic 
results generated from cobalt(II)TPP were very similar to cobalt(II) tetramethoxyTPP, 
except Co(TMeOPP) had an even higher yield (97%) and slightly greater five member 
sultam selectivity (155:156 = 59:41). Therefore, in sterically similar ligand 
environments it was observed that the more electron deficient the metal center, the 
lower the yield and the greater the preference for the six member ring sultam. 
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Table 53. Five and Six-Member Ring Formations via Intramolecular C‒H Amination 
Catalyzed by Cobalt Macrocycles 
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The sterics of the ligand environment also have a great impact on the 
chemoselectivity profile (Table 53). Sterically crowded cobalt(II) 5,15-(2,6-
diisobutyramidophenyl)-10,20-(3,5-di-tert-butylphenyl)porphyrin with its electron 
donating amino groups produced nearly quantitative yields (99%) with strongly favored 
five member ring selectivity (155:156 = 82:18). In comparison, the cobalt(III) 5,15-
(2,6-diisobutyramidophenyl)-10-(3,5-di-tert-butylphenyl)corrole triphenylphosphine, 
which even has an open meso-position has a slightly decreased yield (93%) presumably 
attributed to the cobalt(III) oxidation state, while maintaining a sterically crowded 
environment above the metal from the 2,6-substituted isobutyramides which generated 
five member ring selectivity (155:156 = 85:15). 
Cobalt(II) 5,15-(2,6-dibromophenyl)-10,20-(3,5-di-tert-butylphenyl)porphyrin 
with its electron withdrawing bromo groups generated a decreased yield (45%) with a 
small increase in six member selectivity (155:156 = 54:46) in comparison to cobalt(II) 
TPP. In comparison, cobalt(III) 5,15-(2,6-dibromophenyl)-10-(3,5-di-tert-
butylphenyl)corrole triphenylphosphine has an open meso-position and relatively 
unencumbered environment, which resulted in an increased yield (96%). Presumably 
the electron deficient cobalt(III) oxidation state is responsible for the shift towards six 
member ring selectivity (155:156 = 35:65), where surprisingly the non-benzylic 
secondary carbon is favored. Slight improvement in six member ring selectivity can be 
achieved by further reducing the steric bulk of the ligand environment and using 
cobalt(III) 5,15-(2,6-dibromophenyl)-10-(phenyl)corrole triphenylphosphine (155:156 
= 30:70) while maintaining a high yield (96%). 
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In an attempt to explain the observed chemoselectivity, the following 
mechanism is proposed (Scheme 62). Cobalt is a d7 metal with electrophilic character 
and an unpaired electron. The cobalt radical decomposes the benzenesulfonyl azide as 
the nitrene forms homolytically between the cobalt and the nitrogen, giving off 
molecular nitrogen. The resulting nitrene has a nitrogen-centered radical which initiates 
hydrogen abstraction to form a seven-membered intermediate, transferring the carbon 
radical homolytically to the non-benzylic position. The radical then attacks back to the 
nitrogen as the Co‒N bond cleaves homolytically to regenerate the d7 cobalt radical 
catalyst, and the kinetic C‒H aminated six-member ring product is released.  
When electron-donating groups are present on the porphyrin ligand, the cobalt is 
less electrophilic, the resulting Co‒N bond is more stabilized, and the intermediate has 
a longer lifetime. The radical has time to abstract hydrogen from the benzylic position 
before the ring closing step providing greater chemoselectivity for the benzylic position 
and producing the thermodynamically favored five-member ring. When electron-
withdrawing groups are present on the porphyrin ligand, the cobalt is more electrophilic 
and the resulting Co‒N bond is destabilized. This leads to a shorter intermediate 
lifetime and greater chemoselectivity for the non-benzylic position, producing the 
kinetic six-membered ring.  
When the dibutylbenzene sulfonylazide 157 was explored using cobalt(II) 
tetraphenylporphyrin as the catalyst, lower yields (90%) and higher five member 
selectivity (158:159 = 72:28) were observed as compared to the dipropylbenzene 
sulfonylazide. Therefore, there also appears to be a steric factor that contributes to this 
288 
 
mechanism which further promotes the formation of the benzylic radical to give the 
thermodynamic five-membered ring product in sterically encumbered environments.  
 
Scheme 62: : Proposed C-H amination mechanism of cobalt porphyrin catalysts where 
5 and 6-member ring selectivity is observed  
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Enantioselectivity Studies 
Exploration of asymmetric variants of this process began with the screening of 
the “group of six” chiral cobalt(II) porphyrin catalysts to identify characteristics of the 
ligand environment that would enhance both yield and enantioselectivity of these 
prochiral substrates. Using the 2-ethyl-5-nitrobenzene sulfonylazide, it was observed 
that at 80 °C all six catalysts produced nearly quantitative yields, although at room 
temperature nearly all the catalysts had significant decreases in yield. Generally, 
enantioselectivity was improved at lower temperatures (Table 54). 
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Table 54: The “Group of Six Catalysts Catalyze 2-Ethyl-5-Nitrobenzene Sulfonylazide 
O2N S
O
N3
O
O2N S
O
NH
O
entrya temp (°C) yield (%)
PhCl, 18 h
R R* ee (%)
N
N N
N
R
R
Co
R*
R*
*R
*R
3
4
OMeMeO
OMeMeO
OMeMeO
N
H
O
N
H
O
N
H
O
O
H
OMe
H
H
N
H
O
H
N
H
O
H
OMe
N
H
O
O
H
80
80
80
80
80
80
RT
RT
RT
RT
RT
>99
57
99
13
92 +49
+14
+8
+33
+28
>99
92
99
77
>99
7
+32
+44
0
+31
-93
-86
1
2
5
6
7
8
9
10
11
12
catalyst
Co(63o)
Co(63q)
Co(63r)
Co(63j)
Co(63k)
Co(63l)
160 161
a Reaction conditions: 2 mol% catalyst, 50 mg molec. sieves, 0.10mmol 160 in 0.5ml solvent. b Isolated yields.
c %ee determined by chiral HPLC.  
 
A balance of steric ligand environment and chiral groups were necessary to 
optimize the yield and enantioselectivity of this catalytic system. The best 
enantioselectivity was generated by Co(63l), the cobalt(II) [(2,6-dimethoxy)ZhuPhyrin]. 
In the presence of the more rigid cyclic Zhu amide, other non-chiral aryl groups were 
291 
 
screened to determine if they could further enhance the enantioselectivity and yield 
(Table 55). Depending on the non-chiral aryl group used, both senses of optical activity 
could be observed +49 to -93% ee (Table 55). The importance of the non-chiral R-
group attached to the meso-positions is highlighted through an enantiomeric switch. 
Using the Zhu amide, both the 3,5-di-tert-butylphenyl and the 2,6-di-
(phenylthio)phenyl R-groups generated +49 ee (entries 2 & 5, Table 55), while the 2,6-
dimethoxyphenyl R-group generated -93% ee (entries 3, Table 55). 
 Taking the optimal conditions for compound 160 and applying them to a variety 
of substrates. First, the yield appeared as it was a problem of sterics, low yields for the 
aryl substituted azides and the longer the aryl chain the lower the corresponding yield. 
However, unlike cobalt’s carbene electronic insensitivity, the cobalt nitrene is now 
believed to have a significant electronic component. Electron withdrawing substrates 
with bromo substitutions generated higher yields and enantioselectivity; moreover, the 
nitro substituted substrate that most catalytic systems would find inefficient gave the 
highest yields of any substrate, regardless of the cobalt catalyst used. On the other hand, 
the presence of an electron donating amide 168 didn’t react with this catalytic system at 
all (entry 6, Table 56). Generally, the enantioselectivities were good 75-78 %ee, 
although significantly higher for the more electron withdrawing nitro substrate 160, 93 
%ee (entry 5, Table 56). The increased symmetry of the triethyl substrate 162 (entry 2, 
Table 56) is believed to have contributed to its having significantly lower 
enantioselectivity than the other substrates. 
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Table 55: Effects of Non-Chiral R-groups on Asymmetric Intramolecular Amination 
O2N S
O
N3
O
O2N S
O
NH
O
entrya temp (°C) yield (%)
PhCl, 18 h
R ee (%)
2
OMeMeO
OO
SS
80
80
80
80
80
>99
92 +49
+46
>99
>99
35
-93
-65
+49
1
3
4
5
160 161
a Reaction conditions: 2 mol% catalyst, 50 mg molec. sieves, 0.10mmol 160 in 0.5ml solvent. b Isolated yields.
c %ee determined by chiral HPLC.
N
N N
N
R
NH
NH
HN
O
O
O
HN
O
Co
H
H
H
H
O O
OO R
 
 
Additional substrates were created by Dr. Yang Hu based on this idea that 
electron withdrawing groups could improve both the yield and enantioselectivity. To 
demonstrate that the sterics were not the factor leading to low yield of entries 1-3 in 
Table 56, an unsubstituted substrate was synthesized. The 2-ethylbenzenesulfonylazide 
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produced 44 % yield and 76% ee, which is actually a 3% decrease in yield and has 
lower selectivity than the 2,5-diethylbenzenesulfonylazide. Another substrate 
comparison was changing the 4-bromo-2-ethylbenzenesulfonylazide 166 (entry 5, Table 
56) to a 5-bromo-2-ethylbenzenesulfonylazide, which gave essentially the same yield 
(77%) and slightly lower enantioselectivity with 72% ee. Finally, a 5-cyano-2-
ethylbenzenesulfonylazide was created to provide another strong electron withdrawing 
group. As expected, both a high yield (83%) and high %ee (82%) were produced.  
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Table 56: Co(2,6-dimethoxyphenylZhuPhyrin) Co(63l) Catalyzed Intramolecular 
Amination 
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aReaction conditions: Co(2,6-MeO-ZhuPhyrin) (2 mol %) in PhCl for 18 h in the presence of 5 Å molec.
sieves; [azide] = 0.20 M. bIsolated yields. cBased on HPLC.
-- --
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As a result of the difficulty in preparing a broad range of substrates, the 
substrate scope is fairly limited. As a separate project, group members Dr. Hongjian Lu 
and Joseph Gill are currently exploring aliphatic sulfonyl azides as C-H insertion 
substrates to compliment this work focused on the aromatic attachment of the sulfonyl 
azide. This project demonstrates the ability of the cobalt porphyrin ligand environment 
to influence the regioselectivity and enantioselectivity of the products produced. It 
highlights the electronic nature of the catalytic system, both concerning the porphyrin 
ligand, the metal oxidation state, and the substrate. It is also the first demonstration of 
corroles as active catalysts for the C-H insertion.  
The project will be reported as follows:  Fields, K. B., Hu, Y., Ruppel, J. V., Cui, X., 
Lu, H., Kim, C., Gill, J., Peart, M., Zhang, X. P. Enantioselective C‒H Amination of 
Aryl Sulfonylazides by Chiral Cobalt(II) Porphyrins to Form Aryl Sultams. Org. 
Lett., 2011, Planned for submission by end of December 2010. 
 
C-H Amination Experimental Section, HPLC Traces, and Spectra 
General considerations  
All intramolecular C-H amidation reactions were performed under nitrogen in 
oven-dried glassware following standard Schlenk techniques. 5 Å molecular sieves 
were dried in a vacuum oven prior to use. Chlorobenzene was dried over calcium 
hydride under nitrogen and freshly distilled before use. Toluene and THF were distilled 
under nitrogen from sodium benzophenone ketyl. Substituted benzenes and sulfonyl 
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chlorides were purchased from commercial sources and used without further 
purification. Thin layer chromatography was performed on Merck TLC plates (silica gel 
60 F254). Flash column chromatography was performed with ICN silica gel (60Å, 230-
400 mesh, 32-63μm). 1H NMR and 13C NMR were recorded on a Varian Inova400 (400 
MHz) instrument with chemical shifts reported relative to residual solvent. Infrared 
spectra were measured with a Nicolet Avatar 320 spectrometer with a Smart Miracle 
accessory.  
 
Note on Safety: Careful control experiments showed the arylsulfonyl azides reported in 
this work were stable under the conditions used. But it should be noted that some of the 
azide compounds may be explosive and should be handled with great care.  
 
General procedure for the synthesis of sulfonyl azides 
A solution of the sulfonyl chloride (1-10 mmol) in water: acetone (1:1, 6 ml/mmol) was 
stirred in a round bottom flask and cooled in an ice bath to 0 °C for 15-20 minutes. 
Sodium azide (1.5 eq) was added in portions to the sulfonyl chloride mixture and the 
reaction was monitored by TLC to completion (typically 2-5 hrs). After the reaction 
was complete, the flask underwent rotary evaporation until the acetone was removed. 
The crude product was extracted from the water using ethyl acetate or dichloromethane 
(3 x 5 ml/mmol). It was then washed with brine (10 ml/mmol), dried over sodium 
sulfate, and concentrated by rotary evaporation. The resulting oil was then purified by 
flash column chromatography (9:1, hexanes: ethyl acetate). The fractions containing 
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product were collected and concentrated by rotary evaporation to afford the pure 
compound. 
 
2,5-Dipropylbenzene-1-sulfonyl azide, 154 (Table 53 & Table 56, Entry 1) was 
obtained from 2,5- dipropylbenzene-1-sulfonyl chloride using the general procedure as 
colorless oil in 78% yield. 1H NMR (400 MHz, CDCl3): δ 7.83 (s, 1H), 7.41 (d, J = 7.6 
Hz, 1H), 7.34 (d, J = 8.0 Hz, 1H), 2.92 (t, J = 7.6 Hz, 2H), 2.64 (t, J = 7.2 Hz, 2H), 
1.73-1.63 (m, 4H), 1.02 (t, J = 7.6 Hz, 3H), 0.95 (t, J = 7.2 Hz, 3H). 13C NMR (125 
MHz, CDCl3): δ 141.3, 140.2, 136.1, 134.7, 131.9, 129.1, 37.18, 34.60, 24.49, 24.21, 
14.10, 13.61. IR (neat, cm-1): 2962, 2933, 2123, 1365, 1165.  
 
2,4,6-Triethylbenzene-1-sulfonyl azide, 162 (Table 56, Entry 2) was obtained from 
2,4,6-triethylbenzene-1-sulfonyl chloride using the general procedure as colorless oil in 
95% yield. 1H NMR (400 MHz, CDCl3): δ 7.0 (s, 2H), 3.02 (q, J = 7.2 Hz, 4H), 2.62 (q, 
J = 7.6 Hz, 2H), 1.27-1.20 (m, 9H). 13C NMR (100 MHz, CDCl3): δ 150.6, 146.3, 
132.4, 129.6, 28.5, 28.3, 16.7, 14.7. IR (neat, cm-1): 2968, 2119, 1597, 1363, 1162.  
 
2,5-Diethylbenzene-1-sulfonyl azide, 164 (Table 56, Entry 3) was obtained from 2,5-
diethylbenzene-1-sulfonyl chloride using the general procedure as colorless oil in 94% 
yield. 1H NMR (400 MHz, CDCl3): δ 7.83 (d, J = 1.6 Hz, 1H), 7.44 (dd, J = 1.2, 7.6 Hz, 
1H), 7.35 (d, J = 8.0 Hz, 1H), 2.98 (q, J = 7.6 Hz, 2H), 2.69 (q, J = 7.6 Hz, 2H), 1.28 (t, 
J = 7.6 Hz, 3H), 1.25 (t, J = 7.6 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 142.8, 141.6, 
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136.1, 134.3, 131.3, 128.5, 28.19, 25.6, 15.3, 15.2. IR (neat, cm-1): 2970, 2123, 1363, 
1164, 1190.  
 
4-Bromo-2-ethylbenzene-1-sulfonyl azide, 166 (Table 56, Entry 4) was obtained from 
4- bromo-2-ethylbenzene-1-sulfonyl chloride using the general procedure as a white 
solid in 98% yield. 1H NMR (400 MHz, CDCl3): δ 7.89 (d, J = 8.0 Hz, 1H), 7.61 (d, J = 
2.0 Hz, 1H), 7.53 (dd, J = 2.0, 8.0 Hz, 1H), 3.01 (q, J = 7.2 Hz, 2H), 1.32 (t, J = 7.6 Hz, 
3H); 13C NMR (100 MHz, CDCl3): δ 146.4, 135.4, 134.3, 130.8, 130.1, 129.6, 25.97, 
14.88. IR (neat, cm-1): 2979, 2126, 1579, 1364, 1164. 
 
2-Ethyl-5-nitrobenzene-1-sulfonyl azide, 160 (Table 54, Table 55, & Table 56, Entry 
5) was obtained from 2-ethyl-5-nitrobenzene-1-sulfonyl chloride using the general 
procedure as a yellow solid in 92% yield. 1H NMR (400 MHz, CDCl3): δ 8.89 (d, J = 
2.4 Hz, 1H), 8.46 (dd, J = 2.4, 8.8 Hz, 1H), 7.68 (d, J = 8.4 Hz, 1H), 3.15 (q, J = 7.6 
Hz, 2H), 1.38 (t, J = 7.6 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 151.6, 145.8, 138.1, 
132.6, 128.8, 124.6, 26.43, 14.84. IR (neat, cm-1): 2972, 2141, 1522, 1349, 1168. 
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Synthesis of 4-Isobutyramido-2-ethylbenzene-1-sulfonyl azide, 168 (Table 56, Entry 
6) (3 steps) 
S
O
Cl
O
Br
S
O
NH2
O
Br
NH3 in MeOH
[7 N]
 
 
4-Bromo-2-ethylbenzene-1-sulfonyl amide (SI-1). Dried 4-bromo-2-ethylbenzene-1-
sulfonyl azide (1 equiv, 1.62 g) was placed in a round bottom flask under nitrogen. 
Anhydrous ammonia in methanol solution (7 N) was SLOWLY added (exothermic) in 
excess (10 equiv, 8.2 ml) and allowed to react overnight at room temperature. The 
product was diluted in hexanes:ethyl acetate = 8:2 and washed with water until neutral. 
The organic layer was condensed to give the desired product as a white solid in 85% 
yield. 1H NMR (400 MHz, CDCl3): δ 7.88 (dd, J = 7.2 Hz, 1H), 7.61 (s, 1H), 7.53 (d, J 
= 7.2 Hz, 1H), 6.71 (s, 2H), 3.08 (q, J = 7.2 Hz, 2H), 1.29 (t, J = 7.2 Hz, 3H); 13C NMR 
(100 MHz, CDCl3): δ 146.9, 143.1, 135.1, 131.4, 130.7, 127.7, 27.4, 16.4. 
 
S
O
NH2
O
N
H
O
S
O
NH2
O
Br
NH2
O
+
Pd(OAc)2
Xantphos
Cs2CO3
THF, 80 °C, 12 h
  
4-Isobutyramido-2-ethylbenzene-1-sulfonyl amide (SI-2). Into an oven dried Schlenk 
tube the following was added: 4-Bromo-2-ethylbenzene-1-sulfonyl amide (1 equiv, 
200mg) was cross coupled to isobutyramide (4 equiv, 264 mg) using Pd(OAc)2 (10 mol 
%, 17mg) with Xantphos (20 mol %, 88mg) and Cs2CO3 (2 equiv, 493mg) as the base. 
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The Schlenk tube was evacuated and backfilled with nitrogen. The cap was removed 
and quickly replaced with a rubber septum. Anhydrous THF (5ml) was added as solvent 
through the septum and the tube was flushed with nitrogen for 2 minutes. The Teflon 
cap was replaced and the tube was placed in an oil bath for 12 hours at 80 °C. After 
reacting, the tube was taken from the oil bath and allowed to cool. The contents were 
transferred to a round bottom flask and evaporated. Flash chromatography (hexanes: 
ethyl acetate = 1:1 then 3:2) was used to elute the desired compound as a white solid in 
84% yield (174 mg). 1H NMR (400 MHz, CDCl3): δ 9.28 (s, 1H), 7.88 (d, J = 8.8 Hz, 
1H), 7.71 (s, 1H), 7.65 (d, J = 8.8 Hz, 1H), 6.51 (s, 2H), 3.04 (q, J = 7.2 Hz, 2H), 2.65 
(p, J = 6.8 Hz, 1H), 1.26 (t, J = 7.2 Hz, 3H), 1.17 (d, J = 6.8 Hz, 6H); 13C NMR (100 
MHz, CDCl3): δ 176.4, 144.3, 143.7, 136.8, 129.5, 121.0, 116.5, 36.6, 26.5, 19.7, 15.4.  
 
 
S
O
N3
O
N
H
O
K2CO3
H2O/tol/t-BuOH
RT, 40 h
S
O
NH2
O
N
H
O
H-Cl
N
NSO2N3
+
 
4-Isobutyramido-2-ethylbenzene-1-sulfonyl azide, 168 (Table 56, Entry 6) 4-
Isobutyramido-2-ethylbenzene-1-sulfonyl amide (1 equiv, 145mg) was placed in a 
large test tube and 1-imidazole-1-sulfonyl azide (1.2 equiv, 136 mg) and K2CO3 (4 
equiv, 300 mg) were added. Then a blend of H2O (0.32 ml), toluene (0.36 ml), and t-
butanol (2.16 ml) was added and allowed to stir, covered, at room temperature for 40 
hours. After reacting, the contents were diluted in ethyl acetate and washed with water. 
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The water layer was then subjected to 3 x 50 ml ethyl acetate and the organic layers 
were condensed. Flash chromatography (hexanes: ethyl acetate = 7:3) was used to elute 
the desired compound as a white solid in 87% yield (160 mg). 1H NMR (400 MHz, 
CDCl3): δ 1H NMR (400 MHz, CDCl3): δ 9.28 (s, 1H), 7.88 (d, J = 8.8 Hz, 1H), 7.71 (s, 
1H), 7.65 (d, J = 8.8 Hz, 1H), 3.04 (q, J = 7.2 Hz, 2H), 2.65 (p, J = 6.8 Hz, 1H), 1.26 (t, 
J = 7.2 Hz, 3H), 1.17 (d, J = 6.8 Hz, 6H); 13C NMR (100 MHz, CDCl3): δ 176.4, 144.3, 
143.7, 136.8, 129.5, 121.0, 116.5, 36.6, 26.5, 19.7, 15.4. IR (neat, cm–1):  
 
General procedure for intramolecular C-H amidation 
An oven dried Schlenk tube, that was previously evacuated and backfilled with 
nitrogen gas, was charged with azide (if solid, 0.2 mmol), catalyst (0.004 mmol), and 
5Å MS (100 mg). The Schlenk tube was then evacuated and back filled with nitrogen. 
The Teflon screw cap was replaced with a rubber septum and 0.5 ml of solvent was 
added followed by azide (if liquid, 0.2 mmol) and the remaining solvent (total 1mL). 
The Schlenk tube was then purged with nitrogen for 2 minutes and the rubber septum 
was replaced with a Teflon screw cap. The Schlenk tube was then placed in an oil bath 
for the desired time and temperature. Following completion of the reaction, the reaction 
mixture was concentrated and purified via flash chromatography. The fractions 
containing product were collected and concentrated by rotary evaporation to afford the 
pure compound. 
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Characterization and spectra 
Compound 155 (Table 56, Entry 1, isolated 5 membered ring) was synthesized by the 
general procedure from 2,5- dipropylbenzene-1-sulfonyl azide as tan oil (19% yield 
total 5& 6). 1H NMR (400 MHz, CDCl3): δ 7.57 (s, 1H), 7.42 (d, J = 8.0 Hz, 1H), 7.27 
(d, J = 8.4 Hz, 1H), 4.62 (m, 2H), 2.68 (t, J = 7.6 Hz, 2H), 2.05-2.00 (m, 1H), 1.83-1.78 
(m, 1H), 1.67 (sext, J = 7.6 Hz, 2H), 1.03 (t, J = 7.2 Hz, 3H), 0.95 (t, J = 7.2 Hz, 3H). 
13C NMR (100 MHz, CDC13): δ 144.6, 137.5, 135.7, 133.6, 123.7, 120.6, 58.85, 37.56, 
28.72, 24.22, 13.66, 9.88. IR (neat, cm–1): 3272, 2964, 2931, 2872, 1489, 1458, 1379, 
1281, 1151, 1094, 1049.  
 
Compound 156 (Table 56, Entry 1, combined 5 & 6 membered rings) was synthesized 
by the general procedure from 2,5-dipropylbenzene-1-sulfonyl azide as tan oil (19% 
yield total 5& 6). 1H NMR (400 MHz, CDCl3): δ 7.59 (s, 1H), 7.25-7.20 (m, 1H), 7.07 
(d, J = 8.0 Hz, 1H), 4.41 (d, J = 11.2 Hz 1H), 4.03- 3.94 (m, 1H), 2.89 (dd, J = 17.2, 3.6 
Hz, 1H), 2.72 (dd, J = 17.2, 11.2Hz, 1H), 2.57 (t, J = 7.6 Hz, 2H), 1.69-1.59 (m, 2H), 
1.35 (d, J = 6.8 Hz, 3H), 0.92 (t, J = 7.2 Hz, 3H). 
 
Compound 163 (Table 56, Entry 2) was synthesized by the general procedure from 
2,5- diethylbenzene-1-sulfonyl azide as a tan oil in 22% yield. 1H NMR (400 MHz, 
CDCl3): δ 7.57 (s, 1H), 7.44 (d, J = 8.0 Hz, 1H), 7.27 (d, J = 8.0 Hz, 1H), 4.81 (s, 1H), 
4.78-4.70 (m, 1H), 2.74 (q, J = 7.6 Hz, 2H), 1.58 (d, J = 6.8 Hz, 3H), 1.26 (t, J = 7.6 
Hz, 3H). 13C NMR (100 MHz, CDC13): δ 146.2, 139.3, 135.7, 133.5, 123.8, 120.1, 
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53.40, 28.77, 21.75, 15.46. IR (neat, cm–1): 3256, 2932, 1489, 1455, 1417, 1372, 1282, 
1211, 1150.  
 
Compound 165 (Table 56, Entry 3) was synthesized by the general procedure from 
2,4,6- triethylbenzene-1-sulfonyl azide as a tan oil in 47% yield. 1H NMR (400 MHz, 
CDCl3): δ 7.11 (s, 1H), 6.96 (s, 1H), 4.68 (m, 1H), 4.64 (m, 1H), 2.98 (q, J = 7.6 Hz, 
2H), 2.70 (q, J = 7.6 Hz, 2H), 1.57 (d, J = 6.8 Hz, 3H), 1.33 (t, J = 7.6 Hz, 3H), 1.25 (t, 
J = 7.6 Hz, 3H). 13C NMR (100 MHz, CDC13): δ 150.6, 142.4, 140.1, 131.3, 128.6, 
120.2, 52.64, 28.99, 24.62, 21.55, 15.36, 14.57. IR (neat, cm–1): 3251, 2976, 2935, 
2875, 1600, 1459, 1374, 1279, 1174, 1146.  
 
Compound 167 (Table 56, Entry 4) was synthesized by the general procedure from 4-
bromo-2- ethylbenzene-1-sulfonyl azide as a tan solid in 78% yield (48.9 mg). 1H NMR 
(400 MHz, CDCl3): δ 7.65-7.59 (m, 2H), 7.53 (s, 1H), 4.96 (s, 1H), 4.78-4.71 (m, 1H), 
1.60 (d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDC13): δ 143.8, 134.6, 132.5, 127.8, 
127.2, 122.5, 52.91, 21.15. IR (neat, cm–1): 3268, 2966, 2924, 2871, 1727, 1572, 1459, 
1389, 1320, 1284, 1193, 1165, 1138, 1073. 
 
Compound 161 (Table 56, Entry 5) was synthesized by the general procedure from 2-
ethyl-5- nitrobenzene-1-sulfonyl azide as a tan solid in >99% yield (45.2 mg). 1H NMR 
(400 MHz, CDCl3): δ 8.60 (d, J = 1.6 Hz, 1H), 8.49 (dd, J = 8.4, 2.0 Hz, 1H), 7.60 (d, J 
= 8.4 Hz, 1H) 4.91 (s, 1H), 4.87 (m, 1H), 1.69 (d, J = 6.4 Hz, 3H). 13C NMR (100 MHz, 
304 
 
CDC13): δ 148.5, 147.7, 137.5, 128.1, 125.3, 117.4, 53.32, 21.40. IR (neat, cm–1): 3243, 
1600, 1529, 1351, 1282, 1162, 1137, 1094, 1049, 1025.  
 
Characterization previously published as follows: 
Ruppel, J. V.; Kamble, R. M.; Zhang, X. P. Cobalt-Catalyzed Intramolecular C–H 
Amination with Arylsulfonyl Azides, Org. Letters, 2007, 9(23), 4889-4892. 
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1H NMR (400 MHz) 2,5-Dipropylbenzene-1-sulfonyl azide, 154 
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13C NMR (100 MHz) 2,5-Dipropylbenzene-1-sulfonyl azide, 154 
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1H NMR (400 MHz) 2,4,6-Triethylbenzene-1-sulfonyl azide, 162  
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13C NMR (100 MHz) 2,4,6-Triethylbenzene-1-sulfonyl azide, 162  
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1H NMR (400 MHz) 2,5-Diethylbenzene-1-sulfonyl azide, 164 
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13C NMR (100 MHz) 2,5-Diethylbenzene-1-sulfonyl azide, 164  
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1H NMR (400 MHz) 4-Bromo-2-ethylbenzene-1-sulfonyl azide, 166 
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13C NMR (100 MHz) 4-Bromo-2-ethylbenzene-1-sulfonyl azide, 166  
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1H NMR (400 MHz) 2-Ethyl-5-nitrobenzene-1-sulfonyl azide, 160  
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13C NMR (100 MHz) 2-Ethyl-5-nitrobenzene-1-sulfonyl azide, 160  
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1H NMR (400 MHz, D6-acetone) -4-Bromo-2-ethylbenzene-1-sulfonyl amide (SI-1) 
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13C NMR (100 MHz, D6-acetone) 4-Bromo-2-ethylbenzene-1-sulfonyl amide (SI-1) 
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1H NMR (400 MHz, D6-acetone) 2-Ethyl-4-isobutyramidobenzene-1-sulfonyl amide  
(SI-2) 
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13C NMR (100 MHz, D6-acetone) 2-Ethyl-4-isobutyramidobenzene-1-sulfonyl 
amide  (SI-2) 
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1H NMR (400 MHz, D6-acetone) 2-Ethyl-4-isobutyramidobenzene-1-sulfonyl azide, 
168  
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13C NMR (100 MHz, D6-acetone) 2-Ethyl-4-isobutyramidobenzene-1-sulfonyl azide, 
168  
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HPLC trace showing enantioselectivity of 5 and 6 member ring products 
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1H NMR (400 MHz) 155 & 156 (combined) 
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1H NMR (400 MHz) 155, 5 member ring isolated  
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13C NMR (100 MHz) 155, 5 member ring isolated  
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HPLC trace showing enantioselectivity of products 
22% yield
PhCl, 18 h
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1H NMR (400 MHz) 163 
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13C NMR (100 MHz) 163 
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HPLC trace showing enantioselectivity of products 
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1H NMR (400 MHz) 165 
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13C NMR (100 MHz) 165 
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HPLC trace showing enantioselectivity of products 
78% yield
PhCl, 18 h
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1H NMR (400 MHz) 167 
 
S
O
NH
O
Br
333 
 
13C NMR (100 MHz) 167 
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HPLC trace showing enantioselectivity of products 
>99% yield
PhCl, 18 h
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1H NMR (400 MHz) 161 
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13C NMR (100 MHz) 161 
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Conclusions 
 The use of chiral porphyrin ligands for asymmetric atom/group transfer 
reactions has significantly evolved since the first report by Groves and Myers in 1983. 
Various metal complexes of chiral porphyrin ligands have been used for asymmetric 
epoxidation, cyclopropanation, aziridination, and in several reports of carbon-hydrogen 
bond functionalizations. The greatest efforts have focused on the development of 
porphyrin catalysts for asymmetric epoxidation.  Much of this research has been 
devoted to the synthesis and evaluation of metal complexes of the Halterman ligand  93. 
This ligand system provides for a very robust catalyst that is capable of several 
thousand TON in some systems. Complexes of Collman’s binap-strapped ligand, 
including the derivatives produced by Rose, have generated the highest 
enantioselectivities for any porphyrin catalyzed asymmetric epoxidation system. 
Both the Halterman ligand and Collman’s binap-strapped porhyrin ligand 
emphasize the need for open access to the active site. The nature of these ligands 
facilitates high reaction rates in epoxidation processes, minimizes the oxidation of the 
catalyst, and orients the chiral moieties within a close proximity to the active site while 
maintaining a balance of steric interactions. 
Research into metalloporphyrin mediated asymmetric cyclopropanation was 
also dominated by the use of the Halterman ligand 93. Similar to the development of 
porphyrin ligands for asymmetric epoxidation, various metal complexes of the 
Halterman ligand have been employed as catalysts producing cyclopropanes in high 
diastereo- and enantioselectivities and high TON. The development of another type of 
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D2-symmetic picket fence porphyrin ligand by Zhang and co-workers has resulted in 
one of the most selective and practical cyclopropanation systems, routinely generating 
excellent diastereo- and enantioselectivities across many classes of substrates using a 
variety of carbene sources.   
 The examples of asymmetric carbon-hydrogen bond functionalization reactions, 
developed in conjunction with other atom/group transfer processes, are another 
indication of the versatility of porphyrins as ligands. Further development of these 
systems is a continuing goal in asymmetric catalysis, in general.  
 Finally, the diverse porphyrin ligand systems already developed and the great 
amount of progress achieved in epoxidation and cyclopropanation ensure that the 
continued development of porphyrins as ligands for all atom/group transfer reactions 
will remain a goal for many research groups in the years to come. 
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CHAPTER 3: MEDICINAL APPLICATIONS OF PORPHYRINS AND SMALL 
MOLECULES 
 
Introduction  
Collaboration between scientists is perhaps our best weapon against disease. 
These projects are collaborative efforts between an organic chemistry lab, which has 
synthesized numerous novel porphyrins and various small molecules, and six 
medicinal biology labs. These labs specialize in methicillin resistant Staphylococcus 
aureus research (Dr. Lindsay Shaw), Alzheimer’s disease research (Dr. Patrick 
Bradshaw), Influenza (Dr. Alberto VanOlphen), Malaria (Dr. Dennis E. Kyle), 
Ferrochelatase (Dr. Gloria Ferriera), and cancer (Dr. Nick Lawrence, Dr. Jingfeng 
Cai). Additionally, a partnership is being set up with the help of Dr. Roth’s lab at the 
Sanford-Burnham Institute, Orlando, FL for submitting samples to the National 
Institutes of Health.  
The chemicals synthesized in the Zhang’s chemistry lab were originally 
designed for use in chemistry related research as the end product. This project is 
designed to determine whether these compounds are also useful in other areas of 
science, in particular, the biomedical sciences. As a result, undergraduates Rebecca 
Burt and Nicole Barbara have assisted in the location, cataloging, weighing, and 
submission of approximately 250 different porphyrins and small molecules to allow for 
efficacy screening against these dread diseases. 
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Bacteria – Methicillin-Resistant Staphylococcus aureus (MRSA) 
Introduction 
Staphylococcus aureus is a gram positive, cocci shaped bacteria. It is ubiquitous 
among humans and is normally part of the natural flora of the skin and nasal passages.1 
However, it can cause a variety of infections ranging from mild to life threatening. In 
the community, most MRSA infections are skin infections. These include skin 
infections such as folliculitis, furnucles, carbuncles, and impetigo and more serious 
infections such as mastitis, wound infections (surgical and trauma inflicted), 
bacteremia, endocarditis, meningitis, pericarditis, pulmonary infections, osteomyelitis 
and septic arthritis.2 Staphylococcal scalded skin syndrome and toxic shock syndrome 
are two other very serious infections caused by S. aureus. Staphylococcal scaled skin 
syndrome is a condition where the exfoliative toxin produced by S. aureus causes 
blistering and or pealing of the other layer of skin.3 This disease affects mainly infants 
and children.4 Toxic shock syndrome is a serious life-threatening infection that results 
from toxins released by S. aureus.  
 Methicillin resistant Staphylococcus aureus (MRSA) is S. aureus that is 
resistant to certain antibiotics called beta-lactams.5 These antibiotics include methicillin 
and other more common antibiotics such as oxacillin, penicillin, and amoxicillin.5 
Typically, MRSA strains are also resistant to other antibiotics. MRSA has become a 
problem both in the hospital setting and in the community setting. Adverse effects of 
antibiotic resistance include: increased hospital mortality, increased cost and length of 
stay, increased antibiotic costs due to the need to treat infections with multiple 
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antibiotics, and failure of treatment due to resistance to the antibiotic used.5 It is 
important now more than ever to develop new antibiotics to treat resistant strains of S. 
aureus. 
 
MRSA Testing 
 The strain used was USA 100 #635. This strain is resistant to the entire beta 
lactam family, cethromycin, azithromycin, erythromycin, clindamycin, 
chloremphenocol, linezolid, daptomycin, and gentamycin. The chemicals were tested 
using the disk diffusion method (Figure 27). The concentration of each chemical was 1 
mg/ml.  Each chemical was tested for efficacy in the light and the dark. This was done 
by incubating the bacteria in the light and in the dark with each chemical (Figure 28).  
 
 
 
Figure 27: Zones of MRSA inhibition around the treated disks on an agar plate. 
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Figure 28: Incubator fitted to accommodate “light” conditions. 
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Light Active Porphyrins 
 
Figure 29:  Average zone of inhibition (in mm), after 3 trials, when incubated in light. 
These compounds showed activity when incubated in the light and no activity when 
incubated in the dark. 
 
 The group of compounds that is effective in light only is made up solely of 
porphyrins (Figure 29 and 30). This is most likely due to the fact that porphyrins are 
photosensitizers, which upon absorption of light releases singlet oxygen, a reactive 
oxygen species. In general, the compounds that showed the greatest zones of inhibition 
in the light only were the smaller polar diphenylporphyrin derivatives. RB-15, which 
showed the largest zone of inhibition, is the only porphyrin in the group that contains an 
amide. Porphyrins with hydroxyl groups are also effective in the light: RB-256, RB-84, 
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RB-85, RB-93, and RB-88. Activity is present in both free base and metalated 
porphyrins. 
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Figure 30: Structures of compounds that showed activity in the light only.  The 
structures are presented in decreasing order of zone of inhibition size from left to right. 
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Dark Active Porphyrins and Small Molecules 
 
Figure 31: Average zone of inhibition (in mm), after 3 trials, when incubated in 
darkness.  
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Figure 32a: Structures of compounds that showed activity in the dark only. 
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Figure 32b: Structures of compounds that showed activity in the dark only. These 
compounds showed activity when incubated in the dark and no activity when incubated 
in the light. The structures are presented in decreasing order of zone of inhibition size 
from left to right. 
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 The group of compounds that is effective in the dark only is made up mostly of 
small molecules (Figure 31 and 32a & b). These small molecules include 
cyclopropanes, aziridines, and cyclic esters. RB-118, which shows the largest zone of 
inhibition, contains a cyclopropane substituted with a phenyl group and a succinimide. 
The structures of RB-118 and RB-114 are very similar, however, RB-118 produces a 
zone 4 mm larger than RB-114. It is possible that the methyl group at the para-position 
on the phenyl ring of RB-114 could be reducing the compounds ability to interact with 
a binding site on the target enzyme. Further studies are needed to determine the mode of 
action and target enzyme or protein.  
It is interesting to note the presence of both porphyrins and corroles in this 
group. Porphyrins substituted wih ethoxy linkages at the meso position were 
particularly prominent: RB-12, RB-298, RB-301, RB-302, RB-303, RB-290, RB-292, 
RB-300, and RB-291. Although the group attached varied, they were all di-meso-
substituted with phenyl or benzyl appendages. Five different corroles showed activity as 
well. All five shared the similar feature of having 5,15-(2,6-dibromophenyl) 
appendages and the other 10-aryl groups increased in activity with the presence of more 
polar groups. Potentially, this corresponds with an increase in solubility. 
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Light and Dark Active Porphyrins and Small Molecules 
 
Figure 33: Average zone of inhibition (in mm), after 3 trials, when incubated in light 
and dark for each compound. These compounds showed activity when incubated in the 
dark and activity when incubated in the light. 
 
 The compounds that were effective in light and dark are the most interesting 
(Figures 33 and 34 a & b). The size of the zone of inhibition in the light vs. the dark is 
different for many of the compounds. This indicates there may be two modes of action 
for these compounds: one mode in the light and a different mode in the dark.  
RB-87, which is a tetraphenyl porphyrin (TPP) with carboxylic acids at the 
para-positions, shows the largest zone of inhibitions in both the light and the dark. One 
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of the recurring structural themes; however, is the presence of multiple hydroxy and 
methoxy substitutions: RB-254, RB-280, RB-253, RB-86, RB-259, RB-21, RB-263, 
RB-279, RB-271, and RB-250. In contrast to the dark only group of active porphyrins, 
there are several with alkyl meso ethoxy linkages: RB-1, RB-20, RB-4, and RB-5.  
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Figure 34a: Structures of compounds that showed activity in the light and the dark. 
The structures are presented in decreasing order of zone of inhibition size from left to 
right. 
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Figure 34b: Structures of compounds that showed activity in the light and the dark. 
The structures are presented in decreasing order of zone of inhibition size from left to 
right. 
 
 
 The minimal inhibitory concentrations (MICs) were then determined for the top 
6 chemicals that were effective in the light and the dark (Table 57). Two compounds 
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from each activity area were tested. Minimum inhibitory concentrations (MICs) were 
determined for these six compounds. Of these compounds, RB-197 and RB-256 were of 
notable activity.  The RB-197 compound is a cyclopropane substituted with a meta-
methylphenyl on one one carbon and a nitro group and an ethyl ester on another. RB-
256 is 3,5-dihydroxyphenylporphyrin. The vast differences in these two compound 
structures points again towards there being multiple modes of action. Shown below are 
the small molecule catalytic products (Figure 35) and porphyrins (Figure 36) that in 
many ways are very structurally similar, but not active.  
 
Table 57: Minimum Inhibitory Concentrations Determined for Six of the Most 
Effective Compounds. 
 
Minimum Inhibitory Concentrations 
Structure MIC Light (µg/ml) MIC Dark (µg/ml)  
12 > 100 > 100 
85 > 200 > 100 
119 > 200 > 200 
147 > 100 > 100 
197 70-75 70-75 
256 75-80 75-80 
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Inactive Compounds Tested 
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Figure 35a: Small molecules tested having no activity toward bacteria. 
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Figure 35b: Small molecules tested having no activity toward bacteria  
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Porphyrins 
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Figure 36a: Porphyrins tested having no activity toward bacteria 
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Figure 36b: Porphyrins tested having no activity toward bacteria 
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Figure 36c: Porphyrins tested having no activity toward bacteria 
361 
 
RB-245
RB-246 RB-247
RB-248
RB-251RB-252
RB-257
RB-258
RB-266RB-267
RB-268
RB-272
RB-273
RB-276
RB-278
N
N N
N
MeO OMe
OMe
OMe
OMeMeO
MeO
MeO
Zn
OMe
OMe
OMe
MeO
N
NH N
HN
MeO OMe
OMe
OMe
OMeMeO
MeO
MeO
N
NH N
HN
OMe
OMe
MeO
OMe
MeO
OMe
OMe
MeO
N
N N
N
OMe
OMe
MeO
OMe
MeO
OMe
OMe
MeO Zn
N
NH N
HN OMe
MeO OMe
MeON
NH N
HN OMe
MeO OMe
MeO
OMeMeO
N
N N
N
MeO
OMe
MeO OMeZn
N
NH N
HN
MeO
OMe
MeO OMe
N
N N
N
OMe
OMe
MeO
MeO
Zn
N
N N
N
OMeMeO Zn
MeO
MeO
OMe
OMe
N
N N
N
Zn
MeO
MeO
OMe
OMe
N
NH N
HN OMe
MeO OMe
MeO
Br
Br
OMeMeO
N
NH N
HN
MeO OMe
OMe
OMe
OMeMeO
MeO
MeO
OMe
MeO
OMe
OMe
N
N N
N
MeO OMe
OMe
OMe
OMeMeO
MeO
MeO
Zn
N
NH N
HN OMe
MeO OMe
MeO
Br
Br
 
Figure 36d: Porphyrins tested having no activity toward bacteria 
 
362 
 
RB-314
NH
N HN
HN
Br
Br
Br
Br
RB-249
RB-255 RB-259
RB-265
RB-270
N
N N
N
OMe
MeO
MeO
OMe
Zn
MeO
OMe
OMe
MeO
N
NH N
HN OH
HO OH
HO
HO OH
N
NH N
HN
MeO
OMe
MeO
OMe
N
NH N
HN
HO OH
OH
OH
OHHO
HO
HO
OH
HO
OH
OH
N
N N
N
OHHO
HO OH
HO
HO
OH
OH
Zn
RB-101
RB-103
N
NH N
HN
MeO O
OMe
O
MeO O
MeO
O
N HN
NNH
OMe
O
MeO
O
RB-89
M=Co RB-90
M=Cu RB-91
M=Pd RB-92
N
NH N
HN
OH
OH
OH
HO
OMe
OMe
MeO
MeO
N
N N
N
OH
OH
OH
HO M
 
Figure 36e: Porphyrins tested having no activity toward bacteria 
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Conclusions 
 There appears to be more than one mode of action, based on the differences of 
activity in light and dark conditions. It is possible that the porphyrins that were active 
in the light only were particularly efficient at producing singlet oxygen as a result of 
being photosensitized in air. Additional research will be conducted to determine the 
modes of action of the porphyrins and small molecules on MRSA cells. 
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Alzheimer’s Disease 
Introduction 
The disease is named after the German doctor, Dr. Alois Alzheimer, who first 
described the disease in 1906.1 Approximately 2.4-4.5 million Americans are living 
with Alzheimer’s disease and by 2050, estimates indicate that 14 million Americans 
may be affected. In 2007, it was ranked as the 6th leading cause of death in the United 
States for people over 65.2 It also ranks as the third most costly disease, falling behind 
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only cancer and heart disease as number one and two, respectively.2 Alzheimer’s is an 
age related disease, the odds of acquiring it increases exponentially with age. 
Alzheimer’s disease is the most common form of dementia, brought on by the 
shrinkage and loss of neurons. This leads to to the overall atrophy of the brain, with 
focused damage to the hippocampus. The disease is characterized by the accumulation 
of plaques and tangles in the brain. These plaques and tangles are the cause of 
symptoms, which begin with progressive memory loss and lead to the inability to 
perform everyday tasks and eventually death.1 
Accumulation of β-amyloid is associated with the production of plaques in the 
brain.3 This protein has adverse effects on the function of mitochondria in neurons. 
Mitochondria are the cell’s energy power houses, where O2 is consumed and ATP is 
produced. The mitochondrial membrane is the site of electron transport for all 
eukaryotic cells, including neurons. Mitochondria produce more reactive oxygen 
species with age (increases the Reactive Oxygen Species, ROS) which is thought to 
lead to or accelerate Alzheimer’s disease and other age related diseases. The effects β-
amyloid on mitochondria also include decreased membrane potential (due to an 
increase in permeability of the mitochondrial membrane) and a decrease in ATP 
production (due to a decrease in proton pumping).3 The correlation between 
mitrochondrial function and cognitive disfunction makes the mitrochondria a worthy 
target for therapeutics.  
The transmembrane protein APP is cut by enzymes to give the proteolytic 
byproduct, the αβ fragment. That short peptide sequence builds up selectively in the 
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mitochondria where it aggregates into amyloid fibrils which are cytotoxic. This disrupts 
the Ca+2 channels and leads to cell apoptosis (cell death).   
The N2a-APP cells used in this study are mouse N2a neuroblastoma cells which 
express mutant APP (Figure 37). These cells are characterized by increased αβ levels 
and have decreased mitochondrial function. Therefore, a potential therapeutic could be 
screened to determine if it could improve mitochondrial function.  
 
 
Figure 37: Plated N2a-APP cells 
 
Porphyrin Screening 
 While at the University of Tennessee, the Zhang group collaborated with Dr. 
Wetzel; however, no definitive results were ever published. There was a correlation 
between the results from that study to the porphyrins submitted by Dr. Ying Chen. 
From these initial results, sixteen of the top performing porphyrins from the previous 
study were subjected to additional testing by Dr. Patrick Bradshaw and Dr. Natasa 
Dragicevic of the University of South Florida.  
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All of the porphyrins screened decreased the production of reactive oxygen 
species in N2a-APP cells (Figure 38), in some cases greater than 90%. They also 
showed an increase in membrane potential. The basal respiration was reported to be up 
to 3-4 times greater than the control, and the maximum respiration was up to 2.5-3.5 
times greater than the control. This was accompanied by a 150-200% increase in ATP 
production. It is thought that the porphyrins were directly binding to the αβ fragments.  
The compound that showed the greatest reduction in reactive oxygen species, 
while still producing an increase in membrane potential and ATP production was RB-
27. RB-27 is a DPP that has an amine in close proximity to an ester. Many of the other 
effective porphyrins are mono- and disubstituted porphyrins which contain meso-
amides (Figure 39a). Other effective porphyrins include those that have hydroxy groups 
on the phenyl rings: RB-80, RB-89, and RB-93; meso-alkyl thioether substituents: RB-
47, RB-57, and RB-58 (Figure 39b). 
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Figure 38: The graph above shows the measurements (in %) of reactive oxygen species 
production, membrane potential, and ATP production in N2aAPP cells treated with 
porphyrins. The control was not treated with porphyrins and shows 100% of ROS 
production, membrane potential, and ATP production. 
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Figure 39a: Porphyrins that contain meso-amides and amines which are beneficial to 
N2a-APP cells.  
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Figure 39b: Porphyrins that contain meso-amides and amines which are beneficial to 
N2a-APP cells. 
 
Conclusions 
 Further testing of the effective porphyrins on N2aAPP cells will also be 
conducted. These porphyrins will also be tested on C. elegans, a model eukaryotic 
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organism.The C. elegans worms have a temperature-inducable promoter, so as the 
temperature is increases from 16 °C to 23°C, the muscle cells begin to express the β-
amyloid protein. After approximately 40 hours, β-amyloid will cause muscle paralysis 
and kill the worm. It is expected that in the presence of the active porphyrins, the 
oligiomer formation will be slowed delaying or stoping the paralysis of the worm’s 
muscle cells to extend the life of the worm.  
 
Results of this study will be published as follows: 
Dragicevic, N.; Buzzeo, R.; Copes, N.; Fields, K. B.; Burt, R.; Zhang, X. P.; Bradshaw, 
P. Therapeutic effects of porphyrin frameworks on N2aAPP cells. In preparation 
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Malaria 
Introduction 
The objective was to develop porphyrin frameworks as new drug leads. The 
design and synthesis of new porphyrins coupled with several potent, known anti-
malarial drugs through direct linkage or various organic spacers. These porphyrins were 
then evaluated in vitro for their potential anti-malarial activity in drug-resistant cell 
lines. These investigations were carried out through a collaboration between Dr. X. 
Peter Zhang in the University of South Florida, Department of Chemistry and Dr. 
Dennis Kyle in the University of South Florida, College of Public Health.  
 
Background  
Malaria is one of the most severe public health problems worldwide, where it 
ranks as a leading cause of in many developing countries. Each year 350-500 million 
cases of malaria occur worldwide, and two to three million people die, most of them 
young children in sub-Saharan Africa.1 There is an ever increasing risk for the world 
population from malaria due to its resistance to traditional anti-malarial drugs and the 
mosquito’s resistance to insecticides. Numerous drugs have been developed for malaria, 
yet resistance has developed to the point that the World Health Organization (WHO) 
recently mandated the need for multiple drug therapy. The discovery of new 
compounds to treat multi-drug resistant malaria is urgently needed to reduce the 
morbidity and mortality of malaria. 
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The parasite degrades up to 75% of the infected cell’s hemoglobin within its 
lysosomal food vacuole during the intra-erythrocytic phase of the malaria parasite’s life 
cycle.2 Hemoglobin proteolysis within the parasite yields metabolically useful free 
amino acids as well as the toxic ferrous-protoporphyrin IX (Fe(II)PPIX), or heme. 
Heme concentrations as low as 400 mM within the food vacuole of the parasite leads to 
the disruption of its metabolic function and results in cell lysis and parasite death. 
However, the parasite has developed a detoxification mechanism involving the rapid 
oxidation of Fe(II)PPIX into ferric-protoporphyrin IX hydroxide (Fe(III)PPIX-OH), 
also known as hematin. The hematin then arranges into an insoluble crystalline heme 
aggregate resulting from iron-carboxylate bonds and hydrogen bonding linking the units 
together to form hemazoin, also known as malaria pigment or β-hematin.3 Therefore, 
efficient inhibition of the hematin aggregation and the subsequent accumulation of 
hematin within the vacuole are important for disrupting the metal homeostasis resulting 
in parasite death (Figure 40). 
 
N
N N
N
Fe
O
O
O
O
Hematin Hemazoin
OH
N
N
N
NFe
O
O
O
O
HO
N
N
N
NFe
O
O
OO
N
N
N
N Fe
O
O
O O N
N
N
N Fe
O
O
O
O
OH
 
Figure 40: Inhibition of the Aggregation of Hematin into Hemazoin. 
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Current therapeutic drugs focus on disrupting the parasite’s ability to aggregate 
and sequester the heme in the parasite’s food vacuole. Quinoline blood schizonticides, 
such as quinine (IC50 of 140µM), are thought to act by inhibiting the heme aggregation 
by binding to the monomeric or dimeric hematin.3a,4 The surface of the aggregated 
hemazoin has a large π-dense region. Quinoline π-π stacking interactions with the 
region were observed, resulting in the formation of quinoline-heme complexes.5 This 
process leads to an increased concentration of free heme present in the food vacuole, 
which induces membrane lysis.6 Several studies have shown that many antimalarial 
drugs accumulate in the food vacuole and effectively bind to the heme.7 Historically, 
the most effective antimalarial agents are derivatives of 4-amino-7-chloroquinoline, 
such as chloroquine (IC50 of 80µM) (Figure 41). Studies demonstrate the possible 
importance of amino and chloro groups as they improve transport into the vacuole or 
increase the heme binding efficacy. 5 
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Figure 41: Structures of a quinoline and two potent hydroxyxanthone drugs. 
 
Hydroxyxanthone-based drugs (Figure 41), such as synergistic rufigallol and 
exifone, exhibit redox interactions to promote the production of oxygen radicals inside 
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parasitized erythrocytes via hydroxyl radicals. These compounds are also capable of 
forming soluble heme-drug complexes, as observed in quinoline based drugs. Structure-
activity relationship studies reveal that inhibition was only observed when the 4- and 5-
positions are hydroxylated and inhibition increased with higher degrees of 
hydroxylation. The hydroxyl functionality is believed to enhance the interaction 
efficacy between the drug and the heme propionate.8  
Schiff-based metallodrugs, which consist of pseudo-octahedral complexes with 
N4O2 donor sets, have been found to disrupt heme aggregation in P. falciparum. This 
class of anti-malarials was developed by Sharma and Piwnica-Worms (Figure 42).9 
Complexes of Al(III), Fe(III), Ga(III), and In(III) were synthesized using an ethylenedi-
aninin-N,N’-bis[2-hydroxy-R-benzylimino] ligand (ENBPI) and the reduced 
ethylenedi-aninin-N,N’-bis[2-hydroxy-R-benzylamino] ligand (ENBPA). When the 
substituted phenolic R group was 3-methoxy, only the Fe(III) complex showed efficacy; 
however, when 4,6-dimethoxy groups were used Al(III), Fe(III), and Ga(III) all showed 
inhibition of parasite growth and heme aggregation. Of these, [4,6-dimethoxy-
ENBPI]Fe(III) was the most efficacious with an IC50 of 1.0µM against the parasitic 
growth of P. falciparum. The conclusion of this study suggested that the “spatial 
orientation of the aromatic periphery was critical to imparting the favorable biotransport 
properties” and that although the exact mode of action was unknown it is believed that 
it inhibits the same target as chloroquine for the inhibition of hemozoin formation. 9 In 
further studies by Ito and Tsang, crystal structures of [ENBPI] Fe(III) and Ga(III) 
complexes reveal a trans- configuration of the phenolic oxygens across the central 
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metal ion. Transport of these trans- configured ligands is recognized by an analog of 
MDR1 P-glycoprotein for transport into the organism, where a cis- configuration is 
transported less effectively. 10 
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Figure 42: Structures of N4O2 Schiff Base Complex (ENBPI), where R3 or R4 & R6 are 
methoxy groups. 
 
Analogs of the Schiff base complexes mentioned previously, the porphyrin 
plane would provide four amines around a central metal ion with the fifth and six ligand 
sites in a trans- configuration. This strategy of drug development uses the heme 
scaffold itself as a hematin aggregation inhibitor. Several published reports have shown 
that porphyrins can inhibit the process of heme aggregation in the acidic food vacuole 
of the malaria parasite. Similar to other therapeutics, porphyrin ring structures exhibit 
large π-interfaces which result in strong π-π stacking interactions to form heme-
porphyrin complexes. Furthermore, they stand out in their ability to act as a general 
scaffold to which a variety of functionalities can be attached to optimize their potential 
therapeutic capability. As a result, several porphyrins have been studied for their use in 
heme aggregation inhibition.  
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Protoporphyrin (PPIX) and hematoporphyrin (HPPIX) have both been shown to 
inhibit in vitro aggregation of hemazoin in the studies by Basilico and coworkers 
(Figure 43).11a Protoporphyrin was able to inhibit aggregation via formation of a 3: 1 
ratio of PPIX: heme adduct, in a way similar to inhibition activity of chloroquine. 
Interestingly, hematoporphyrin bearing the two α-hydroxy ethyl side chains showed six 
times greater anti-aggregation activity via formation of a 0.5: 1 ratio of HPPIX: heme 
adduct. Similar to the hydroxyxanthone based anti-malarial drugs, this study indicated 
that the mode of inhibition of HPPIX is through π-π adducts and that enhanced activity 
results from hydroxyl group involvement in either heme iron binding or propionate-OH 
interactions. 
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Figure 43:  Protoporphyrin IX and Hematoporphyrin. 
 
In another study, Cole and coworkers demonstrated the significance of the 
central metal ion in metalloporphyrin-based inhibition of hemazoin aggregation using 
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an in vitro assay of various metallated protoporphyrins. The most effective inhibitors 
corresponded to metals with the most rapid water exchange rates in its octahedral aqua 
complex. Metal complexes of protoporphyrin IXs, including  Fe(III), Cr(III), Co(III), 
Cu(II), Mn(III), Mg(II), Zn(II), and Sn(IV), were studied. Among them, Mg(II), Zn(II), 
and Sn(IV) had activities six times more efficacious than the free ligand PPIX and four 
times as effectual as the chloroquine control.11b The results suggest that high oxidation 
state metalloporphyrins are still capable of forming complexes with heme through the 
Fe-propionate linkages, while being effective aggregation inhibitors. It was noted that 
metalloporphyrins may hinder other stabilizing interactions, such as the hydrogen 
bonding, which lead to the formation of hemazoin. Furthermore, it was observed that 
the more soluble metalloporphyrins maintained higher concentrations in vitro and 
increased the potential for interacting with the solublized heme to prevent hemazoin 
formation.  
Several other porphyrins and metalloporphyrins have also been studied by 
Wataya and coworkers for hematin inhibition. They include free base protoporphyrin, 
deuteroporphyrin, and hematoporphyrin, and their corresponding complexes with 
Ga(III), Ag(III), Zn(II), Pd(II), Co(III), Mn(III), Sn(IV), Cr(III), Fe(II), and Fe(III) ions 
(Table 58).11 Once again, Sn(IV)(PPIX) at 15.5 μM is shown to have increased efficacy 
over the chloroquine control. To a lesser extent, both Ga(III)(PPIX) and Ga(III)(DPIX) 
showed increased efficacy as well. 
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Table 58: IC50 Values of Protoporphyrin, Deuteroporphyrin, and Hematoporphyrin. 
N HN
NNH
HOOC COOH
N N
NN
M
HOOC COOH
Protoporphyrin IX                Metalloporphyrin IX
N N
NN
HOOC COOH
HO
OH
OH
HOGa
N N
NN
HOOC COOH
HO
OH
Ga
Gallium deuterotoporphyrin IX   Gallium Hematoporphyrin IX 
Compounds IC50 Value (μM) 
Ga PPIX 23 ± 9.6 
Ga PPIX Na2 Not tested 
Ag PPIX > 1,000 
Pd PPIX > 1,000 
Co PPIX 230 ± 53 
Mn PPIX 150 ±14.4 
Sn PPIX 6.5 ±3.6 
Cr PPIX 320 ±40 
Ga DPIX 78 ±45 
Ga HPPIX 118 ±59 
Chloroquine 85 ± 20 
 
 
Rodriguez and coworkers tested Mn(II) complexes of alkylated 
tetraphenylporphyrin with a fluorinated artemisinin derivative (Figure 44). Significant 
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antimalarial activity was demonstrated with an IC50 of 2.6 nM. This is a two-fold 
improvement over the potent anti-malarial β-artemether (Figure 45). This Mn(II) 
complex of alkylated tetraphenylporphyrin 170 was also shown to protect mice from 
infection in vivo.12 
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Figure 44: Mn(II) Complex of Tetraphenylporphyrin Alkylated with Fluorinated 
Artemisinin. 
 
Fe(II) and Mn(II) complexes of meso-tetrakis(4-sulfonatophenyl)porphyrins 
(TPPS) (Figure 7) and meso-tetrakis(3,5-disulfonatomesityl)porphyrins (TMPS) were 
shown to have a positive synergistic effect on the in vitro antimalarial activity of β-
artemether. While neither Mn(TPPS) nor Mn(TMPS) had signifigant activity, 
synergistically they increased the efficacy of β-artemether. The synergistic effect was 
found to be a factor of 3.5 times more effective after 32 h of incubation and 5.5 times 
more after 72 h of incubation. This activity was then demonstrated in vivo on mice with 
Mn(TPPS) (2, 10, and 20 mg/kg/day) and artemisinin (1 mg/kg/day) again showing the 
synergistic effect and protecting the mice from parasitemia (46% mean value) and death 
(100%, no fatalities) as compared to a control group where 32 out of 33 mice died 
between days 5-14.13 
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Figure 45: Mn(TPPS) and Endoperoxide Antimalarial Drug Derivatives. 
 
Although these studies have demonstrated that porphyrins are effective agents 
for inhibiting aggregation, they have been limited to only a few porphyrin derivatives. 
The extent of the variety of porphyrins tested for hematin inhibition are limited to free 
base protoporphyrin, deuteroporphyrin, hematoporphyrin, and their corresponding 
metalloporphyrins, as well as the four substituted metallated tetraphenylporphyrin 
examples mentioned above. While the variety of metals was broad enough to reveal the 
trend noted above, the porphyrin platform itself has been insufficiently explored. 
Synthesis of a series of porphyrin analogs for the development of structure-activity 
relationships is typically quite difficult; however, the new synthetic methodologies 
developed in the Zhang lab over the past several years have made this task considerably 
more efficient. 
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Anti-malarial Porphyrin Project 
Aims  
The aim was to design and synthesize relatively inexpensive, biologically 
soluble, functionalized porphyrins that provide high anti-malarial activity based on 
knowledge from two approaches: (1) previously reported results in literature, and (2) 
initial screenings to provide a structure activity relationship regarding choice of metal 
ions and peripheral functional groups (Zhang Lab). Then, identify synthetic targets with 
desirable solubility, sterics, electronics, and metal center for optimal anti-malarial 
therapeutic activity and synthesize these target compounds for screening. Finally, assess 
the in vitro biological activity of synthesized porphyrins against Plasmodium 
falciparum, the parasite responsible for the most harmful strains of malaria (Kyle Lab).  
 
Porphyrin Synthesis 
It has been well documented that the physical, chemical, and biological 
properties of porphyrins and metalloporphyrins can be fine tuned or dramatically 
altered through the use of different peripheral substituents having a variety of electronic 
and steric properties. However, porphyrins are typically made through the 
tetramerization of aldehydes and pyrrole or the condensation of aldehydes with 
dipyrrolic intermediates under acidic and oxidative conditions. These harsh conditions 
and the inherent unfavorable entropy typically result in low yields, tedious 
purifications, and very poor functional group tolerance.14, 15 These standard synthetic 
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procedures restrain the efficient preparation of functionalized porphyrins with sensitive 
groups (Scheme 63).  
 
Scheme 63: Porphyrin synthesis  
 
  
 
 
 
 
In recent years, the Zhang group has developed powerful synthetic 
methodologies that allow for the efficient production of porphyrins with a variety of 
functionalities that can be developed into potential drugs for the treatment of malaria. 
Brominated porphyrin synthons can be readily prepared in high yields from a variety of 
precursors.16 Mono- and di-brominated aryl groups can be efficiently incorporated into 
the porphyrins in high yield using the methods above. Alternately, meso- and beta- 
brominated porphyrins can be readily made using NBS (N-bromosuccinimide) and a 
radical initiator to selectively brominate diaryl or tetraaryl porphyrins in high yield.  
These bromoporphyrin synthons can then be functionalized using transition 
metal-mediated cross-coupling reactions, which allow for the efficient synthesis of a 
large number of derivatives from a single halogenated porphyrin precursor. These metal 
catalyzed reactions of aryl halides and triflates with soft, non-organometallic 
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nucleophiles have emerged as an efficient process to produce a variety of carbon-
heteroatom bonds. Applying this methodology, brominated porphyrins have been 
demonstrated as general synthons for the efficient coupling of a wide range of amines, 
amides, alcohols, and thiols through palladium-catalyzed carbon-heteroatom bond 
formation reactions under mild conditions as done in Chapter 1 (Scheme 64).14 
 
Scheme 64: Proposed coupling to create fused-antimalarials 
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This approach is practical and has several desirable attributes: (1) 
bromoporphyrin synthons are stable and easily synthesized from bromoaldehydes or 
through selective bromination; (2) the number and position of the bromine atoms can be 
adjusted which allows for different symmetries; (3) the palladium cross-coupling 
conditions are mild, high yielding, and reliable; (4) the diverse electronic and steric 
environments are easily manipulated through cross-coupling with a variety of functional 
groups; and (5) the antimalarial drugs with chiral functional groups can be readily 
coupled to a porphyrin in different positions with other auxiliary aryl groups that may 
improve the drug’s activity and solubility. 
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Of the strategies available, the most straightforward synthesis is the connection 
of a drug with an amine or an alcohol moiety to a bromoporphyrin synthon via 
palladium catalyzed cross-coupling. Hydroxychloroquine has a pendant alcohol on the 
side of chloroquine that is minimally affected by substitution making it a prime 
candidate for attachment. Hydroxychloroquine is also known for having minimal side 
effects, wide availability, being inexpensive. It is also commonly prescribed for Lupis 
and rhumitoid arthritis. 
Indeed, hydroxychloroquine can be attached in good yield to 2 using palladium 
cross-coupling to afford the coupled product (Por-HCQ) 172 in 55% yield. Additional 
metalation steps to make metalloporphyrin derivatives was stymied until results of the 
free-base porphyrin returned from biological testing, therefore only the zinc derivative 
was made. Unfortunately, the year grant was up before additional compounds could be 
made and tested. The synthesis is outlined in Scheme 65 and the details are described 
below. 
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Scheme 65: Attachment of hydroxychloroquine to a porphyrin using palladium-
catalyzed cross-coupling  
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10-hydroxychloroquine-5,15-diphenylporphyrin (Por-HCQ)  172. The 5-
bromo-10,20-diphenylporphyrin 2 (0.25 mmol), hydroxychloroquine (0.45 mmol), 
Pd2(dba)3 (0.005 mmol), DPEphos (0.025 mmol), and Cs2CO3 (0.2 mmol) were 
weighed in air and placed in an oven-dried, resealable Schlenk tube. The tube was 
capped with a Teflon screwcap, evacuated, and backfilled with nitrogen. The screwcap 
was replaced with a rubber septum, and 5 ml toluene was added via syringe. The tube 
was purged with nitrogen for 2 min, and then the septum was replaced with the Teflon 
screwcap. The tube was sealed, and its contents were heated to 100 °C with stirring for 
48 hours. The resulting mixture was cooled to room temperature, taken up in ethyl 
acetate and concentrated in vacuo. The crude product was then purified by flash 
chromatography. The title compound was isolated by flash chromatography [silica gel, 
methylene chloride: hexanes (v/v) = 8:2] as a purple solid (55%). 1H NMR (400 MHz, 
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CDCl3): δ 10.04 (s, 1H), 9.66 (s, 2H), 9.23 (s, 2H), 8.97 (s, 2H), 8.91 (s, 2H), 8.22 (s, 
5H), 7.78 (s, 6H), 7.69 (s, 1H), 7.30 (d, J = 8.4 Hz, 1H), 6.68 (d, J = 8.4 Hz, 1H), 6.23 
(s, 1H), 5.04 (m, 3H), 5.04 (m, 3H), 3.64-0.88 (m, 19H), -2.80 (s, 2H). 13C NMR (100 
MHz, CDCl3): δ 151.3, 149.4, 146.8, 142.4, 141.69, 139.0, 134.9, 131.8, 131.6, 130.4, 
128.0, 127.5, 127.2, 125.1, 121.0, 119.7, 117.0, 1040, 99.2, 83.4, 54.6, 54.3, 49.0, 48.7, 
34.8, 29.9, 24.6, 20.5, 12.2. 
 
Anti-malarial Screening  
Dr. Kyle, a widely recognized malaria researcher, and Co-workers screened the 
synthesized porphyrins for heme aggregation inhibition using his lab’s well established 
models in vitro. Porphyrins were selected and prepared in order for Dr. Kyle’s group to 
assess inhibition results with their assay as well as the solubility and biotransportability 
of each porphyrin. The in vitro effects were evaluated using TM91C235 cell lines at 
different concentrations. Through the use of the colorimetric tetrazolium compound in 
Promega’s CellTiter96 AQ One Solution Cell Proliferation Assay and further analysis 
of blood smears on slides the toxicity of the synthesized porphyrins was assessed. IC50 
values corresponding to the 50% inhibition concentration and IC90 values corresponding 
to the 90% inhibition concentration were determined for these compounds with respect 
to their anti-malarial capacity.  
The results generated for meso-hydroxylchloroquine diphenylporphyrin are 
shown below in Table 59. The targeted parasitic line W2 has known resistance to 
chloroquine and the TM90C2B line is resistant to both chloroquine and atovaquone. 
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The Por-HCQ 172 had several fold lower activity than the drugs that the parasitic lines 
had already developed resistance, therefore, the porphyrin used did not appear to act as 
a resistance reversal agent for the drug chloroquine. 
 
Table 59: Anti-Malarial Activity of Meso-HydroxylchloroquineDPP, Cloroquine, 
Atovaquone, and Dihydroartemisinin on W2 and TM90C2B Drug Resistant Parasitic 
Lines. 
 
     Synonym   Target     IC50      IC90     [Start]   Units    R2 
              
Por-HCQ W2 1203.6104 1994.5005 2500 ng/ml 0.982 
Por-HCQ TM90C2B 1077.3767 3075.8985 2500 ng/ml 0.974 
              
chloroquine  W2 38.8583 146.3694 625 ng/ml 0.969 
chloroquine TM90C2B 39.3892 120.2603 625 ng/ml 0.946 
              
atovaquone  W2 0.1545 0.3406 62.5 ng/ml 0.972 
atovaquone  TM90C2B >62.5000    62.5 ng/ml   
              
dihydroartemisinin W2 0.1843 0.6359 62.5 ng/ml 0.985 
dihydroartemisinin TM90C2B 0.2635 1.1510  62.5 ng/ml 0.955 
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1H-NMR (400 MHz) 10-hydroxychloroquine-5,15-diphenylporphyrin (172) 
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13C-NMR (100 MHz) 10-hydroxychloroquine-5,15-diphenylporphyrin (172) 
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Conclusions 
It was anticipated that novel porphyrins would be identified as important leads 
to provide momentum for further exploration. Unfortunately, the initial results caused 
some to consider only the negative results and not really see the potential that the 
project holds. Literature demonstrates the importance of the metal, so without 
attempting to determine the efficacy using a gallium or tin metalloporphyrins it is hard 
to disregard the proposal altogether. There is still a definite need and much room for the 
development of effective new antimalarial compounds for use against chloroquine 
resistant strains of Plasmodium falciparum. 
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Ferrochelatase 
Introduction 
Ferrochelatase, the only known human metal chelatase, is responsible for 
production of heme, which plays a critical role in diverse biological processes. The 
intractable chemistries of the natural substrates (protoporphyrin IX and Fe2+) have 
hindered the development of reliable methods for routine acquisition of robust and 
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unambiguous kinetic data, and thus elucidation of the ferrochelatase reaction 
mechanism. The goal of this collaboration was the assembly of a collection of new 
porphyrins that will permit the characterization of the reaction mechanism of the 
enzyme.  
Ferrochelatase catalyzes the terminal step of heme biosynthesis, the chelation of 
ferrous iron into protoporphyrin IX, and thus links iron and porphyrin metabolisms. 
Mutations in the ferrochelatase gene can cause erythropoietic protoporphyria (EPP), an 
inherited disorder which is presently without cure, characterized by protoporphyrin IX 
accumulation and acute photosensitivity. Porphyrin accumulation is also observed in 
acute myeloid leukemia and other types of cancer. In addition, the absence of all heme 
biosynthetic enzymes, or of all except ferrochelatase, in parasitic nematodes, helminths, 
and trypanosomatid protozoa Leishmania spp. makes the understanding of the 
mechanism of this enzyme critical in developing future solutions to control infections 
that afflict more than two billion people. 
Previous attempts to elucidate information regarding the reaction mechanism 
have been limited to commercially available porphyrins and metalloporphyrins. The 
ability of the Zhang group to synthesize a large and diverse assortment of porphyrin and 
corrole scaffolds is unique and provides exciting speculations of the mechanistic 
consequences. Through the integration of these two disciplines, we desired to define the 
mechanism of the mammalian ferrochelatase-catalyzed reaction through the assessment 
of enzyme-induced porphyrin distortion, deprotonation, metallation, and catalysis. 
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The interplay between porphyrin substrate, porphyrin non-planarity, and 
ferrochelatase catalysis was assessed using the synthesized porphyrins as substrate 
analogs. The aims were to answer the following questions regarding the enzyme 
reaction mechanism: 1) What is the mechanistic basis for the differential preference of 
the divalent metal ion and porphyrin substrates?; 2) Does the degree of distortion of the 
porphyrin substrate affect the reaction rate of ferrochelatase?; 3) Does ferrochelatase 
control the rate of the deprotonation of the porphyrin macrocycle?; 4) Can the chemical 
step be the rate-limiting step of the ferrochelatase-catalyzed reaction?  
 
Background 
Porphyrins, Heme, and Ferrochelatase  
Heme, an iron-containing porphyrin, plays a critical role in diverse biological 
processes, including oxygen transport, binding and sensing of diatomic molecules, 
electron transfer, extracellular signaling, regulation of transcription and translation, 
miRNA processing, xenobiotic detoxification and catalysis.1-3 Heme is synthesized in a 
multi-step biosynthetic pathway, which culminates with the insertion of ferrous iron 
(Fe2+) into protoporphyrin IX by ferrochelatase (protoheme ferrolyase, E.C. 4.99.1.1) 
(Figure 46).4-5 With a few exceptions, the heme biosynthetic enzymes are evolutionarily 
conserved,3 and even parasitic nematodes, helminths, and trypanosomatid protozoa such 
as Leishmania spp., which lack some or all of the heme biosynthetic enzymes, 
compensate for this deficiency by ingesting heme or its precursor, protoporphyrin IX.3 
Curiously, Leishmania spp. retained ferrochelatase, while losing the other seven 
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enzymes.3 Indeed, exploring the subtleties of metabolic pathways, specifically the heme 
biosynthetic pathway, becomes an attractive option as future drugs targets to control 
helminthic infections, which afflict more than two billion people.3  
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Figure 46: Diagram of heme biosynthesis in mammalian cells. Heme is synthesized via 
an enzymatic eight-step pathway in the mitochondrion and the cytosol. 
 
Mutations in the human ferrochelatase gene yield defective enzymes of 
decreased activity and, consequently, lead to an accumulation of free protoporphyrin, 
predominantly in erythrocytes.6  These features are the hallmarks of the inherited blood 
disorder, erythropoietic protoporphyria. In fact, many disease states (e.g., inherited or 
acquired porphyrias, anemias, leukemias and hepatocellular carcinomas) are 
characterized by porphyrin overproduction, due to defective heme biosynthesis.   
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Ferrochelatase Structure vs. Porphyrin Binding 
The X-ray crystallographic structures of ferrochelatase from Bacillus subtilis,7 
Saccharomyces cerevisiae,8 and man,9 reveal a conserved overall fold (Figure 47).  
Each molecule contains two similar Rossmann-type domains delimiting the porphyrin-
binding cleft and active site, which is rich in conserved residues proposed to be 
important for catalysis.7-10 A π−helix, considered an uncommon structural element, is 
conserved among ferrochelatases and is located approximately 10 Å from the active site 
(Figure 47).7-11 Acidic residues align along the helical edge of the π-helix, forming a 
channel that connects the interior of the active site to the protein exterior. This 
alignment within an π-helix permits the retention of an acidic residue at every fourth 
position, which may function to coordinate divalent metal ions.12-13  
 
 
Figure 47: Porphyrin-binding site in ferrochelatase.   
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Porphyrin Distortion, Metal Ion Binding, and Shuttling vs. Reaction Mechanism 
With the determination of the crystallographic structures, two possibly 
interacting metal ion-binding sites were clearly identified: one located on the surface of 
the molecule and the other, 7 Å apart, in the porphyrin-binding cleft close to the 
distorted porphyrin ring.12 In fact, the nitrogen of this ring was directed towards the 
invariant H183 and E264 residues (B. subtilis numbering), previously postulated to be 
Fe2+ substrate ligands.12  Al-Karadaghi and co-workers proposed that the metal ion, by 
coordinating with acidic residues arranged along the helical edge of a π-helix, would be 
shuttled from the site at the surface to the inner substrate binding site (Figure 48).12  
The structure of B. subtilis ferrochelatase complexed with N-methyl meso-
porphyrin is shown in Figure 47. The structure is composed of two Rossmann-type 
domains (lower left and lower right), which define a cleft accommodating the 
porphyrin- and metal-binding sites.  N-Methyl Mesoporphyrin is shown within the cleft 
(carbon atoms). The metal ion is proposed to bind initially at the outer site (occupied 
with Mg2+) and translocate through the π-helix until it reaches the inner site occupied 
here by Zn2+.  The distance between the metals is ~7 Å.  The side chains of the acidic 
residues are aligned along the π-helix, at a line connecting the two metal sites. 
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Figure 48: Inner and outer metal ion-binding sites in B. subtilis ferrochelatase.   
 
Similar to several other proteins in which π-helix residues function to coordinate 
metal ions required for enzymatic activity,13  in ferrochelatase the residues along the π-
helix appear to form a channel that connects the interior of the active site to the protein 
exterior. Al-Karadaghi et al. further advanced the hypothesis that Fe2+ channeling 
through the π-helix would require an exchange of ligands, initially between the solvent 
to which the metal is coordinated and the π-helix acidic residues and ultimately 
between the protein ligands and the pyrrole nitrogens, thereby culminating in the metal 
ion insertion into the porphyrin macrocycle.12 However, Dailey and co-workers 
proposed that the π-helix has a central role in “product release” due to its 
conformational change during the catalytic cycle.  
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The ferrochelatase-catalyzed reaction involves binding of the metal ion and 
porphyrin substrates to the enzyme, distortion of the porphyrin ring, and metal ligand 
exchange with the release of the heme product.4 The enzyme distorts the bound 
porphyrin and stabilizes it in its transition state form, facilitating the exposure of the 
two lone pairs of electrons on opposite pyrrole nitrogens to the incoming metal ion 
(Figure 49).4  Once metal-porphyrin coordination occurs, it is followed by ligand-
exchange to form the ‘sitting-atop’ complex (ii); and the sequential deprotonation of the 
two pyrrole nitrogen atoms to form the metallated porphyrin (iii).  
 
 
Figure 49: Reaction mechanism of porphyrin metallation. (a) Out-of-plane saddling 
deformation (b) Reaction mechanism. 
 
The notion of ferrochelatase-induced porphyrin distortion has received support 
from both experimental and theoretical studies.10-11 Using molecular mechanics 
calculations, distortion of porphyrin by ferrochelatase was shown to be energetically 
feasible. Theoretical analyses also suggested additional functions of the porphyrin 
deformation. In particular, a pKa decrease of the two protonated pyrrole rings should 
allow easy deprotonation of the pyrrole rings to promote reaction progress.  
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Further, product release may be facilitated, as metalloporphyrins are harder to distort 
than the free-base porphyrin, and thus they have lower affinity for the active site.  
 
Interplay between Porphyrin, Ferrochelatase, and the Enzyme Reaction Mechanism 
Ferrochelatase is the only chelatase present in humans, albeit other members of 
the chelatase family are responsible for the incorporation of other divalent metal ions 
(i.e., Co2+, Mg2+ and Ni2+) to yield metallated tetrapyrroles, such as cobalamin, 
chlorophyll, bacteriochlorophyll, and coenzyme F430. Thus, understanding how 
substrate specificity arises and how porphyrin distortion, deprotonation, and metallation 
occur in the ferrrochelatase-catalyzed reaction will also greatly contribute to the 
elucidation of the poorly described reaction mechanisms of the entire chelatase family. 
Moreover, it will open the door to interpret the function of ferrochelatase in the normal 
and disease states associated with protoporphyrin accumulation and porphyrin 
metallation by metal ions rather than Fe2+ (e.g., zinc protoporphyrin formation instead 
of heme). 
In non-enzymatic porphyrin metallation, deformation of the porphyrin nucleus 
has been recognized to generate a conformation with enhanced coordinating ability of 
the lone pairs, as they would point away from the center of the macrocycle, and 
increased apparent acidity of the protons due to the elimination of the N-H tautomerism.  
While ferrochelatase-induced distortion of porphyrin substrate has been accepted as a 
critical step in the enzymatic reaction4  and the catalytic efficiency of ferrochelatase 
toward protoporphyrin has been demonstrated to correlate with the degree of porphyrin 
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saddling deformation, a complete examination of the ferrochelatase reaction 
mechanism, including the determination of the microscopic reaction rates and relevance 
of porphyrin distortion to these rates, remains to be achieved. 
Based on structural, kinetic and time-resolved crystallographic studies, it has 
been hypothesized that the ferrochelatase-induced distortion of porphyrin substrate not 
only enhances the reaction rate, by decreasing the activation energy of the reaction, but 
also modulates which divalent metal ion is incorporated into the porphyrin ring. Thus, 
the extent and type of porphyrin distortion in chelatase-catalyzed reactions would 
represent an important dimension to the functional value of porphyrin deformation. 
A major setback in defining the reaction mechanism for ferrochelatase has been 
the difficulty in establishing reliable, reproducible reaction conditions for two main 
reasons: 1) porphyrin substrate is highly hydrophobic and aggregates in aqueous 
solutions and 2) ferrous iron oxidizes rapidly in aqueous solutions, particularly at 
neutral to basic pH. The problems associated with the intractable chemistries of the 
natural substrates have, to a certain extent, been circumvented. Porphyrin solubility in 
aqueous solutions can be improved by the addition of detergents to the assay buffer, but 
use of the alternative substrates deuteroporphyrin IX and mesoporphyrin, which are 
both more water soluble and substantially better substrates in vitro, is common. The 
oxidation of ferrous iron to the ferric form, which is not a substrate for ferrochelatase, 
can be reduced by inclusion of complexing agents such as β-mercaptoethanol or 
buffers, but the use of complexing agents casts doubt on the kinetic data collected under 
these conditions due to the likelihood that ferrochelatase reacts differently with the 
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complexed and uncomplexed metal ion pools. Consequently, the more stable alternative 
substrate zinc is often utilized to assess ferrochelatase activity.  
Therefore, the design and implementation of a research strategy that will 
contribute significantly to the understanding of ferrochelatase has to adequately 
acknowledge and address the issues outlined above. Experimental conditions have been 
defined that allow for the use of Fe2+ without the addition of reducing agents and, 
recently, an optimal set of conditions has been defined that allows for the direct 
comparison of the naturally occurring substrates to alternative metal ion substrates.   
Conceivably, the ferrochelatase-induced distortion of the porphyrin substrate 
controls the deprotonation and the divalent metal ion incorporated into the porphyrin 
macrocycle.  Therefore, it is hypothesized that the use of various porphyrins as 
substrates could be used to test for porphyrin distortion, deprotonation, metallation and 
catalysis. 
 
Preliminary Studies 
In order to monitor the binding of porphyrin substrates to ferrochelatase and to 
evaluate the extent of distortion the tetrapyrrole macrocyle undergoes during the 
ferrochelatase-catalyzed reaction, the resonance Raman (RR) spectral changes 
associated with the binding of several porphyrins (i.e., protoporphyrin (H2(ProtoP)), 
Ni(II)-protoporphyrin and hemin) to murine ferrochelatase were examined under 
conditions which amplify the RR spectra of the porphyrin bound specifically to the 
protein. Of relevance, the RR spectra of porphyrin-protein complexes revealed a 
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saddling distortion of the porphyrin. Compelling evidence for distortion comes from 
analysis of the low frequency region of the RR spectra. Upon protein binding, the γ15 
mode appears at 699 cm-1 as the H2(ProtoP)/protein ratio decreases (Figure 50). γ15 is a 
B2u-symmetry (saddling-like) mode, and its appearance at 699 cm-1 in the spectra of 
ferrochelatase-bound protoporphyrin immediately suggests that a saddling deformation 
occurs upon binding. 
 
 
Figure 50: Resonance Raman (RR) spectra in the low frequency region for 
protoporphyrin IX in buffer (a) and bound to wild-type ferrochelatase; (b) and to 
porphyrin-loop variants (c)-(g) after incubation with a 0.1 molar ratio of the porphyrin 
to protein; (c) K250M/V251L/W256Y triple mutant; (d) P255R single mutant; (e) 
P255G single mutant; (f) S249A/K250Q/V251C triple mutant; (f) 
Q248P/S249G/K250P/G252W quadruple mutant].  Note the sharpening and up-shift of 
ν7 and the decrease of γ15 intensity upon protein binding. 
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Using resonance Raman spectroscopy, the degree of distortion endured by the 
bound porphyrin macrocycle in relation to the enzymatic activity (i.e., steady-state 
kinetic parameters) of selected, active site ferrochelatase variants can be assesed. The 
degree of specific porphyrin non-planarity correlates with the catalytic efficiency of the 
ferrochelatase variants. In particular, the low frequency RR spectra indicated that the 
W256Y-containing variant, which exhibited a catalytic efficiency (for protoporphyrin) 
one-tenth that of the wild-type, gave less than 30% of the porphyrin saddling-distortion 
induced by wild-type protein.  
Recently the Ferreira group established experimental conditions that allow us to 
directly compare the naturally occurring substrates to alternatives. Divalent zinc, cobalt, 
nickel, and copper are each good substrates for both yeast and murine ferrochelatases, 
but are subject to strong substrate inhibition with inhibitory constants in the low 
micromolar range. Remarkably, substrate inhibition was not observed with ferrous iron 
at concentrations of up to 100 μM. The presence of a selective inhibitory metal ion 
binding site may be one means whereby metal ion substrate specificity is enhanced in 
vivo. Inclusion of complexing agents in the reaction buffer increases activity with 
alternative metal ion substrates through competition with the inhibitory binding site.  
For instance, 3 mM imidazole increases the rate of reaction with copper by over two 
orders of magnitude. A variety of alternative porphyrin substrates are required to 
perform studies similar to those carried out with different divalent metal ions and to 
allow us to define the reaction mechanism of ferrochelatase. 
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Scientific Approach 
Chemist 
Porphyrins are extremely versatile substrates and allow for modification 
through many different modes. From the statistical choice of pyrrole and aldehyde to 
the selective functionalizations possible post-construction, the porphyrin platform has 
many opportunities for tailoring towards a specific need. The porphyrin periphery can 
be adjusted to create protoporphyrin IX, or heme, although it is often easier to mimic, 
in a more general nature, the groups as they occur in space and create analogs of the 
initial heme substrate. The addition of polar groups to the framework, such as 
hydroxyl, amino, carboxylate, and amido groups to name a few, can aid in 
solubilizing these large aromatic rings in buffer systems created to simulate biological 
systems. Strained porphyrins which are forced to have various degrees of non-
planarity are possible as well through either methylating a pyrrolic nitrogen or adding 
bulky substituents around the periphery that will sterically interfere with each other’s 
space to create ruffled or saddled substrates that can act as transition state analogs. 
It has been well documented that the physical, chemical, and biological 
properties of porphyrins and metalloporphyrins can be fine tuned or dramatically 
altered through the use of different peripheral substituents having a variety of electronic 
and steric properties. However, porphyrins are typically made through the 
tetramerization of aldehydes and pyrrole or the condensation of aldehydes with 
dipyrrolic intermediates under acidic and oxidative conditions. These harsh conditions 
and the inherent unfavorable entropy typically result in low yields, tedious 
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purifications, and very poor functional group tolerance.  The use of these standard 
synthetic procedures restrains the efficient preparation of functionalized porphyrins 
with sensitive groups. 
In recent years, the Zhang group has developed powerful synthetic 
methodologies that allow for the efficient production of porphyrins with a variety of 
functionalities. Brominated porphyrin synthons can be readily prepared in high yields 
from a variety of precursors.  Mono- and di-brominated aryl groups can be efficiently 
incorporated into the porphyrins in high yields. Alternately, meso- and beta- brominated 
porphyrins can be readily made using NBS (N-bromosuccinimide) and a radical 
initiator to selectively brominate the meso- and beta-positions of porphyrins in high 
yields. 
These bromoporphyrin synthons can then be functionalized using transition 
metal-mediated cross-coupling reactions, which allow for the efficient synthesis of a 
large number of derivatives from a single halogenated porphyrin precursor.  These 
metal catalyzed reactions of aryl halides and triflates with soft, non-organometallic 
nucleophiles have emerged as an efficient process to produce a variety of carbon-
heteroatom bonds. Applying this methodology, brominated porphyrins have been 
demonstrated as general synthons for the efficient coupling of a wide range of amines, 
amides, alcohols, and thiols through palladium-catalyzed carbon-heteroatom bond 
formation reactions under mild conditions (Scheme 66). Additionally, aromatic 
nucleophilic substitution can be used to replace the bromines. 
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This approach is practical and has several desirable attributes: (1) 
bromoporphyrin synthons are stable and easily synthesized from bromoaldehydes or 
through selective bromination; (2) the number and position of the bromine atoms can be 
adjusted, allowing for different symmetries; (3) the palladium cross-coupling conditions 
are mild, high yielding, and reliable; (4) the diverse electronic and steric environments 
are easily manipulated through cross-coupling with a variety of functional groups; and 
(5) drugs with chiral functional groups can be readily coupled to a porphyrin in 
different positions with other auxiliary aryl groups that may improve the drug’s activity 
and solubility.  
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Scheme 66: Various porphyrin-heteroatom bonds are possible through palladium-
catalyzed cross couplings with amines, amides, alcohols, and thiols 
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The porphyrin periphery can be adjusted to create protoporphyrin IX, or heme, 
although it is often easier to mimic, in a more general nature, the groups as they occur 
in space and create analogs of the initial heme substrate. The porphyrin platform has 
many opportunities for tailoring towards specific needs. The statistical choice of 
pyrroles and aldehydes, the incorporation of new pyrroles and aldehydes recently 
made available, and the selective functionalizations made possible for post-ring 
construction can be utilized together to produce a broad variety of heme mimics. 
Therefore, structure-activity relationships, including solubility trends; sterically 
hindered substituents; effects of halogen, amino, amido, alkoxy, carboxyl, sulfonato, 
and hydroxyl group functionalities as well as the number and position of those groups 
could be explored.  
 
Biologist  
Murine ferrochelatase (wild-type enzyme) and directly evolved variants of 
ferrochelatase, already isolated in the Ferreira lab, with distinct metal ion selectivity and 
enzymatic activity from those of ferrochelatase, were used. These variants exhibit 
enhanced enzymatic activities towards other metal ions than Fe2+. The variants are: 
R61L, which preferentially uses Cu2+ (with an enhancement of greater than 30-fold in 
specific activity over that of wild-type ferrochelatase), does not accept Co2+ and Zn2+ as 
substrates and is inhibited by Ni2+ at concentrations greater than 1 μM; F283L, which 
uses both Co2+ and Zn2+ as substrates (with enhancements of greater than 15- and 25-
fold in Co-chelatase and Zn-chelatase activities, respectively, over those of wild-type 
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ferrochelatase) and it does not recognize either Ni2+ or Cu2+ as substrates; 
S143T/F323L, which selects Ni2+ over the other tested divalent metal ions and exhibits 
an increase of 10-fold in Ni-chelatase activity when compared to the wild-type 
ferrochelatase. Since the S143T/F323L variant harbors 2 mutations, S143T and F323L 
variants will also be examined, as they both display enhanced Ni-chelatase activity, 
independently.   
Upon preparation of stock solutions of the different porphyrins, their solubility in 
the reaction buffer, and properties either as substrate or inhibitor of ferrochelatase will be 
tested by monitoring ferrochelatase activity. Using a 96- or 384-microplate platform and 
robotic liquid handling, porphyrins will be tested as inhibitors by assaying ferrochelatase 
activity, with Fe2+ and protoporphrin IX as substrates, in the presence of each of the 
porphyrins and determining the degree of inhibition in relation to the activity results 
obtained in the absence of the respective porphyrin. To determine if any of the synthesized 
porphyrins functions as an alternate substrate, ferrochelatase activity will be determined 
using Fe2+ and the porphyrin in study as substrates and monitoring porphyrin consumption 
at a specific wavelength.  
Resonance Raman (RR) spectroscopy and molecular mechanics calculations will 
be used to evaluate the binding of different porphyrins to wild-type ferrochelatase (or 
evolved variants) and the distortion of the porphyrin macrocyle. 13  
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Results 
In our initial studies, twenty-four porphyrins, selected to maximize variety in 
size, shape, and functionality, were created in the Zhang lab and submitted to the 
Ferreira group to test for ferrochelatase inhibition. Of the porphyrins submitted, 5-
bromo-10,20-diphenylporphyrin stood out by showing inhibition in the μM 
(micromolar) range. It was the smallest of the porphyrins submitted and contained 
bromine in the meso position. As a result of this initial success, the idea developed to 
modify smaller commercially available porphyrins to contain bromines or thiols, such 
as octaethylporphyrin and mesoporphyrin, for their inhibition and potential covalent 
attachment to the active site.    
 
Future Potential 
The addition of polar groups to the framework, such as hydroxyl, amino, 
carboxylate, and amido groups to name a few, will aid in solubilizing these large 
aromatic rings in buffer systems created to simulate biological systems (Figure 51, A1 
& A2). Furthermore, corrole scaffolds, which are porphyrin analogs with one direct 
pyrrolic linkage, have recently been explored in our labs and have similar potential to 
create porphyrin analogs using our established methods (Figure 51, A3).  
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Figure 51: Porphyrins and corroles targeted to improve current: (a) Substrate analogs, 
(b) Transition state analogs. 
 
Strained porphyrins which are forced to have various degrees of non-planarity 
are possible as well through either methylating an internal pyrrolic nitrogen or adding 
bulky substituents around the periphery that will sterically interfere with each other’s 
space to create ruffled or saddled substrates that can act as transition state analogs. N-
methylated porphyrins have been recognized as transition state analogs; however, 
tailoring beta-substituted pyrroles, diethyl or dimethoxy, with either bulky aldehydes 
such as isopropanal or tert-butanal or the addition of similar groups post-construction 
through palladium-catalyzed cross-couplings to produce this effect will broaden the 
variety of analogs currently available (Figure 7, B1 & B2).  
Finally, through the collaboration of biochemists/enzymologists specializing in 
ferrochelatase (Ferreira group) and organic chemists specializing in porphyrin synthesis 
(Zhang group), potential sites of covalent attachment have been mapped using 
molecular modeling techniques and potential porphyrin structures have been surveyed. 
Porphyrins have been identified which would fit within the active site of Bacillus 
subtilis ferrochelatase, as seen in its crystal structure,7 and either inhibit the enzyme 
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through hydrogen bond acceptor interactions or covalently link to it through a disulfide 
bond formation. The unique opportunity to chemically alter a mesoporphyrin or another 
heme mimic to generate substrates that are modified to target specific residues is unique 
and a needed resource for this ferrochelatase investigation (Scheme 67). 
 
Scheme 67: Proposed suicide inhibitor synthesis based on molecular modeling results 
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Virus/Influenza 
Introduction  
According to the Center of Disease Control (CDC), every year 5% to 20% of 
the population gets the flu in the United States.1 Over 200,000 people are hospitalized 
and 36,000 people die from flu-related complications each year.1 Globally, the 
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numbers are staggering. There are 1 billion cases of flu globally, which leads to 3–5 
million cases of severe illness and 300,000–500,000 flu-related deaths annually.1  
 Adamantane-based anti-virals have been used since 1966. Adamantadine 
“Symmetrel” (Figure 52a) and rimantadine “Flumadine” (Figure 52b) are the two 
effective adamantine derivatives.2 Over time, both adamantanes have developed 
resistance to the seasonal flu.2 Two other drugs target the inhibition of influenza 
neuraminidase-to slow the spread of the virus, these include oselttamivir “Tamiflu” 
(Figure 52c) and zanamivir “Relenza” (Figure 52d).2 Although it has been on the 
market since 1999, 99.6% of the seasonal H1N1 flu has developed resistance to 
oselttamivir. The last effective drug available is zanamivir.2 Rapid mutations of viruses 
create new and often drug-resistant strains quickly, therefore it is only a matter of time 
until resistance develops.1-3 
New drugs without developed resistance are needed for high risk populations.1 
Novel templates are preferred so the development of resistance will take longer. It is to 
this end that the Zhang group has sent compounds to Dr. Alberto VanOlphen’s Lab for 
efficacy testing with Dr. Cynthia Bucher.  
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Figure 52: Current influenza therapeutics a) adamantadine “Symmetrel”,  
b) rimantadine “Flumadine”, c) oselttamivir “Tamiflu”, d) zanamivir “Relenza”. 
 
 
Active Porphyrins and Small Molecules 
In 2008, only twelve porphyrins were submitted for testing. It was an excellent 
opportunity to be part of a biological lab, even if only for a week. Cells were plated in 
96 well plates with three rows reserved for controls. Cells were incubated with the 
compounds submitted and were tested for efficacy against H3N2 influenza, nH1N1 
influenza, and Human Herpes Virus 1. The plates were then stained and reviewed for 
cell count. Encouraging results prompted the full screening of all available 
compounds.  
With the assistance of undergraduate Rebecca Burt, one hundred forty four 
porphyrins and small molecules were weighed out, diluted to 1 mg/ml in DMSO and 
submitted in a second round in 2010. Of the compounds tested, a surprising sixteen 
compounds generated further interest and more of these compounds have been 
417 
 
submitted for additional testing. More interesting, is that the compounds that 
demonstrated efficacy fell into both the porphyrin and the small molecule categories 
(Figure 53). 
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Figure 53a: Porphyrins and small molecules as influenza inhibitors. 
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Figure 53b: Porphyrins and small molecules as influenza inhibitors. 
 
Conclusions  
Looking at trends, many of the porphyrins have hydroxyl and methoxy 
moieties: RB-271, RB-270, RB-266, RB-265, RB-254, RB-253, RB-250, RB-249, RB-
247, RB-246. This activity may be partially attributed to the increased solubility in 
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water; however, there are two bromoporphyrins that are highly non-polar as part of the 
compounds of interest as well: RB-243, RB-111. There are two other porphyrins that 
show activity as well with meso-substitutions: RB-27, RB-3. Finally, there are two 
small molecules of interest, more specifically cyclopropane derivatives with two ester 
groups attached. Hopefully, continued collaborations will produce useful drugs out of 
these initial compounds of interest. 
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Cancer 
Introduction  
According to NIH and the American Cancer Society, in the United States alone, 
there were 1,479,350 new cases of cancer in 2009. There were 562,340 people who 
died of cancer as a result of the 13 basic categories, or types, of cancer. There are 
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approximately 400 drugs currently available for chemotherapy cocktails. In addition, 
there are other forms of treatment including radiation and photodynamic therapy 
(PDT). 
Cancer cells have abnormal growth as a result of various cellular mechanisms. 
As a result, no one drug can treat all the different types of cancer effectively. 
Resistance and sensitivity to cancer drugs is common. Cancer drugs target many 
different metabolic pathways that are different in cancerous cells versus healthy cells. 
Unfortunately, some portions of healthy cells are killed as well as the cancerous ones 
leading to drug toxicity and the horrible side effects of most cancer drugs. New drugs 
are desparately needed to reduce toxicity to the host and increase efficacy of cancer 
cell destruction. To this end, several collaborations have been established.  
 
Porphyrin-Based Studies 
German physician Friedrich Meyer–Betz performed the first study with 
porphyrins in humans in 1913. Since then, a variety of porphyrins, chlorophylls, and 
dyes have been used as photosensitizers for use in cancer therapies. The drawback of 
cancer therapies that utilize photosensitizers is that light rarely penetrates more than 
about 1/3 of an inch (1 cm), which makes it impractical for large tumors.  
Typically, porfimer sodium, or Photofrin, is the first porphyrin (or oligiomer of 
porphyrins) that is thought of when porphyrins are mentioned in association with 
cancer (Figure 54). This photodynamic therapy agent has gained worldwide acceptance 
as a photosensitizer with a λmax = 630nm, ɛ = 2 x 103 M-1 cm-1, which corresponds well 
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to red lazer light. It consists of sodium salts of oligiomers of up to eight units of 
protoporphyrin IX connected by ether and ester bridges. 
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Figure 54: Photophyrin an oligiomer of protoporphyrin IX. 
 
Therefore, it is with a bit of irony that a different target brought the first spark 
of interest from a cancer researcher. Dr. Nicholas Lawrence of University of South 
Florida’s Moffitt Cancer Center contacted the Zhang group wanting to confirm the 
Japanese report that simple DPP, diphenylporphyrin 1, was a capable STAT-3 
inhibitor. The referenced paper follows: 
 
Uehara, Y.; Mochizuki, M.; Matsuno, K.; Haino, T.; Asai, A. Biochemical and 
Biophysical Research Communications, 2009, 380(3),627-631.  
 
The STAT-3 protein functions as a signal transducer and activator of 
transcription 3. It is important in cell processes like cell growth and apoptosis. STAT3 
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activation is associated with various human cancers and commonly suggests poor 
prognosis. Therefore, it is important target for determining the efficacy of potential 
drugs as inhibitors. 
Twelve porphyrin samples were given to Dr. Lawrence in 2009. The samples 
consisted of DPP and primarily smaller DPP derivatives in hopes that both the initial 
report could be confirmed and that a DPP derivative might improve its inhibition 
ability. Unfortunately, Dr. Lawrence has not yet replied with results from these studies. 
 
Small Molecule-Based Studies 
Another type of molecule was targeted by Dr. Jianfeng Cai in 2010. After 
reviewing the poster created for the Research One symposium at the University of 
South Florida, which was originally displayed in October of 2008. He chose twelve of 
the larger sulfonamides and phosphoramides generated from our catalytic work for a 
murine double minute (mdm2) study (Figure 55).  
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Figure 55: Compounds sent to Dr. Cai for cancer testing.  
 
The murine double minute (mdm2) oncogene, which codes for the mdm2 
protein, is an important negative regulator of the p53 tumor suppressor. Several human 
tumor types have been shown to have increased levels of mdm2, including soft tissue 
sarcomas and osteosarcomas as well as breast tumors. One of the compounds, RB-326, 
generated a small amount of activity against mdm2. The small molecule identified as 
having activity is shown below in Figure 56. 
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Figure 56: Compound RB-326 has a small amount of activity against mdm2. 
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 National Institutes of Health (NIH) 
The National Institutes of Health (NIH) can mass screen compounds for a 
variety of medicinal applications. On September 15, 2010, a trip was made to Sanford-
Burnham Medical Research Institute to initialize process of compound submission 
with Dr. Pasha Khan of Dr. Roth’s group. Initial positive screening results could 
potentially have a huge impact. Results could lead to both the establishment of 
additional collaborations and demonstrate basis results for grant submissions. 
Undergraduate Nicole Barbara is currently working on locating the first batch of 
compounds requested and preparing the sdf file for submission. 
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